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ABSTRACT 
The work presented herein describes synthetic methodologies leading to the 
design of a wide array of magnesium and calcium based phosphinate and phosphonates 
with possible applications as bone scaffolding materials or additives to bone cements. 
The challenge to the chemistry of the alkaline earth phosphonate target compounds 
includes poor solubility of compounds, and poorly understood details on the control of 
the metal’s coordination environment. Hence, less is known on phosphonate based 
alkaline earth metal organic frameworks as compared to transition metal phosphonates. 
Factors governing the challenges in obtaining crystalline, well-defined magnesium and 
calcium solids lie in the large metal diameters, the absence of energetically available d-
orbital to direct metal geometry, as well as the overall weakness of the metal-ligand 
bonds.  
A significant part of this project was concerned with the development of suitable 
reaction conditions to obtain X-ray quality crystals of the reaction products to allow for 
structural elucidation of the novel compounds. Various methodologies to aid in crystal 
growth including hydrothermal methods and gel crystallization were employed. 
We have used phosphinate and phosphonate ligands with different number of 
phosphorus oxygen atoms as well as diphosphonates with different linker lengths to 
determine their effects on the overall structural features. An interesting correlation is 
observed between the dimensionality of products and the increasing number of donor 
oxygen atoms in the ligands as we progress from phosphinic acid to the phosphorous 
acids. As an example, monophosphinate ligand only yielded one-dimensional 
compounds, whereas the phosphonates crystallize as one and two-dimensional 
compounds, and the di- and triphosphonate based compounds display two or three-
dimensional geometries.  
This thesis provides a selection of calcium and magnesium compounds with one-
dimensional geometry, as represented in a calcium phosphinate to novel two-dimensional 
sheets of magnesium and pillared calcium phosphonates. The preparation of these novel 
compounds has led to the establishment of synthetic protocols that allow for the direct 
preparation of compounds with defined structural features.  
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CHAPTER 1 
Background 
1.1 Introduction 
The study of bone substitute materials is of great research interest to improve on the 
materials and methods that are applied to treat fractured bone and bone related diseases. 
Extensive research led to the discovery of therapeutic potential of the diphosphonate 
drugs,1-3 which have since been developed for clinical applications due to their ability to 
inhibit bone resorption.2 As these drugs have adverse side effects,4 there is a need to 
search for alternative and biocompatible materials to treat bone disorders.  
Various materials have been developed as bone implant however, research has proved 
that the success of an implant is determined by the biomaterial-tissue interface where an 
interfacial bond is established between the implant and the bone.5 Hence the use of 
bioactive and biocompatible materials such as bone cements (calcium phosphate), 
bioceramics (clay) and Bioglass® (consisting of SiO2, Na2O, CaO and P2O5 in specific 
proportions) have been developed for bone treatment. These materials however lack 
mechanical strength, and for this reason, efforts to improve on bone cements have led to 
the development of composite and hybrid biomaterials.6 Another means to overcome the 
weakness in bone cements is the use of scaffold materials. These scaffolding materials 
must be three dimensional and allow for bone in-growth. 
The objective of this project is to explore the use of phosphonate based ligands in the 
synthesis of three-dimensional frameworks that may be developed into scaffolds 
appropriate for bone substitution. The material is preferably bioactive and biocompatible, 
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suggesting it’s use as additives to existing bone cements in order to improve their 
biometric properties. 
 The first three chapters of this thesis will focus on (a) a general introduction of bone 
and its properties, (b) metal-organic frameworks and (c) potential ligand systems used for 
this purpose. The remaining five chapters discuss the results of the studies. 
 This chapter starts with a description of the bone cell structure and function, 
followed by an overview of existing methods and materials, and how these impact bone 
therapy. The chapters conclude with the properties of currently used scaffold materials. 
 
1.2 Bone Cell Structure and Function 
Bone is a rigid, light-weight but strong and hard connective tissue found in 
vertebrates.7 The human skeletal system is a network of bone and cartilage. The bone 
cells are living tissues that are mainly needed for support, motion, production of blood 
cells (hemopoesis), storage of minerals, and protection of sensitive organs such as the 
brain, heart and lungs in the body.7-9 There are three types of bone cells; osteoblasts 
which synthesize the bone matrix and ensure bone mineralization, osteoclasts which are 
responsible for matrix resorption or breakdown in addition to osteocytes, which are 
inactive osteoblasts or mature bone cells.   
Osteocytes are embedded in a matrix material (extra cellular material) which 
contains organic and inorganic materials.8 The bone’s flexibility therefore stems from the 
organic part which is a fibrous protein called collagen that makes up 35% of the bone 
mass. The rest of the bone is inorganic in nature and is made up of mineral salts which 
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afford the bone its compression strength, hardness, and durability.9 The principal mineral 
is amorphous calcium phosphate (PCA) as “nanophosphate rods”,10 along with 4-6% of a 
mixture of calcium carbonate, traces of magnesium phosphate, sodium oxide and sodium 
chloride. Hydroxyapatite (Ca5(PO4)3OH) is therefore a model compound of the inorganic 
component of bone.11 The matrix, mineral and water in the bone are in the percentages of 
60, 30 and 10 respectively.12 
Bone is resorbed as a result of digestion by enzymes produced by large bone cells 
called osteoclasts; so throughout life, bone resorption and bone formation continuously 
occur. All together, an estimate of one fifth of the skeleton in an adult is replaced each 
year. Unfortunately, beyond 30 years of age, the rate of resorption outpaces the rate of 
formation leading to a decline in bone density. This is especially problematic in cases of 
bone disease, where damaged bone cannot be quickly rebuilt. In these cases, it might be 
advantageous to aid the healing process by using bone templating materials. Our research 
is geared towards the development of light-weight, flexible, bioactive and biocompatible 
materials that can be used in this application. These materials may also be used as 
components in bone cement that will make it bioactive ensuring a close connection 
between an implant and the living bone. 
           Figure 1.1 provides a detailed figure of bone material, representing a general 
overview of bone tissue. A typical bone consists of a shaft known as diaphysis which 
begins with the proximal and ends in epiphysis. In the hollow of the diaphysis lie the 
marrow, blood vessels and leukocytes (white blood forming cells). The diaphysis is 
covered by the periosteum (Figure 1.1a), a tough fibrous tissue which contains blood 
vessels, lymph vessels and nerves.9  
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Figure 1.1. Detailed structure of human bone.13 
 
Bone may be compact or spongy (Figure 1.1 a). The matrix in compact bone 
consists of closely packed structural units called the Haversian system (Figure 1.1c). The 
Harvesian system is made up of a central Haversian canal through which the blood 
vessels and lymphatic vessels run. The Volkmann’s canal connects one Haversian canal 
to the other. The Haversian canal is bound by concentric, cylindrically shaped layers of 
calcified matrix known as lamellae. Imbedded in the spaces between the lamellae 
(lacunae), are the osteocytes. (Figure 1.1b) The lacunae are small cavities that contain 
periosteocytic fluid that contain calcium and phosphate ions. Small canals called 
canaliculi radiate from the lacunae to other canals.   
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In spongy bone however, there is no Harvesian system, instead, there is a web-
like arrangement of marrow filled spaces that are separated by thin plates and bars of 
bone called trabeculae.8 The human bone can therefore be described as a natural 
composite comprising of nano-apatite rods (<100 mm) arranged in lamellae and bound to 
collagen.14,15   
 
1.3 Bone Fracture and Treatment 
A fracture is a broken bone16 and considered as a type of tissue failure (Figure 
1.2). The bone becomes more prone to fracture as a result of bone cell loss. The 
propensity for fractures increase with age, and most occur between the ages of 50 to 59 
years.17  In addition, bone diseases such as osteoporosis lead to reduced bone mass.18 
Also, dislocation, effects of pathogens, falls and traffic accidents can exert an enormous 
pressure on the bone and bring it to fracture.  
Osteoporosis is ranked the highest cause of bone fracture. It is estimated that an 
osteoporotic fracture occurs every three seconds in the world and 6.3 million fractures 
occur each year in the U.S.17 Osteoporosis is the most common bone disease but other 
metabolic diseases such as diabetes and kidney diseases also reduce the quality and 
amount of bone mass.7 In 2005, the cost of treating fractures that are related to 
osteoporosis in the US was estimated to be $17 billion, 72% of this cost is spent on hip 
fractures .19  
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Figure 1.2. Fracture in a hip bone.20 
 
A fractured bone may require bone replacement which is termed prosthesis.6 
Though there are several materials such as ceramics and coated metals for treating bone 
fractures by grafting or total replacement,5 each procedure is associated with problems 
that must be dealt with. It has therefore become essential to find appropriate materials to 
treat bone fractures. This chapter describes various materials and procedures that are in 
practice for bone treatment. 
 
1.4 Bisphosphonate Based Drugs 
The development of diphosphonic acid based drugs for the treatment of bone loss 
began about three decades ago21 when trace amounts of polyphosphonates were shown to 
be capable of inhibiting the crystallization of calcium salts. The collaborative work of 
several research groups led to the discovery of compounds containing P-N-P, P-C-P 
(bisphosphonates) and P-C-C-P (diphosphonates) motifs, that confirmed the potential of 
diphosphonates for the improvement of bone density, as the diphosphonates inhibit the 
dissolution of hydroxyapatite crystals.22 By 1969, publications on diphosphonates based 
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drugs such as Clodronate® indicated their efficacy in resorbing osteoclasts, the cells that 
destroy bone. Editronate® became the first drug to be used in humans.3 The selectivity of 
bisphosphonate drugs for their target organ made it efficient.23 Further studies showed 
that the P-C-P backbone was a more effective inhibitor to bone resorption than the P-C-
C-P and P-N-P based compounds. A few examples of bisphosphonate based drugs are 
shown in Table 1.1. 
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Table 1.1. Bisphosphonate based drugs. 
Clodronic acid
Etidronic acid
Alendronic acid
Ibandronic acid
Zoledronic acid
Name Structure
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1.5 Hydroxyapatite 
The word apatite is from the Greek word ‘apate’ meaning to deceive. Three main 
forms of calcium phosphate compounds include hydroxyapatite (HA)Ca5(PO4)3(OH), 
fluorapatite Ca5(PO4)3F, and chlorapatite Ca5(PO4)3Cl. The apatites have an appearance 
similar to gemstones (Figure 1.3), their main use is in the production of phosphorus 
containing fertilizers. 
 
                                    
                        a.                                            b.                                        c.  
Figure 1.3. Apatite based minerals: a. Hydroxyapatite,24 b. fluorapatite25and c. chlorapatite.26 
 
 
The apatites belong to the hexagonal crystal system with two formula units in 
each unit cell. Figure 1.4 describes the crystal structure of hydroxy, fluoro and chloro 
apatite.  
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Figure 1.4. Crystal structure of Hydroxyapatite, purple sphere represent OH-, pink tetrahedra are PO43- 
polyhedra, yellow sphere is Ca in CaO6OH and green is representing Ca in the CaO9 polyhedra. 
 
The main mineral component of bone (69 % vol.) and tooth enamel (98 % vol.) is 
hydroxyapatite (HA).27 HA is a natural mineral that provides the rigidity needed for bone 
and teeth functionality.  HA is composed of a nanoscale crystallites made up of a Ca/P 
ratio of 1.67, but also contains other ions such as CO32-, F-, Na+, Mg2+ and Sr2+.27 Being 
biocompatible and bioactive, synthetic HA has been developed for biomedical 
applications with the goal to attain materials to substitute natural bone.19,28 The limitation 
to the use of HA in load bearing applications is due to its brittleness, lack of toughness 
and flexibility.27 However, HA is used as coatings on implants, or fillers.  
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1.6 Bone Substitute Materials 
A range of materials including calcium orthophosphates,6,29,30 bioceramics,5 
glass31 and polymers6 are the major materials that are used to repair, replace, regenerate 
and accelerate the growth rate of bone cells. It is important that these materials form 
bonds with the surface of living tissue and have the mechanical strength and flexibility to 
mimic the functions of natural bone.31 In each of these bone materials, efforts are made to 
achieve the unique properties that are comparable to HA but in a less dense form. 
Bioglass® , composed of SiO2, Na2O, CaO and P2O5 is one of such materials that was 
discovered to provide the interfacial bonding needed between an implant and the body 
soft tissue or bone depending on the amount of SiO2 in the glass.31 The following 
paragraph will describe each of these materials in more details. 
 
1.6.1 Metal Implants 
Stainless steel,32 titanium33 and transition metal based alloys (NiTi,34 Ti6Al4V35) 
are the common metal used for bone replacement as they provide strength and the 
toughness needed in load bearing parts of the body such as the hip and knee. NiTi alloys 
are mainly employed as intervertebral infusion devices.34 Other metals used afor implant 
applications include alloys containing Mg,36 Zr, Hf, V, Nb, Ta, Re,37 Ni, Fe, Cu, Ag38 in 
the form of plates, rods and pins as depicted in Figure 1.5. 
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Figure 1.5. Bone fixation metal implants and devices.39 
 
Placement of metal implants requires a surgical procedure and may include the 
use of plates, pins and screws.40 Metals are not biomimetric but rather bioinert, but with 
time, they may corrode and release ions that react with human fluids to form undesirable 
precipitates and complexes in the body. In addition, the ions may hydrolyze to form 
oxides and hydroxides that can greatly trigger pH changes in the body.41 To prevent the 
metals from dissolving,42 they are either coated with biocompatible materials such as 
hydroxyapatite43 or polyacrylic acid.41  
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1.6.2 Bioceramics 
Bioceramics have been developed 
fractures and in dentistry as restorative materials. Based on their pr
may be classified as bioinert (alumina), biodegradable (tricalcium phosphat
(hydroxyapatite). Figure 1.
used for hip replacement.
time,45 and they also make noise.
approved the use a ceramic ball and metal socket for total hip replacement following a 2
year clinical trial.46 
 
      
     (a)                                                 
Figure 1.6. a. Examples of bioceramics used for bone treatment
prosthesis in place
Aluminum silicates with particle sizes less than 2 micrometers are termed c
They have been in existence as an important molding material for decades 
plasticity when wet and hard on drying
moistening, casting into vari
improve the quality of life.
                                                                                                       
to facilitate the healing process of bone 
operties
6 shows a few examples of bioceramics; ceramic 
44
 The major problem with these inplants is the wearing over 
 Recently, the US Food and Drug Administration 
       
(b)                                         
20
 b. showing hip joint with 
,
47
 c. hydroxyapatite artificial bone .48 
 
.
49
 Clay can be transformed into ceramics by 
ous shapes and firing, thereby producing many 
 Bioceramics were designed for repair and reconstruction of 
13 
, bioceramics 
e) or bioactive 
alumina is 
-
   
(c) 
lay.  
due to their 
devices to 
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various body parts with applications in the health care industry, in dentistry as restorative 
material and in orthopedics as implants. 
 Bioceramics used for the repair of musculo-skeletal systems, are categorized as 
bioinert, resorbable, bioactive, or porous based on the type of interaction or response of 
the implant in the living tissue. The major setback to the application of bioceramics as 
implants is their structural weakness.5  
 
1.6.3 Bioglass 
 Bioglass is a bioactive glass composed of Na2O, SiO2, CaO and P2O5.  It was first 
used in 1985 with the trade name MEP® as a device that replaces the bone of the middle 
ear to treat conductive hearing loss. Bioglass has other uses in head and neck surgery and 
tooth implants but due to limited mechanical strength and toughness, the material is 
combined with polymers or metals to enhance mechanical properties.31 
 
1.6.4 Polymers 
 Several examples of polymers with biomedical applications exist, notable among 
them are biocompatible polymers including polyacrylates, poly(acrylonitrile-co-
vinylchloride), polylysine, polyorthoester, poly(ε-caprolactone) (PCL), polylactic acid 
(PLA), polyglycolic acid (PGA), poly(lactic-co-glycolic acid) (PLGA), polyethylene 
tetrafluoroethylene (PETE), polyanhydrides, polyurethanes, poly(propylene-co-fumarate) 
(PPF), polymethylmethacrylate (PMMA) and polyethylene (PE).6,50 An important 
property of these polymers is viscoelasticity which makes it possible to form complex 
and porous structures with diverse applications, ranging from coating surfaces (for 
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example polyurethanes), drug delivery (polyanhydrides), orthopedic purposes 
(polyanhydrides, PMMA) and bone replacement (PPF, PE). With the exception of PLA, 
PGA and PGLA the polymers mentioned above are not degradable or bioactive, which is 
a major setback in their usage. In addition, the polymers lack mechanical strength hence 
they are usually combined with other materials or polymers.  
 
1.6.5 Composite Biomaterials 
Whereas each of the bone substitute materials described above has some desirable 
properties, none of them possesses them all, and this has challenged more research to 
identify a more suitable material that may better suit the function. As a result, composite 
materials are explored, aimed at combining the unique properties of well known materials 
to produce many biomaterials for biomedical applications. Table 1 lists the properties of 
some materials used as biomaterials.6,51,52 
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Table 1.2 Properties and limitations to some biomaterials. 
Biomaterial Examples Properties Limitation 
Metal  Ti Mechanical strength for 
load bearing bone 
implants 
Bioinert, corrosion 
Glass Bioglass® Bioactive Limited 
mechanical 
strength 
Bioceramic Alumina  Biocompatible, bioactive Limited 
mechanical 
strength 
Calcium 
orthophosphate 
Hydroxyapatite, β-
tricalcium 
phosphate 
Biocompatible, bioactive, 
non-toxic, degradable, 
osteointegrative 
Brittle, poor 
fatigue resistant 
Polymers  PMMA 
Polyanhydrides 
Viscoelastic, form porous 
network and channels 
Lacks rigidity, 
ductility, non 
degradable and 
bioinert. 
 
 
There are many composite materials developed with careful consideration of the 
mechanical strength, osteogenis, osteoconductivity, osteoinduciveness, biocompatibility, 
biodegradability, biosorbability, porosity and viscoelasticity that is needed for the 
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specific functions of the composite biomaterial.6  Biocomposites and hybrid biomaterials 
include PMMA/HA, (PMMA = Polymethylmethacrylate),53 HA/PE or HAPEXTM (PE = 
polyethylene) used as implants for the shafts in the middle ear,6 as well as HA/collagen 
used as biodegradable drug delivery system.54 
 
1.6.6 Scaffolds for Bone in growth 
In tissue engineering, the growth of new cells is enhanced with a scaffold.55,56 The 
scaffolds are usually modeled after the structure of the natural bone with pore sizes 
greater than 100µm to allow for bone cells in-growth.56  Metal organic frameworks 
(MOFs) with open pores are currently being explored as scaffolds for bone repair and 
regeneration.57 They are advantageous because the open pores allow for fluid 
transport,58,59  new tissue vascularization and proliferation of cells.60,61 We are 
particularly interested in finding three dimensional (3D) calcium and magnesium 
phosphonate based frameworks that are both bioactive and mechanically strong to form 
scaffolds for growing bone. 
 
1.7 Conclusions 
The bone is the supporting framework of the body that is needed for movement 
and other essential functions. Diseases and undue pressure on the bone can cause 
fractures leading to deformity and malfunction. Fortunately, the bone has a built-in 
mechanism to regenerate, so the goal will be on enhancing the healing process by 
introduction of a mechanically strong scaffold. Recent findings on the side effects of 
bisphosphonate drugs used widely to treat osteoporosis make it imperative to find an 
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alternative and more natural process to heal bone. This is why this project focused on the 
use of calcium and magnesium phosphonate compounds to prepare scaffolds to improve 
bone healing. One of the objectives of this work is therefore to prepare bioactive and 
biocompatible scaffold materials that have appropriate mechanical properties as a bone 
substitute.  
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CHAPTER 2 
Metal Organic Frameworks 
2.1 Introduction  
Metal organic frameworks (MOFs) are a class of inorganic-organic hybrid materials 
based on coordination chemistry.1 MOFs are also called coordination polymers and are 
defined as extended arrays composed of metal atoms or clusters that are linked by 
polyfuctional organic ligands.2 MOFs are therefore solid state crystalline compounds 
with geometrically well defined structures, similar to zeolites.3  
The wide application of MOFs, spans from gas storage,4 gas separation,5 catalysis, 1 
to use in nonlinear optics, as fluorescence materials in sensors,6 in molecular recognition 
in drug delivery7 and chemical sensing8,4,51,9,10 are described in details below. The wide 
variety of applications has led to the proliferation of MOF research over the last 20 
years11 as shown in Figure 2.1. The graph summarizes MOFs reported between 1978-
2006.12   
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Figure 2.1. Number of metal
Database (CSD) from 1978 through 2006. The bar graph illustrates the recent drastic increase in the 
 
The majority of these MOFs are based on transi
even fewer s-block metal phosphonates exist.
We are interested in synthesizing metal organic frameworks base
earth metals magnesium and calcium in combination with 
denticities, as these compounds have potential uses in bone therapy agents.
 
2.2 Metal Organic Frameworks
The quest for a safe, efficient, and affordable storage system for hydrogen fuel has 
sparked extensive research leading to the synthesis
                                                                            
–organic framework (MOF) structures reported in the Cambridge Structural 
number of reports.  
tion metals, only few main group and 
 
d on the alkaline 
phosphonate ligands of various 
 Applications  
 of more than 200 porous MOFs.
23 
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The advantages of porous MOFs as storage materials include  large surface areas and the 
high volume of open pores.15 MOFs designed for this purpose are designed to store large 
volumes of methane (natural gas), acetylene and hydrogen although the storage volumes 
achieved remain modest. 16   Recently, the synthesis of  a MOF with methane storage 
capacity of 196 cm3/cm3 has been achieved, exceeding the United States Department of 
Energy (DEO) methane gas storage capacity of 180 cm3/cm3 target17  that has long been 
the standard. A series of lanthanide based MOFs have also shown reasonable capacity for 
gas storage.18,19  
Gas separation is another goal, including the removal of CO2 as the major impurity in 
natural gas.20,21 One of the most cost effective methods employed for the removal of 
atmospheric carbon dioxide by adsorption22 is based on porous materials including 
zeolites, alumina and carbonaceous materials. Other gas mixtures such as O2/N2, 
CO/CO2, and CO2/C2H4 can also be separated by adsorption with MOFs. Recent research 
has shown that MOFs can also function as solid adsorbents for gas separation because of 
their characteristic high specific surface area and tunable pore size volume,23,24 and 
achieved by employing linkers based on halogens, amine, amide or alkyl groups to affect 
the host-guest interactions.9  
 
2.3 Metal Organic Framework Structure and Composition 
Two examples of MOFs are shown in Figure 2.1, where the abbreviations bpdc, 
DMF, trz and BPT stand for biphenyldicarboxylate, N,N′-dimethylformamide, 1,2,4- 
triazolate and biphenyltriazolate respectively. 
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[Cu(3,4′-bpdc)(H2O)·2DMF·4.5H2O]n25                             [Cu3(trz)3(OH)3(H2O)4]·4.5H2O 26 
Figure 2.2. Some examples of Metal Organic Frameworks (MOFs).  
 
MOFs with various dimensionality are constructed by the interaction of metal ions 
with ligands or from the assembly of secondary building units (SBUs) made of small, 
metal containing clusters in the presence of multidentate organic ligands.  
The organic component of a MOF usually serves as a bridge between metal centers. 
Due to the special role of the organic groups in the building of MOFs, they are often 
described as spacers or linkers.27  
Various organic linkers21,22 have been employed in the synthesis of MOFs, and have 
been shown to play a major role in framework design. Carboxylate ligand systems are 
listed in Table 2.1;28 phosphonate ligands that are employed in this work will be 
discussed in the next chapter. 
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  Table 2.1. Common organic building units in MOFs. 
 
Organic ligands 
 
 
 
2-amino-1,4-benzenedicarboxylate29-35 
 
 
 
 
1,4-diazabicyclo[2.2.2]octane36 
 
 
azopyridine37 
 
 
 
 
2-methylimidazolate38,39 
 
 
 
 
 
 
1,4-benzenedicarboxylate40 
 
  
 
1,4-naphtalenedicarboxylate 41-42 
 
 
 
 
1,3,5-benzenetricarboxylate43,44 
 
 
 
 
 
 
pyrazine45-47 
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       Table 2.1 Common organic building units in MOFs (continued).  
Organic Ligands 
 
 
 
 
 
 
1,4-benzenedi(4’-pyrazolyl)48 
 
 
 
2,3,5,6-tetrafluorobenzene-1,4-
dicarboxylate49 
 
 
 
 
4,4’-bipyridine28 
 
 
 
 
2,3,5,6-tetramethyl-1-4-
benzenedicarboxylate40,50,51 
 
 
 
 
 
 
 
biphenyl-3,4,5-tricarboxylate26 
 
 
 
 
 
triphenylene-2,6,10-tricarboxylate52 
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The inorganic subunits in MOFs traditionally comprise of transition metals and to a 
much lesser extent of main group elements, lanthanides or actinides. Among these, the 
majority of examples are monometallic, but there are a few heterometallic organic 
frameworks based on combinations of Cd/Ca, Cd/Sr53 or Ln/Ba.54 
Many MOFs have special characteristics such as uniform structured cavities, 
permanent pores with functionalities, extended network architectures and robust and high 
surface areas,12 making them potential hosts for guest molecules.55 Depending on the type 
of functional group in the layered framework, the channels may be either hydrophilic or 
hydrophobic,12 with functional groups interacting with guest molecules.56  
One of the greatest challenges in making MOFs is to predict and accurately design the 
structure of desired final products. The common route for their synthesis is by 
hydrothermal or solvothermal procedures where reaction conditions such as temperature, 
type of solvent, pH and concentration of solution are varied leading to diverse structural 
forms.57 Limited predictability of structural features can be achieved through a careful 
selection of inorganic bridging ligands.  
 
2.4 Metal Phosphonates  
Phosphonate ligands have wide applications in industrial water treatment, oilfield 
drilling, mineral processing, corrosion control and metal sequestration by complexation. 
Metal phosphonates often occurring as MOFs displaying microporous structures that are 
applied in catalysis, sorption and ion exchange.58  Extensive studies on phosphonate 
based MOFs gave rise to a large variety of compounds, mainly based on first row 
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transition metals.59-64 Limited examples exist for Al, Ga and Pb,65 and even fewer 
examples exist for lanthanide and s-block metals.  
The study of metal phosphonates has been hindered by the formation of dense, 
insoluble compounds making it difficult to obtain crystals. In addition, the structures of 
the phosphonates are also are less predictable than that of the carboxylates.66,67 The other 
reason why the field of metal phosphonates is challenging is that the synthesis is often 
independent of reagent ratios; hence the rational design for the synthesis of a specific 
targeted compound  is challenging.68 
Despite these setbacks, extensive studies have been conducted on mono-, di-, tri- 
and tetraphosphonates based on transition metals.2,69-73  The use of  heterofunctional 
ligands  such as carboxyphosphonates74-77 and sulfonophosphonates 78-80 has led to the 
preparation of many novel MOFs with interesting structural motifs and properties.81 
Majority of the studies have been conducted on diphosphonates. The vast majority of 
these are dense, few are microporous, an example being the three-dimensional 
{[Zn(DHBP)](DMF)2)}n, (DHBP = dihydroxy-2,5-benzenediphosphonate).82 Other 
examples include aryl phosphonates based MOFs where the aryl groups in the ligand 
function as rigid spacers to achieve open structures.83  
 
2.5 Alkaline Earth Metal Organic Frameworks 
Compared to transition metal MOFs, limited examples of  MOFs based  on alkaline 
earth metals exist.84 The s-block metals lack geometric directionality due to the spherical 
nature of the s-orbital. Furthermore, group II metals are very large requiring an extensive 
coordination sphere. In addition, the unavailability of energetically accessible d-orbitals 
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and hence lack of metal- ligand back bonding makes the alkaline earth- ligand bonds 
weaker and geometrically less well defined than that of the transition metals.85 Among 
the group II metals, magnesium,26,86-88 calcium,27,84,89-92 strontium,93-95 and barium54,96-101 
have been explored for MOF synthesis. The main method of synthesis is via 
hydro/solvothermal routes, but recently ionic liquids have also been used.87 Most of the 
alkaline earth MOFs are based on carboxylic acids, which display interesting and varying 
coordination modes based on the number of carboxylic acid functional groups on the 
ligand as well as the coordination number around the metal center.102-108  
Considering that the phosphonate  MOF has been plagued with insolubility and that 
heavy alkaline earth metals are large, it is not surprising that very few alkaline earth 
metal phosphonates have been reported.109  
 
2.6 Zeolites 
The first well defined three-dimensional solid state materials were zeolites. Zeolites 
are microcrystalline aluminosilicate minerals (Mx/nn+[(AlO2)x(SiO2)y]x-) with uniform pore 
size of  0.3-1. 2 nm in diameter.110,111 The pores may contain a cation, water or other 
small molecules. Based on their pore size and shape, zeolites can allow specific 
molecules to pass through their channels hence the zeolites are also termed molecular 
sieves. Zeolites are used as adsorbents in fields of medicine, agriculture and industry for 
water purification, as catalysts in nuclear processing and in the production of laundry 
detergents. In zeolites [SiO4]n- and [AlO4]n- units are the building blocks, to provide a 
network through oxygen bridging.110 
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2.7 Porous Metal Organic Frameworks 
A porous material is a framework in which guest molecules can be removed or 
exchanged without loss of framework integrity. 112 The open framework structure 
depends on the rigidity and directionality of the building units in the framework. The 
voids in MOFs are usually filled by guest molecules. Examples of MOFs with different 
pore sizes exist; they are termed microporous (<2nm), mesoporous (2-50nm) 113 or 
macroporous ( >50nm).114 Depending on the size of the pores, they might be accessible to 
small organic molecules while others are too small to incorporate any molecule. 
Examples include mesoporous MOFs, where the pores are used for drug delivery.115  
Not all MOFs retain their structure upon removal of guest molecules. Though 
there are many examples of MOFs containing pores reported in literature, for many, there 
is no experimental basis to document the stability and accessibility of the pores. Only a 
limited number of examples exist where the pores have been shown to be reversibly 
accessible.116 Many three dimensional MOFs do not meet the criteria for porous 
materials, such as materials with isolated cavities in the framework that are classified as 
non-porous.116  
Careful analysis is needed to establish the porosity of a material. Fluid exchange 
and isothermal sorption of gases prove permanent porosity for those porous MOFs.117 
Though extensive work has been done to deliberately design material with different pore 
sizes and shapes, very limited knowledge exists about the mechanism of formation.  
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2.8 Ligand Denticity and Dimensionality in Metal Organic Frameworks 
Extensive studies on hybrid metal organic frameworks have improved the 
understanding of the relationship between ligand denticity and the final architecture of a 
MOF. Whereas the preferred coordination of the metal in the framework plays a 
significant role in the determination of MOF geometry, the denticity of the ligand and its 
binding modes greatly influence the MOF structure, generating intriguing networks of 
different dimensions. While a basic rationale between these factors exists, the prediction 
of MOF architecture remains the ultimate challenge. 
Occasionally the functional groups on a ligand may be found in the open framework 
of the MOF structure. These functional groups could be modified to change the property 
of the MOF. It is of interest to note that the dimensionality of porous MOFs can be 
maintained even when the ligand bound functional groups in the cavities are carefully 
modified. The three-dimensional crystal structure of a gadolinium MOF ({[Gd2(N-
BDC)3(dmf)4]}n, BDC = benzenedicarboxylate) remains unchanged when the amino 
functional groups in the cavities were chemically transformed to acetamide (CH3CONH), 
urethane (CH3CH2NHCONH-) groups when ethylisocyanate (CH3CH2NCO) and acetic 
acid (CH3COOH) are used respectively during the synthesis.35 Though denticity 
influences framework dimensionality, synthetic conditions and routes also have a role to 
play.77 
 
2.9 Hydrothermal and Solvothermal Synthesis 
Hydrothermal synthesis is the preparation of crystalline products based on the 
increased solubility of inorganic substances in water at temperatures above the boiling 
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point. Typically, temperatures in the range of 100-350 oC, and elevated pressure between 
20-25 mTorr are utilized.114 When the solvent is not water, the process is termed 
solvothermal. Since the products from a hydrothermal condition are dependent on 
pressure, temperature, pH, and concentration of the solution, it becomes difficult to 
predict or even rationalize product formation. The reaction is usually conducted in 
autoclaves. Autoclaves are steel pressure containers lined with Teflon 
(polytetrafluoroethylene). Special autoclaves used for hydrothermal synthesis are 
described as pressure container bombs, digestion tanks or polymerization reactors. Figure 
2.3 displays an autoclave bomb. 
 
 
Figure 2.3. Autoclave and Teflon liner for hydrothermal synthesis.118 
 
The advantages in using these containers include low incidence of pollution 
because the solutions are tightly sealed, volatile compounds can dissolve quickly without 
any loss and the Teflon liner resists corrosion. The disadvantage in using an autoclave is 
that the reaction cannot be monitored to determine when crystallization occurs. To 
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circumvent this problem we have used sealed Carius tubes. The aim is to obtain single 
crystals suitable for X-ray diffraction. To ensure thorough mixing of reagents, aqueous 
solutions of each reagent were prepared separately prior to combining these.119  The 
pressure is often within the tube may be as high as 22.5 mTorr, depending on fill volume 
and temperature, although due to safety reasons, pressures will be kept below 7.5 mTorr. 
As the water evaporates the pressure above the solution in the sealed Carius tube 
increases and this enhances solubility.  
A new variant in hydrothermal synthesis involves the use of microwaves, as 
shown with the formation of nickel phosphonate.120 Microwave-assisted hydrothermal 
synthesis reaches high temperatures in a shorter time and thereby reduces crystallization 
time. 
 
2.10 Conclusions 
Metal organic frameworks (MOFs) consist of metal centers that are associated 
through organic linkers that form three-dimensional structures.  MOFs are typically 
robust, rigid and thermally stable; they have a wide range of applications. The properties 
and special characteristics of magnesium and calcium based MOFs may be explored for 
medicinal applications such as bone scaffolds. In this work the synthesis and 
characterization of phosphonate based calcium and magnesium frameworks are explored 
via hydrothermal and solvothermal synthesis. 
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CHAPTER 3 
Ligand Systems 
3.1 Introduction 
Several phosphorus based compounds of magnesium and calcium with diverse 
structural motifs are described in this thesis. The target compounds are based on a group 
of phosphonate, phosphinate and phosphite ligands (Figure 3.1). Also included is one 
compound based on formic acid (HCO2H) shown in Figure 3.2, obtained as a 
decomposition product from the solvent dimethyl formamide (DMF). This chapter 
provides a detailed discussion on the ligands utilized, including phenylphosphinic acid 
(HPPA), phenylphosphonic acid (H2PPA), phosphonic acid (H3PO3), phosphoric acid 
(H3PO4), methylenediphosphonic acid (H4MDPA), ethylenediphosphonic acid 
(H4EDPA), propylenediphosphonic acid , 4,4′-biphenyldiphosphonic acid (H4BDPA), 4-
(4′-phosphonophenoxy) phenyl phosphonic acid (H4PPPA), amino 
trimethylenephosphonic acid (H6ATMPA) and ethylenediamine tetramethylene-
phosphonic acid (H8EDTMPA), as summarized in Table 3.1. 
Two of the ligands, HPPA and H3PO3 were commercially obtained while H3PO4 
was a decomposition product from ethylenediphosphonic acid. H4MDPA was a gift from 
the Zubieta laboratory, while H4EDPA, H4PDPA, H4BDPA, H4PPPA H6ATMPA and 
H8EDTMPA ligands were synthesized. Two methods outlined below were employed for 
the syntheses of the ligands; the Michaelis-Arbuzov’s reaction and a Mannich-type 
reaction. The ligands H4EDP, H4PDPA, H4BDPA and H4PPPA were synthesized by the 
Michaelis-Arbuzov reaction while H6ATMPA and H8EDTMPA ligands were synthesized 
by the Mannich reaction.  
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Figure 3.1. P-based ligands utilized in this work, (a). phenylphosphinic acid (HPPA), (b). phenylphospho-
nic acid (H2PPA), (c). phosphonic acid (H3PO3), (d). phosphoric acid (H3PO4), (e). methylenediphosphonic 
acid (H4MDPA), (f). ethylenediphosphonic acid (H4EDPA), (g). propylenediphosphonic acid (H4PDPA), 
(h). 4,4-biphenyldiphosphonic acid (H4BPDPA), (i). 4-(4′-phosphonophenoxy) phenylphosphonic acid 
(H4PPPA), (j). amino trimethylenephosphonic acid (H6ATMPA) and (k). ethylenediamine tetramethylene-
phosphonic acid (H8EDTMPA). 
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Figure 3.2. Formic acid ligand from decomposition of DMF solvent. 
 
Several of the above mentioned phosphinic and phosphonic acids have important 
applications as drugs for calcium related disorders,1-5 as well as scale and corrosion 
inhibition.6-9   
In this chapter, some key properties of the ligands, such as the stepwise 
deprotonation of the diphosphonates and zwitterionic effect of the triphosphonates are 
also discussed.  
 
3.2 Nomenclature of Phosphorus Containing Ligands 
 Phosphorus plays a major role in the biochemistry of all living organisms. Table 
3.1 gives a summary of some of the most common phosphorus oxoacids along with their 
oxidation states.10 Phosphonic and diphosphonic acids are called phosphonates in their 
deprotonated state while deprotonated phosphinic acid is termed phosphinate. Anions of 
phosphorus acid are termed phosphite and those of phosphoric acid are called phosphate. 
This is summarized in Table 3.2. 
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     Table 3.1. Names of common phosphorus oxyacids 
 
R  = alkyl, aryl
(RPO3H2)
(R(PO3H2)2)
Diphosphonic acid
3
R  = alkyl, aryl
3
Formula/Name Oxidation state of P
(H3PO4)
Structure
   Phosphoric acid 
              or
Orthophosphoric acid 5
3
1
4
5
Phosphorous acid
Hypophosphoric acid
Pyrophosphoric acid
(H3PO2)
(H3PO3)
Phosphinic acid
(H4P2O6)
Phosphonic acid
(H4P2O7)
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         Table 3.2 Nomenclature of the deprotonated forms of P-based acids 
 
Name of acid Name of deprotonated form
Phosphoric acid Phosphate
Phosphorus acid Phosphite
Phosphonic acid Phosphonate
Phosphinic acid Phosphinate
Diphosphonic acid Diphosphonate
 
 
 
3.3 Ligand Deprotonation  
Significant literature exists on metal organic frameworks (MOFs) based on 
ethylenediphosphonic acid, H2O3P(CH2)2PO3H2.11 This ligand system depicts a variety of 
metal binding modes and deprotonation types. The degree of deprotonation is pH 
dependent. The most common deprotonation state is based on a double deprotonation, 
involving a single deprotonation on each of the phosphonate units, leaving a symmetrical 
arrangement. More rare is a combination of single/double deprotonation, as seen in the 
novel {CaNa[(HO3P(CH2)2PO3H)(HO3P(CH2)2PO3H2)n]}compound 11 in chapter 7 and 
the literature examples of (MIII(H2O)(HO3P(CH2)2PO3) where M = Fe, Ga, Al.12 
Diphosphonates of the alkali metals typically exhibit single deprotonation of only one 
CHAPTER 3: Ligand Systems                                                                                                     45 
 
phosphate group, an example includes Na(HO3P(CH2)2PO3H2).13 Scheme 3.1 illustrates 
the stepwise deprotonation for ethylenediphosphonic acid . 
2
2
2
2
2
2
2
2
pKa < 2
pKa ≅ 2.6 
pKa ≅ 7 
-H
+H
-H
-H
+H
+H
pKa ≅ 9 
-H
+H
 
Scheme 3.1. Stepwise deprotonation of ethylenediphosphonic acid (f). 
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3.4. General Synthetic Routes 
 Two types of reaction routes were employed for the synthesis of ligands. These 
include Michealis- Arbuzov reaction for the synthesis of the esters of H4EDP and 
H4PDPA followed by acid hydrolysis to afford the corresponding acids. The Mannich 
reaction was used for the preparation of H4BDPA, H4PPPA and H6ATMPA ligands. 
 
3.4.1 Michealis-Arbuzov Reaction 
The synthesis of phosphonates (RPO(OR)2) by the treatment of trialkyl phosphate 
with alkyl halides was first discovered by Augustus Michaelis and further explored  by 
Alexandra Arbuzov, hence the name Michealis-Arbuzov or simply Arbuzov reaction.14,15 
The reaction involves the formation of a carbon-phosphorus bond and is useful in the 
preparation of phosphinates (R2PO(OR)) and phosphine oxide (OPR3). The R group may 
be alkyl, aryl or an acyl group. The most commonly used alkyl halides RX are based on 
X = Cl, Br, I. A modified form of the Arbuzov reaction is employed for the synthesis of 
the alkylene diphosphonate compounds.16 The reaction is shown in Scheme  3.2. 
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P(OR)3  + R'X +   RXP
R'RO
OR
O
RP(OR)2  + R'X +   RXP
R'RO
R
O
R2P(OR)  + R'X +   RXP
R'R
R
O
a.
b.
c.
                                               
Scheme 3.2. Michealis-Arbuzov reaction for the synthesis of 3.2a. phosphonate, 3.2b. phosphinate, 3.2c. 
phosphine oxide 
 
 The mechanism of the reaction involves a SN2 nucleophilic attack of the alkyl 
group in R’X by the lone pair of electrons on phosphorus to form an unstable 
intermediate. In a second step, dissociation of one alkyl group from the phosphite results 
in P=O bond formation yielding the phosphonate. The halide then attacks the alkyl to 
form the new alkyl halide RX (Scheme 3.3). 17 When phenyl groups are involved, a 
nickel catalyst is required for the formation of the phenyl phosphonate.18 
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Scheme 3.3. Mechanism of Michealis-Arbuzov reaction 
 
3.4.2 Mannich Reaction 
 In the Mannich reaction, ammonia or a primary or secondary amine reacts with a 
carbonyl group to form a Schiff’s base, which under condensation affords a N-C 
bond.19,20  
 
3.4.3 Acid Hydrolysis 
In the preparation of the diphosphonates, hydrolysis of the four alkyl esters via 
concentrated HCl leads to the formation of the diphosphonic acids (Scheme 3.4).21 
 
R2O3P(CH2)nPO3R2    +   4HCl H2O3P(CH2)nPO3H2    +   4RCl
 
Scheme 3.4. Hydrolysis of tetraalkyldiphosphonate to form diphosphonic acid. 
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3.5. Hydrogen Bonding 
The occurrence of hydroxyl groups on the ligand systems and water molecules in 
some of the compounds results in hydrogen bond formation. The hydrogen bonds play a 
major role in increasing the dimensionalities of the structures by connecting sheets into 
three-dimensional structures or linking chains into sheets. The presence of the hydrogen 
bonds necessitated special considerations during the structural determination of the 
compounds. 
A hydrogen bond is an attractive interaction between hydrogen and an 
electronegative atom (acceptor atom, A) such as F, O, N.22 The hydrogen atom is bonded 
to another electronegative atom (donor atom, D), typically represented as D-H···A. 
Hydrogen bonds are stronger than Van de Waals forces. Typical hydrogen bond 
interactions are 1.60-2.00 Å in length, with the H···A distance directly related to the 
strength of the interaction.  Geometry also plays a major role; typically in the strongest 
bonds a linear D-H···A geometry is observed, but the angle is always above 110 o. 
All the ligand systems in this project bear at least one hydroxyl groups or an 
amino group that may be involved in hydrogen bonding. Among the compounds that are 
discussed, the majority has intermolecular hydrogen bonding that occur between the 
layers, or in some cases are solely responsible for the extension of dimensionality from 
two to three as seen in the magnesium hexaqua compound (7) or from one to two 
dimensions as seen in compound 8. In a few compounds, such intermolecular hydrogen 
bonds occur within the sheets of the compound. In this latter case, (compound 3, chapter 
4) the dimension of the structure remains unchanged.  
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3.5.1 Crystallographic location of Hydrogen Atoms  
Hydrogen atoms scatter X-rays weakly due to low electron density. Their location 
in an X-ray diffraction experiment poses significant limitations.23 It is however important 
to determine the exact location of the H atom in order to reliably assign the chemical 
structures. There are two ways to include hydrogen atoms in the crystallographic 
experiment: hydrogen atoms are either added at calculated positions or they are located 
from the electron density map during structure refinement. The located hydrogen atoms 
are typically refined using restraints. 
A careful examination of the Fourier difference map can help locate the position 
of the H atom but the distances are typically too short, due to the low nuclear charge and 
long distances between nucleus and electrons.24 The application of restraints helps in 
representing a more accurate distance. 
On the other hand, hydrogen atoms may also be placed in calculated positions, 
often the more accurate of the two methods, as the above problems are circumvented. In 
this case, the hydrogen atoms “ride” on the atoms to which they are bound.25 
Different categories of hydrogen bonding are identified in this work that require 
different treatment; these include water (O-H2), hydroxyl (P-O-H), phosphinates (P-H ) 
and amine(N-H) groups.25 The use of calculated hydrogen positions in some of the cases 
is not possible due to a significant variation of location, as the case for waters of 
crystallization; therefore location of hydrogen atoms in a Fourier map is essential. Some 
of the hydrogen atoms involved in hydroxyl groups in this work are therefore located in 
Fourier difference maps and refined with restraints, in others cases, data quality did not 
permit their location, resulting in the placement of the atoms in calculated positions. 
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Finally, all the H atoms on nitrogen and phosphorus were located in the respective 
difference maps. 
 
3.6 Conclusions 
The structures, properties, nomenclature and preparation of the phosphorus 
containing ligands used in this work have been discussed. The ligands fall into the 
category of mono-, di- and triphosphonates. The ability of the ligands to form metal 
complexes is based on their acid/base chemistry, and the dimensions of the resulting 
compounds rely on the number of deprotonated oxygen atoms in the sample. The 
oxyacids are able to form hydrogen bonds especially if water molecules are present.  
 
3.7 Experimental 
3.7.1 Synthesis of Ethylenediphosphonic Acid, H4EDPA: 
A modified synthesis for ethylenediphosphonic acid was employed.15 1, 2-
Dibromoethane (23.6 mL, 0.23 mol) and triethylphosphite (142 mL, 0.82 mol) were 
measured into a 500 mL three-necked flask equipped with a stir bar. The flask was fitted 
with a condenser, an addition funnel and connected to a Schlenk line. The flask was 
purged with N2 and heated (using a heating mantle) with stirring to about 165 oC. The 
resulting pale, oily product was vacuum dried, treated with 150 mL of concentrated HCl, 
and refluxed for three days. Rotary evaporation yielded a white, solid product which was 
washed with acetonitrile to yield colorless crystalline products. The colorless crystals 
were dried under vacuum and hot water bath. The reaction is summarized in Scheme 3.5. 
Yield: 26.8 g, 0.14 mol, 51.1 %; m.p. 223-225 oC; 1H-NMR (300 MHz, [D6]DMSO, 25 
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oC): δ = 1.7
 
pm (d, JP-C-H = 6 Hz, 4H, CH); IR (Nujol): 3871.3(w), P-O 2721.7(m), PO-H 
1461.2(s), 1373.7(s),1152.0 (m), 1017.8(m), 924.4(m), P-C 714.3(m), 486.7(w). 
 
2P(OCH2CH3)3  +  Br(CH2)2Br 
HCl
(CH3CH2O)2OP(CH2)2PO(OCH2CH3)2  +  2EtBr 
(OH)2OP(CH2)2PO(OH)2  +  4CH3CH2Cl
 
                    Scheme 3.5. Synthesis of ethylenediphosphonic acid, H4EDPA. 
 
3.7.2 Synthesis of Propylenediphosphonic Acid, H4PDPA: 
A modified synthesis for propylenediphosphonic acid was employed.15 Into a 250 
mL three necked flask equipped with a stir bar, 1, 3-dibromopropane (7.05 mL, 0.069 
mol) and triethylphosphite (35.5 mL, 0.21 mol) were measured. The flask was fitted with 
a condenser, an addition funnel and connected to a Schlenk line. The flask was purged 
with N2 and heated with a heating mantle to about 165 oC. The resulting pale oily product 
was vacuum dried, treated with 50 mL concentrated HCl and refluxed for three days. 
Rotary evaporation yielded a white solid product which was washed with acetonitrile to 
yield colorless crystalline products. The colorless crystals were dried under vacuum using 
a hot water bath. The reaction is summarized in Scheme 3.6. Yield: 8.52g, 0.04 mol, 60.5 
%; m.p. 175-178 oC; 1H-NMR (300MHz, [D6]DMSO, 25oC): δ = 1.6 pm (m, 6H, CH); IR 
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(Nujol): 3871.3(w), PO-H 2721.7(m), 1461.2(s), 1373.7(s), 1152.0(m), 1018.8(m), 
924.4(m), P-C 714.3(m), 487.7(w).  
 
(CH3CH2O)2OP(CH2)3PO(OCH2CH3)2  +  2EtBr 
HCl
2P(OCH2CH3)3  +  Br(CH2)3Br 
(HO)2OP(CH2)3PO(OH)2  +  4CH3CH2Cl
 
                    Scheme 3.6. Synthesis of propylenediphosphonic acid, H4PDPA. 
 
3.7.3 Synthesis of 4,4′-Biphenyl Diphosphonic Acid, H4BPDPA: 
 The synthesis of 4,4′-biphenyl diphosphonic acid  following a slight modification 
of a recorded procedure.26 4,4-Dibromophenyl (6.27 g, 0.02 mol) were placed into a 
250mL flask equipped with a stir bar and containing 50 mL of 1,3-diisopropylbenzene. 
The mixture was heated to 185 oC and NiBr2 (0.5 g, 0.002 mol) was added with stirring. 
The flask was purged with N2 while triethylphosphite (P(OC2H5)3) (10 mL, 0.058 mol), 
was added slowly
 
over a period of
 
6 hours. The brown mixture, which was refluxed for 24 
hours turned black. An additional NiBr2 (0.25 g, 0.001 mol) and P(OC2H5)3 (5 mL, 0.029 
mol) were added to the black mixture and heated for 24 hours. The resulting black 
solution was distilled to remove the diisopropylbenzene and excess P(OC2H5)3. The 
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resulting black sticky product was extracted with 50 mL cyclohexane three times and the 
colorless solution was kept at room temperature over night. The solution was filtered to 
obtain a white solid which was recrystallized from petroleum ether. The crystals were 
dissolved in 40 mL concentrated HCl and refluxed for 12 hours, thereafter, 40 mL 
distilled H2O was added and stirred for 12 hours. The resulting precipitate was filtered, 
washed with distilled H2O and air dried to obtain a dirty white solid (Scheme 3.7). Yield: 
1.55 g, 0.005 mol, 18 %; m.p.: 163 oC (decomposition); 1H-NMR (300MHz, [D6]DMSO, 
25oC): δ = 7.40 pm (m, 8H, PhH); IR (Nujol): 2897.2(s), PO-H 2722.0(m), 2354.6(w), 
1596.1(w), 1467.8(s), P=O 1152.7(s), 1024.3(m), 936.8(m), 814.3(w), P-C 709.1(m), 
551.7(w), 452.1(w). 
 
N21,3-iP
rC6H5
NiBr2
(CH3CH2O)2OP(C6H4)2PO(OCH2CH3)2  +  2EtBr 
2P(OCH2CH3)3  +  Br(C6H4)2Br 
HCl
(HO)2OP(C6H4)2PO(OH)2  +  4CH3CH2Cl
 
Scheme 3.7. Synthesis of 4,4′-biphenyl diphosphonic acid, H4BPDPA. 
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3.7.4 Synthesis of 4-(4’-Phosphono phenoxy) Phenylphosphonic Acid, H4PPPA: 
The 4-(4’-Phosphono phenoxy) phenylphosphonic acid ligand was prepared by a 
modified synthetic route,27 as shown in Scheme 3.8. Bis-(4-bromophenyl) ether (12.21g 
0.04 mol) and 1,3-diisopropylbenzene (93 mL, 0.49 mol) of were measured into a 500 
mL three-necked flask containing a stir bar. The flask was then fitted with a reflux 
condenser with nitrogen inlet, an addition funnel and a thermometer. The flask was 
purged with nitrogen and then heated to 70-80°C while stirring. The addition funnel was 
momentarily removed to add dry anhydrous nickel (II) chloride (0.485 g, 0.003 mol), 
which served as a catalyst. The brown mixture was refluxed under a stream of nitrogen 
gas at 180°C while triethylphosphite (18.6 mL, 0.12 mol) was added over a 3 hour period 
using the addition funnel. The mixture was heated for 24 hours maintaining a temperature 
of around 150°C. Then another portion of dry nickel (II) chloride (0.428 g, 0.003 mol) 
and triethylphosphite (18.6 mL, 0.12 mol) were added. The mixture was heated while 
stirring for another 24 hours and then allowed to cool overnight.  
The solvent was removed from the resulting dark black solution by vacuum 
distillation and then kept at room temperature for two days until it became sticky and tar-
like. The product was extracted with hexane in a Soxhlet extractor. The extraction was 
allowed to continue for four days, and then the hexane was removed by distillation 
affording an oily product.  
The product was dissolved in ethanol (232 mL, 3.9 mol) and then transferred to a 
500 mL three-neck flask fitted with a stir bar, a thermometer, addition funnel, and reflux 
condenser. The solution was heated to 80°C while stirring. Then concentrated HCl (93 
mL, 1.08 mol) was added dropwise over a two hour period to hydrolyze the ester. After 
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the hydrochloric acid was added, the reflux set-up was replaced by a distillation apparatus 
to allow the collection of the ethyl chloride. The solution was heated at 80°C for 5 days 
and allowed to cool to room temperature.  A white solid was obtained upon rotary 
evaporation which was washed with water and dried at 60 oC. Yield: 5.26 g, .015 mol, 
44%; m.p.: 271-275 oC; 1H-NMR (300MHz, CDCl3, 25oC): δ = 7.80 pm (q, 4H, PhH), 
7.13 pm (q, 4H, PhH); IR (Nujol): PO-H 1352.2(s), 1100.6(m), P-C 714.4(w). 
 
N21,3-iP
rC6H5
NiCl2
(CH3CH2O)2OP(C6H4OC6H4)PO(OCH2CH3)2  +  2EtBr 
P(OCH2CH3)3  +  BrC6H4OC6H4Br 
HCl
(OH)2OP(C6H4OC6H4)PO(OH)2  +  4CH3CH2Cl
 
Scheme 3.8. Synthesis of 4-(4’-Phosphonophenoxy) phenylphosphonic acid, H4PPPA 
 
 
3.7.5 Synthesis of Amino trimethylenephosphonic Acid, H6ATMPA: 
The triphosphonate ligand was prepared by the Mannich reaction10 with a few 
modifications, as shown in Scheme 3.9. Into a 1 L three-neck flask containing ammonium 
chloride (17.8 g, 0.33 mol) and a stir bar, H3PO3 (82.0 g, 1.00 mol) diluted in 100 mL 
distilled water was added. The clear solution was immediately acidified with 100 mL 
concentrated HCl while stirring and purging with N2. The mixture was then refluxed for 
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an hour after which 160 mL 37 % (1.61 mol) aqueous formaldehyde (H2CO) was added 
dropwise at a rate of about 2.6 mL/min with the aid of a dropping funnel. The mixture 
was refluxed for another hour and cooled to room temperature. Once the mixture was 
cool, the water was removed by rotary evaporation. The remaining colorless solution was 
left at room temperature until crystals formed after three weeks. The crystals were 
washed with a 5:1 acetone/water mixture. The white solid was air dried and weighed. 
Yield: 66.5 g,  0.20 mol, 67.4%; m.p. 210-212 oC; 1H-NMR (300MHz, D2O, 25oC): δ = 
3.74 pm (d, JP-C-H = 12 Hz, 6H, CH2); IR (Nujol): 2726.9(s), P-OH 2640.6(s), P=O 
1154.6(m), 1368.6(s), 1298.7(m), 930.1(w), 715.5(m), 722.5(s). 
 
NH4Cl  +  3H3PO3  +  3CH2O + 2HCl N(CH2PO3H2)3  + 3HClO + 3H2
H2O
reflux
 
Scheme 3.9. Synthesis of amino tris(methylenephosphonic) acid, H6ATMP. 
 
3.7.6 Synthesis of ethylenediamine tetramethylenephosphonic acid, H8EDTMPA: 
A modified synthesis for ethylenediamine tetramethylenephosphonic acid was 
employed.28 Phosphorous acid (20.5 g, 0.25 mol) were added to concentrated HCl (15.6 
mL, 0.18 mol) in a 100 mL three-necked flask containing a stir bar. To this mixture, 
ethylenediamine (3.3 mL, 0.05 mol) was added slowly with stirring followed by reflux at 
130 oC for ten minutes. To the resulting pale yellow solution, formaldehyde (19.8 mL, 
0.54 mol) was added dropwise over a period of ten minutes. The resulting yellow solution 
was refluxed for another two hours, allowed to cool to room temperature and the solvent 
was reduced under vacuum. White crystalline product formed when the concentrated 
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solution was left at room temperature overnight. The solid was filtered, washed with cold 
water and allowed to air dry (Scheme 3.10). Yield: 15.1g, .004 mol, 78.4 %; m.p.: 216-
220 oC; 1H-NMR (300MHz, D2O, 25oC): δ = 3.80 pm (s, 4H, CH2), 3.50 pm (d, JP-C-H = 
12.3 Hz, 8 H, CH2); IR (Nujol):1590.3(w), H-O 1450.2(s), N-C 1362.7(s), 1152.7(w), 
732.6(m), 528.4(w). 
 
H2N(CH2)2NH2 +  4H2CO  + 4H3PO3 
HCl -H2O
(H2O3PCH2)2N(CH2)2N(CH2PO3H2)2
 
Scheme 3.10. Synthesis of ethylenediamine tetramethylenephosphonic acid, H8EDTMPA. 
 
3.8 Experimental Details 
Triethylphosphite, acetonitrile, 1, 2-dibromoethane, 1, 3- dibromopropane, 4,4′-
dibromophenly, bis-(4-bromophenyl) ether, ammonium chloride, formic acid, 
hydrochloric acid, anhydrous nickel (II) chloride, anhydrous nickel (II) bromide, 
formaldehyde, ethylenediamine, phosphorous acid, 1,3-diisopropylbenzene, cyclohexane, 
petroleum ether, ethanol and acetone were obtained commercially. Triethylphosphite
 
was 
distilled prior to use while others were used as purchased. 
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 Products were analyzed by IR spectroscopy. A Perkin-Elmer PE 1600–FT-IR 
spectrometer was used to collect IR spectra as Nujol mulls between KBr plates. Melting 
points were determined using the Thermocouple VWR thermometer probe. 
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CHAPTER 4  
Synthetic and Structural Studies on Calcium Phosphinate, Phosphonate, Phosphite 
and Phosphate Compounds. 
4.1 Introduction 
Interest in calcium phosphonate chemistry has risen due to the use of 
phosphonate–based drugs that are employed for treatment of bone diseases,1-3 yet very 
little work has been done to understand the coordination chemistry of calcium with 
phosphonate based ligands. The paucity of information is due to difficulties in obtaining 
quality crystals of calcium phosphonates. The large radii of the heavy alkaline earth metal 
ions (Ca2+ =1.14 Å, Sr2+ = 1.272+ Å and Ba2+ = 1.49 Å) result in a significant tendency 
towards aggregation, rendering the resulting products insoluble.4 Aggregation is one of 
the means to achieve coordinative saturation as is the coordination of co-ligands such as 
water.4  
Hydrothermal and solvothermal synthetic routes which are used extensively for 
the preparation of transition metal phosphonates are explored in the synthesis of calcium, 
phosphinate, phosphite and phosphate compounds. To this effect, soluble calcium salts 
and ligands are allowed to react at elevated temperatures and pressures to enhance the 
solubility of the products and thus promote the crystallization process.  
Phenylphosphinic acid has been successfully used in the synthesis of a number of 
phenylphosphinate metal compounds5 with important applications as sorbents, ion 
exchangers in resins,6,7 sensors and catalysts.6 In addition, studies have demonstrated that 
the addition of phenylphosphonic and phenylphosphinic acids to hydroxyapatite (HA) 
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Ca10(PO4)6(OH)2,  have increased its surface area and porosity8  as the P-OH moieties on 
the HA surface are responsible for the adsorption of mineral and organic species.9 HA is 
the major inorganic mineral in bone and therefore plays a major role in biomaterials10 and 
in catalysis.11  
The following ligands (Figure 1.4) are used in forming the compounds that will be 
discussed in this chapter, namely phenylphosphinic acid (HPPA) C6H5PO(OH)H (a) in, 
phenylphosphonic acid (H2PPA) C6H5PO(OH)2 (b), phosphorous acid H3PO3 (c), and 
phosphoric acid H3PO4 (d),  resulting from decomposition products of 
ethylenediphosphonic acid. 
 
(a) (b) (c) (d)
 
 
Figure 4.1. (a). Phenylphosphinic acid (HPPA) pKa 1.7512 (b). Phenylphosphonic acid (H2PPA) pKa1 1.83, 
pKa2 7.0713, (c). Phosphonic acid (H3PO3) pKa1 1.3, pKa2 6.7 14 (d). Phosphorus acid (H3PO4) pKa1 2.12  
pKa2 7.21  pKa3 12.6515 
 
With the exception of the HPPA ligand which is monobasic and therefore forms 
only monoanionic species, the H2PPA, H3PO3 and H3PO4 ligands can exist as mono-, di- 
and trianionic species. The names of the acids and their respective are provided in Table 
4.1. 
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Table 4.1. Nomenclature of some P-based oxoacids and their anions 
Phenylphosphinic acid
phenylphosphonate
phenylphosphinate
Phenylphosphonic acid hydrogen phenylphosphonate
Phosphonic acid hydrogen phosphite phosphite
Phosphoric acid dihydrogen phosphate hydrogen phosphate phosphate
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Six compounds, 1-6 are hereby presented: calcium phenylphosphinate, 1 
involving the HPPA ligand, calcium hydrogen phenylphosphonate, 2 based on the H2PPA 
ligand, anhydrous calcium hydrogen phosphite, 3 and calcium hydrogen phosphite 
monohydrate, 4, involving the H3PO3 ligand in its monoanionic form (H2PO3-), calcium 
phosphite monohydrate, 5, involving H3PO3 ligand in its dianionic form (HPO32-) and 
calcium hydrogen phosphate 6 containing H3PO4 in its dianionic form (HPO42-). Among 
those, the remaining new compounds 1, 3 and 6 will be described in detail. Compound 1 
and 3 are new compounds; no other alkaline earth metal phenylphosphinate compound 
has been reported. Compound 6 is however, a well known mineral but no structural data 
are available. Compounds 2, 4 and 5 have been reported previously so we only report an 
improved crystallographic analysis.16-20  
 
4.2 Synthetic Considerations for compounds 1, 3, and 6. 
To obtain single crystals suitable for single crystal X-ray diffraction, 
hydrothermal synthesis involving a calcium source in aqueous medium with the ligand 
followed by slow evaporation of solvent at room temperature is employed. Details on 
hydrothermal synthesis and its use in the preparation of metal organic frameworks is 
discussed in Chapter 3. Difficulties in obtaining crystalline samples of compounds 1, 3, 
and 6 resulted in extensive work to optimize crystallization conditions, such as the 
introduction of different calcium sources, different stoichiometric ratios of calcium salt to 
ligand etc., leading to specific synthetic and crystallization conditions for each compound 
as provided below. 
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4.2.1 Calcium Phenylphosphinate, {Ca[C6H5PH(O)2]2[C6H5PH(O)OH]2}n (1): 
Multiple avenues to obtain crystalline samples were explored, involving the 
treatment of the ligand with various calcium salts in water or DMF both at room 
temperature and under hydrothermal conditions. Of those, the reaction of CaCl2 with the 
ligand under hydrothermal conditions afforded poorly diffracting samples. Introduction 
of terephthalic acid, phosphorous acid and the coligand 1,4-dioxane under hydrothermal 
conditions only afforded powdery samples. Crystalline samples were obtained in a 
reaction involving CaCl2 and phenyl phosphinic acid, HPPA in the presence of 
ethylenediphosphonic acid, H4EDPA, as shown in Scheme 4.1. 
 
CaCl2  +  C6H5PH(O)OH H2O/C2H8O6P2
80 oC
{Ca[C6H5PH(O)2]2[(C6H5PH(O)OH]2}n  (1)
 
Scheme 4.1. Synthesis of calcium phenylphosphinate, 1. 
 
4.2.2 Anhydrous Calcium Hydrogenphosphite, [Ca0.5(H2PO3]n (3): 
Little is known on the chemistry of the 4-(4’-phosphonophenoxy) phenyl 
phosphonic acid, (H4PPPA) ligand (Figure 4.2), likely a consequence of its low solubility 
in water. Accordingly, any attempts to utilize this ligand failed. However, the presence of 
the ligand during the reaction of calcium chloride and phosphorous acid led to the 
unexpected formation of calcium hydrogenphosphite monohydrate (4). As this has been  
reported previously, its synthesis will not be discussed further in this work.20,21  
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Figure 4.2. 4-(4’-phosphonophenoxy) phenyl phosphonic acid, H4PPPA. 
 
Since the H4PPPA ligand was not contained in the final product, the reaction was 
repeated excluding the ligand to determine if it played any role in the formation of 4. This 
resulted in the formation of anhydrous calcium hydrogenphosphite (3). Compound 3 was 
therefore obtained by treating CaCl2 with H3PO3 under solvothermal conditions in ethanol 
(Scheme 4.2) 
 
CaCl2  + H3PO3 
C2H5OH
150 oC
[Ca0.5(H2PO3)]n  (3)
 
            Scheme 4.2. Synthesis of anhydrous calcium hydrogen phosphite 3. 
 
4.2.3. Anhydrous Calcium Hydrogenphosphate, [CaHPO4]n (6): 
 Anhydrous calcium hydrogenphosphate is a well known dibasic compound but its 
extended crystal structure has not been reported. Extensive crystallographic studies of the 
hydrated form, CaHPO4·2H2O exist due to its established role in the formation of kidney 
stones.22 Thermogravimetric studies on calcium hydrogen phosphate dihydrate indicate 
dehydration upon heating to 294 oC.23 There are no previous crystallographic data on 6. 
Compound 6 was obtained from a likely decomposition of ethylenediphosphonic 
acid. After several unsuccessful attempts to coordinate ethylenediphosphonic acid 
(H4EDPA) to calcium (Chapter 7), we decided to introduce ethylenediamine 
tetramethylenephosphonic acid (H8EDTMPA) as co-ligand to a mixture of calcium 
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nitrate in water under hydrothermal conditions. The result was a 3D extended structure of 
6 (Scheme 4.3). 
 
(HO3PCH2)2N(CH2)2N(CH2PO3H)2 Ca(NO3)2.4H2O  +  H2O3P(CH2)2PO3H2
H2O,170 oC
[CaHPO4]n  (6)
 
Scheme 4.3. Synthesis of anhydrous calcium hydrogen phosphate, 6. 
 
4.3 Structural Aspects 
4.3.1 Calcium Phenylphosphinate, {Ca[C6H5PH(O)2]2[C6H5PH(OH)O]2}n, (1): 
Compound 1 was obtained hydrothermally from the reaction of phenylphosphinic 
acid (HPPA), ethylenediphosphonic acid (H4EDA) and calcium chloride in the ratio of 
2:1:1.  Interestingly, only the phenylphosphinic acid is found in the product. It is difficult 
to rationalize which  factors  may have influenced the deprotonation of one ligand over 
the other, but the two ligands have slightly different pKa values; phenylphosphinic acid 
(HPPA) and ethylenediphosphonic acid (H4EDA)have respective values of 1.65±0.10 and 
1.77±0.14 in DMSO at 25 ºC,24 indicating that HPPA is slightly more acidic than H4EDA. 
In addition the stoichiometric ratios of HPPA:H4EDPA were 2:1. 
          Compound 1 was structurally characterized by single crystal X-ray crystallography. 
The details of crystallographic data and structure refinement parameters are summarized 
in Table 4.2 in the experimental section of this chapter. Compound 1 crystallizes in the 
triclinic space group P-1 and represents the first alkaline earth phenylphosphinate. The 
structure of 1 is shown in Figures 4.3 and 4.4.  
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Figure 4.3. Labeling scheme of 1 showing the polymeric chain viewed from the y axis. The phenyl groups 
have been removed except the ipso carbon atoms shown in black. 
 
 
Figure 4.4. Graphical representation of compound 1. The metal centers are represented by green spheres, 
oxygen (red), carbon (black), hydrogen (gray) and phosphorus by purple spheres. 
 
The asymmetric unit of 1 consist of one calcium and two singly deprotonated 
ligands. The Ca2+ ion is six-coordinated exhibiting a distorted octahedral geometry. There 
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are four singly deprotonated ligands shared between two Ca2+ ions ensuring charge 
balance while two additional neutral ligands are also metal bound. In effect, the structure 
of 1 is constructed from HPPA in two binding modes to the Ca2+ ion; whereas the 
deprotonated PPA- bridges two symmetrically related calcium centres, the neutral ligand 
coordinates to calcium center via the P=O moiety (Scheme 4.5).  
PH O−
O
PH O−
O
PH OΗ
O
PH OΗ
O
Ca
Ca
Ca
PPA-
HPPA
 
Scheme 4.4. Ligand in two deprotonated states with different binding modes in compound 1. 
 
The coordination environment of each Ca2+ consists of six oxygen atoms 
comprising three pairs of symmetrically related oxygen atoms (O1, O3, O4) with calcium 
in an inversion center. The oxygen atoms of PPA- (O3 and O4), bridge the neighbouring 
Ca2+ ions to give a chain structure. The P-O distances of O3 (P1-O3, 1.491(2) Å) and O4 
(P2-O4, 1. 490(2) Å) are shorter compared to P-O distances of O1 (P2-O4, 1.524(2) Å and 
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O2 (P1-O2, 1.555(2) Å) but the longest P-O distance of 1.555(2) Å corresponds to the 
pendant P-OH (O2) moiety of the neutral ligand. The shortest P=O bond length of 1 
1.491(1) deviates only slightly from that of the neutral ligand (1.493(1) Å) shown in 
Figure 4.5.25  
 
 
Figure 4.5. The structure of neutral phenylphosphinic acid,25 showing phosphorus as a purple 
sphere, oxygen as red, carbon black and hydrogen atoms in grey spheres. 
 
 The P=O and P-O bond distances are usually affected by substituents on the 
phenyl group.26 The H atoms on the P atom were located from the electron density map 
and refined freely at a distance of 1.278(3) Å and 1.288(3) Å from P1 and P2 
respectively. Selected bond distances and bond angles are listed in Table 4.3. 
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Table 4.3 Selected bond lengths [Å] and angles [°] for calcium phenylphosphinate 1 
_________________________________________________________________________________ 
 Bond distances                              Bond distances                             Bond angles 
_________________________________________________________________________________ 
Ca(1)-O(1)         2.3055(2)             P(2)-O(4)        1.4929(2)                    O(1)-Ca(1)-O(3)     92.53(6) 
Ca(1)-O(1)#1     2.3055(2)             P(2)-O(1)        1.5236(2)                    O(1)-P(1)-O(2)       116.42(1) 
Ca(1)-O(4)#2     2.3443(2)               O(4)-Ca(1)#4  2.3443(2)                    O(1)-P(1)-C(1)        111.54(1) 
Ca(1)-O(4)#3     2.3444(2)               P(2)-C(7)        1.798(3)                        O(2)-P(1)-C(1)        107.21(1) 
Ca(1)-O(3)         2.3609(2)                P(1)-O(3)        1.4905(2)                    O(4)-P(2)-O(3)        116.93(1) 
Ca(1)-O(3)#1     2.3609(2)               P(1)-O(2)        1.555(2)                        O(4)-P(2)-C(7)        109.87(1)            
C(1)-C(6)           1.393(4)    
P(1)-H1              1.278(2)                
P(1)-C(1)        1.801(3)     
P(2)-H2           1.288(2)       
O(3)-P(2)-C(7)        108.81(1) 
   
__________________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x,-y,-z+2    #2 -x+1,-y,-z+2    #3 x-1,y,z     #4 x+1,y,z       
 
 
A number of alkali and alkaline earth phenylphosphonates are known, specific 
examples include M[(C6H5)P(O)2OH)] [(C6H5)PO(OH)2)]  ) where M = Li, Na, K, Rb, 
Cs,27 Mg (Mg(O3PC6H5)·2H2O) ,28 Ca{[Ca[(C6H5)P(O)2OH)] 2 }n (2),18,19,28,29 Sr 
(Sr(C6H5)P(O)2OH)2),19,28-30 and Ba (Ba(C6H5)P(O)2OH)2).28,29 The Mg compound is the 
only example of alkaline earth phenylphosphonate with a doubly deprotonated ligand.   
Calcium hydrogen phenylphosphonate {[Ca[(C6H5)P(O)2OH)] 2 }n (2)  18,31 was 
synthesized by refluxing calcium nitrate and phenylphosphinic acid in water and 
crystallized under hydrothermal reaction conditions. Compound 2 forms a layer structure 
based on eight-coordinate calcium centers, as shown in Figures 4.6 and 4.7. There are 
three oxygen atoms per ligand which are all involved in metal coordination. The 
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deprotonated O1 bridges two metal centers, P=O3 acts as a donor atom to a single Ca 
center while O2 remains protonated as P-OH. The Ca-O bond lengths in 2 (2.346(3)-
2.667(3) Å) compare to those in 1 (2.348(1)-2.521(1) Å). 
 
 
Figure 4.6. Structure of 2 viewed along the c-axis with partial labeling. 
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Figure 4.7. The layered structure of 2, all atoms of the phenyl group except the ipso carbon atoms have 
been removed for clarity.  
 
Significant differences between the structures of 1 and 2 exist; the most 
fundamental one is the metal coordination number and the dimensionality of the resulting 
solid. Both 1 and 2 form chains via bridging phosphinate and phosphonate oxygen atoms. 
In 2, only O1 is involved in bridging the metal centers  whereas in 1, the metal centers are 
bridged by O-P-O moieties. 
While compound 1 forms a chain, the corresponding calcium hydrogen 
phenylphosphonate compound 2 is a layer structure. Other phenyl hydrogen 
phosphonates such as [Ca(HO3PC6H5)2]n,19,29,31 [Ca(O3PC6H5)·H2O]n,31 
[Ca(O3PC6H5)·2H2O]n 31 and [Ca3(HO3PC6H5)2(O3PC6H5)2]n31 form layered structures. 
Likewise, zinc phenylphosphinate [Zn(O2PHC6H5)2]n, is a chain polymer32,33 whereas the 
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corresponding phenylphosphonate  [Zn(HO3PC6H5)2]n·H2O34 is a layered structure. This 
trend is not limited to the phenylphosphonate and phenylphosphinates, but other divalent 
monophosphonates35 such as Ca(O3PCH3).H2O, Ca(HO3PC6H13)2,36 and 
Zn(O3PCH3).H2O 37-39  have layered structures whereas the corresponding phosphinates 
of  zinc33 and manganese40 are one-dimensional,41 suggesting that the additional oxygen 
atom contributes to the extension of the structure in two dimensions.  
Studies have indicated that in an acidic medium, [Ca(O3PC6H5)·2H2O]n is 
protonated to form [Ca(HO3PC6H5)2]n while the reverse occurs in weak basic medium.31 
 
4.3.2 Anhydrous Calcium Hydrogenphosphite, {Ca[PH(O)2OH]2}n (3):   
The novel anhydrous calcium hydrogenphosphite 3 was formed by the 
hydrothermal synthesis from CaCl2 and phosphonic acid in a Carius tube at 150 oC for 
three days. The hot Carius tube was allowed to cool to room temperature and colorless 
hexagonal plates of crystals deposited overnight. Compound 3 was structurally 
characterized by single crystal X-ray crystallography. The details of crystallographic data 
and structure refinement parameters are summarized in Table 4.2 in the experimental 
section of this chapter. 
 Compound 3 crystallizes in the triclinic P-1 space group with a calcium ion in a 
distorted octahedral geometry. The Ca2+ center is in a special position, with coordination 
to two singly deprotonated phosphonic acid ligands as shown in Figure 4.8. The overall 
structure is two-dimensional. 
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Figure 4.8. Schematic labelling of 3 
 
The P=O1 and P-O-2 distances are similar (1.506(8) Å and 1.507(8) Å) while the 
P-O3H distance is slightly longer (1.570 (9) Å. Bond distances and angles for compound 
3 are summarized in Table 4.4. The P-H distance of 1.389(1) Å compares well with those 
of other phosphite compounds. The distorted octahedral geometry is
 
evident from the 
wide range of O-Ca-O angles (67.55 (3) Å-92.88 (3) Å). 
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Table 4.4.  Selected  Bond lengths [Å] and angles [°] for anhydrous calcium hydrogen phosphite 3. 
__________________________________________________________________________________ 
Bond length                             Bond Angles                                           Bond Angles 
__________________________________________________________________________________ 
Ca(1)-O(2)#1    2.358(8)         O(2)#1-Ca(1)-O(2)#2     166.00(4)         O(1)-P(1)-O(2)     115.69(5) 
Ca(1)-O(1)#3    2.368(8)         O(2)#1-Ca(1)-O(1)#3     86.37(3)           O(1)-P(1)-O(3)     113.99(5) 
Ca(1)-O(2)#5    2.403(8)         O(2)#2-Ca(1)-O(1)#3     84.74(3)           O(2)-P(1)-O(3)     105.64(5) 
Ca(1)-O(3)#5    2.979(1)         O(1)#3-Ca(1)-O(1)#4     101.08(4)         O(1)-P(1)-H(1)     106.30(5) 
P(1)-O(1)          1.506(8)         O(2)#1-Ca(1)-O(2)#5     71.03(3)           O(2)-P(1)-H(1)     111.30(6) 
P(1)-O(2)          1.507(8)         O(1)#4-Ca(1)-O(3)#5     153.18(3)         O(3)-P(1)-H(1)      103.30(6) 
P(1)-O(3)          1.570(9)         O(2)#2-Ca(1)-O(2)#5     120.18(3)         P(1)-O(3)-H(3)     121.50(2) 
P(1)-H(1)          1.389(1)         O(1)#3-Ca(1)-O(2)#5     92.88(3) 
                                                 O(1)#4-Ca(1)-O(2)#5     151.21(3) 
                                                 O(2)#1-Ca(1)-O(3)#5     122.05(2) 
                                                 O(2)#2-Ca(1)-O(3)#5     67.55(3) 
                                                 O(1)#3-Ca(1)-O(3)#5     83.30(3) 
__________________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 x,-y+2,z+1/2    #2 -x,-y+2,-z    #3 -x,y+1,-z+1/2       
#4 x,y+1,z    #5 -x,y,-z+1/2    #6 -x,-y+2,-z+1       
#7 x,y-1,z       
 
The sheet structure of 3 is propagated by O2 in a dual role; first by bridging two 
calcium centers along the b-axis and secondly by connecting the Ca2+ centers through the 
O1-P-O2 moiety, thereby extending the structure along the c-axis, as shown in Figure 
4.9. Apparently, the pendant P-OH (O3) group terminates the propagation, limiting the 
dimensionality of the structure to two.  
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Figure 4.9. A sheet structure of 3 viewed down the b-axis, showing hydrogen bonding in blue dotted lines. 
The metal centers are represented by green spheres, oxygen (red), carbon (black), hydrogen (gray) and 
phosphorus by purple spheres. 
 
 
Due to the presence of an uncoordinated  P-OH group (O3) on each ligand, 
hydrogen bonds occur within the sheets as indicated in Figure 4.10, with a O3···O1 
(donor-acceptor atoms D···A involved in hydrogen bonding) distance of 2.70 Å which is 
shorter than the sum of their Van der Waals radii (3.0 Å).  
Two-dimensional, isostructural sheets of Mg(HPO3)·6H2O,42,43  Ca(HPO3)·H2O 
(5) and Sr(HPO3)·H2O21 have also been reported. In these compounds, the phosphonic 
acid ligand is doubly deprotonated whereas it is singly deprotonated in 3 and in  
{Ca[PH(O)2OH(H2O)]2}n, 4. The extent of deprotonation may be based on the different 
reaction conditions employed. 
The main difference between 3 and 4 is that compound 4 has one coordinating 
water molecule, but compound 3 is anhydrous. The presence of the water molecule in 4 
CHAPTER 4: Phosphinate, Phosphonate, Phosphite and Phosphate Compounds      78 
 
leads to a seven-coordinated metal center versus six in 3, and contributes to an increase in 
dimensionality through hydrogen bonding. In addition, one phosphonate O-H in 4 
coordinates to the metal center. In contrast, in 3 none of the phosphonate O-H is involved 
in extending the structure, resulting in a lower overall dimensionality.  
The crystal structure of 4 has already been reported by Larbot and Cot20 and 
Mahmoudkani and Langer.21 The literature preparation of 4 however involved a 
metathesis reaction between CaCO3 and H3PO3.44 The crystal structure of 4 was 
redetermined to draw a better comparison with compound 3. 
Compound 4 indicates a three-dimensional structure with seven coordinate Ca2+ 
centers. The asymmetric unit of 4 (Figure 4.10) consists of one calcium ion center in 
coordinated to two singly deprotonated H3PO3 ligands and one water molecule (Figure 
4.11). 
 
 
Figure 4.10. Schematic labeling of 4 showing the asymmetric unit of [Ca(H2PO3)2(H2O)]n 
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Figure 4.11. The calcium environment of 4, showing seven coordination made of six phosphite oxygen 
atoms and one water molecule. The metal centers are represented by green spheres, oxygen (red), carbon 
(black), hydrogen (gray) and phosphorus by purple spheres. 
 
 
The Ca-O bond distances in 4 range from 2.35(1) Å to 2.53(1) Å. The P-O bond 
distances 1.504(1)-1.570(2) are different from those in the phosphonates where typically 
three distinct P-O bond distances corresponding to P=O, P-O- and P-OH are observed. 
This is one of the special cases where in one ligand the oxygen with the acidic proton 
(O6, Figure 4.12) coordinates to the metal center, wheras in the second ligand there is a 
pendant P-OH (O3).  
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Figure 4.12. Sheet structure of 3 viewed along the b-axis, showing chelate formation by O4 and O6 and 
bridging involving O5-P-O4 in a eight-atom ring system.  
   
The second ligand is metal-bound in a chelate fashion involving O4 and O6; the 
third oxygen O5 bridges two metal centers through a O4-P-O5 moiety to form an eight-
membered ring system, (shown in Figure 4.9), typical of phosphinate (1) and 
phosphonates 10-13 (Chapter 6). The bridging motif in the ligand is shown in Figure 
4.13, showing how the layers are connected, but leaving one non-coordinated P-OH on 
the ligand. Hydrogen bonds between water molecules and pendant P-OH groups hold 
sheets of 4 together to form a three dimensional structure. In addition, weak hydrogen 
bonds involving O3-H··· O5 exist within the sheets (Figure 4.14). The hydrogen bond 
distances are provided in Table 4.4. 
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Figure 4.13. Structure of 4 viewed along the c axis showing O1-P-O2 linkage between sheets with partial 
labeling of the oxygen atoms.  
 
 
Figure 4.14. Structure showing extended view of 4, with hydrogen bonds between layers (shown by 
vertical dotted blue lines) that hold the sheets into a 3D structure. Hydrogen atoms within the sheets are 
indicated by the horizontal dotted blue line.  
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4.3.3 Calcium Hydrogenphosphate, [CaHPO4]n (6): 
The novel calcium hydrogen
 
phosphate, 6 was prepared by dissolving calcium 
nitrate and ethylenediphosphonic acid in water in the presence of tetramethylene-
phosphonic acid. The mixture was placed in a Carius tube, sealed under vacuum and kept 
at 170 oC for 12 days during which colorless blocks of crystals formed. Compound 6 was 
structurally characterized by single crystal X-ray crystallography. The details of 
crystallographic data and structure refinement parameters are summarized in Table 4.2 in 
the experimental section of this chapter.  
Compound 6 crystallizes in the triclinic space group P-1. It is a three-dimensional 
compound comprised of two hydrogen phosphate ions HPO42- and two 
crystallographically independent calcium ions in the asymmetric unit. Each ligand is 
therefore doubly deprotonated, O2 and O3 and O6 and O7 respectively belong to the two 
hydrogen phosphate ligands. Each ligand also contains a protonated P-OH functionality, 
these are O4 and O8 respectively. The P=O moieties are O1 and O5. 
 All phosphate oxygen atoms are involved in metal coordination and each calcium 
ion is coordinated by seven phosphate oxygen atoms (Figure 4.15).  
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Figure 4.15. Calcium environment of the seven coordinate compound 6.  
 
However the two ligands display two binding modes, in one, O3 and O4 are 
involved in chelate formation, in addition, O1, O3 and O4 bridge between the metal 
centers. In the other ligand, chelate formation involves O5 and O7 whereas O7 bridges 
two Ca1 centers. O8 is responsible for the dense three-dimensional structure (Figure 
4.16). The difference in binding modes of the phosphorus acid ligand is reflected in the 
wide range of P-O bond distances (1.509 (2) Å to 1.589 (2) Å). 
                 
Figure 4.16. The binding modes of phosphorus acids in compound 6 
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The Ca-O bond lengths range between 2.294 (2 ) and 2.684 (2) Å, the shortest 
being Ca(1)-O(5) while the longest correspond to Ca(1)-O(4). Selected bond distances 
and lengths are summarized in Table 4.5. 
 The previously reported CaHPO4 was precipitated from a homogeneous solution 
via urea hydrolysis.45 Alkaline earth phosphonates involving Mg have also been 
reported.46 
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Table 4.5.   Bond lengths [Å] and angles [°] for anhydrous calcium hydrogen phosphate (6) 
__________________________________________________________________________  
Ca(1)-O(5)#1         2.294(2)                     O(5)#1-Ca(1)-O(1)#2          78.77(8) 
Ca(1)-O(1)# 2        2.348(2)                     O(5)#1-Ca(1)-O(8)#3          104.94(8) 
Ca(1)-O(8)# 3        2.407(2)                     O(1)#2-Ca(1)-O(8)#3          110.43(8) 
Ca(1)-O(7)#4         2.419(2)                     O(5)#1-Ca(1)-O(7)#4          157.60(7) 
Ca(1)-O(7)             2.431(2)                     O(1)#2-Ca(1)-O(7)#4          79.73(8) 
Ca(1)-O(3)             2.478(2)                     O(8)#3-Ca(1)-O(7)#4          88.41(7) 
Ca(1)-O(4)             2.684(2)                     O(5)#1-Ca(1)-O(7)              89.60(7) 
P(1)-O(1)                1.509(2)                    O(1)#2-Ca(1)-O(7)              74.09(7) 
P(1)-O(2)                1.529(2)                    O(8)#3-Ca(1)-O(7)              165.30(7) 
P(1)-O(3)                1.554(2)                    O(7)#4-Ca(1)-O(7)              78.52(7) 
P(1)-O(4)                1.556(2)                    O(5)#1-Ca(1)-O(3)              123.58(7) 
P(2)-O(5)                1.518(2)                    O(1)#2-Ca(1)-O(3)              153.19(8) 
P(2)-O(6)                1.522(2)                    O(8)#3-Ca(1)-O(3)              80.01(8) 
P(2)-O(7)                1.543(2)                    O(7)#4-Ca(1)-O(3)              75.87(7) 
P(2)-O(8)                1.589(2)                    O(7)-Ca(1)-O(3)                  90.19(7) 
Ca(2)-O(6)#7          2.378(2)                    O(5)#1-Ca(1)-O(4)              70.22(7) 
Ca(2)-O(2)#8          2.421(2)                    O(1)#2-Ca(1)-O(4)              148.77(8) 
Ca(2)-O(1)#7          2.466(2)                    O(8)#3-Ca(1)-O(4)              75.16(7) 
Ca(2)-O(5)#4          2.470(2)                    O(7)#4-Ca(1)-O(4)             131.   50(7) 
Ca(2)-O(6)#9          2.473(2)                    O(7)-Ca(1)-O(4)                 108.58(7) 
Ca(2)-O(4)#9          2.533(2)                    O(3)-Ca(1)-O(4)                 56.66(7) 
Ca(2)-O(7)#4          2.565(2)                                                                                      
________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
  #1 -x+1,-y,-z+1    #2 x+1, y, z    #3 x, y, z+1    #4 -x+1,-y+1,-z+   #5 x, y-1, z    #6 x-1, y, z     
#7 -x,-y+1,-z+1    #8 -x,-y+1,-z+2    #9 x,y+1,z    #10 -x,-y+2,-z+1    #11 x,y,z-1  
 
4.4 Conclusions 
Three calcium compounds based on phosphorus oxoacids have been synthesized 
and structurally characterized. Of those, two are novel compounds, calcium 
phenylphosphinate (1) and the anhydrous calcium hydrogen phosphite (3). Compound 6 
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is a well known mineral but it was synthesized by a different route. We redetermined the  
crystal structure of 6  since this has not been reported. There is clear correlation between 
ligand type and compound dimensionality.  The monophosphinates (with two oxygen 
donor atoms) were observed to form 1D chains, while the monophosphonates (with three 
oxygen donor atoms) formed 2D sheets. The phosphites and phosphates (with three and 
four oxygen donor atoms respectively) on the other hand display 2D or 3D arrays. 
 
4.5 Experimental 
4.5.1 Synthesis of Calcium Phenylphosphinate
 
(1):  
Phenylphosphinic acid, HPPA (0.28 g, 1.97 mmol), ethylenediphosphonic acid, 
EDPA (0.19 g, 1 mmol) and CaCl2 (0.11 g, 0.99 mmol) were dissolved in 10 mL distilled 
water and refluxed overnight. The resulting clear solution was transferred to a Carius 
tube, sealed at 40 mTorr pressure and heated for five days at 150 ºC. The clear solution 
was filtered into a small vial and concentrated in a water bath at 80 ºC. Tiny colorless 
crystals formed on the sides of the vials within one hour. Yield 0.4 g, 0.66 mmol, 30.5 %; 
m.p. 454 oC (decomposes), IR (Nujol): 3375.3(s), 3188.5(w), 2727.5(m), 1455.4(s), 
1373.0(s), 1041.1(m) 930.2(m), 749.3(m), 550.9(w). 
 
4.5.2 Synthesis of Anhydrous Calcium Hydrogenphosphite (3): 
To 4 ml of ethanol, CaCl2 (0.11g, 1 mmol), was added to form a cloudy mixture, 
to which 3.5 mL of 2M H3PO3 solution were added.  The resulting cloudy mixture was 
sealed in a Carius tube at 40 mTorr pressure. The sealed tube was kept in a 150 oC oven 
for 3 days. When the hot tube was removed from the oven, the entire solution was 
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vaporized. The tube was allowed to cool to room temperature overnight. Colorless 
hexagonal plates of crystals were found in solution the next day. Good quality crystals of 
3 were also formed when the reaction was repeated using water as solvent and warming 
the solution at 80 oC in a vial for 2 hours. The yield was 0.03g, 0.3 mmol, 30 % (g). m.p:  
450 oC (decomposes); IR (Nujol): 2900(s), 2742(w), 1475(s), 1388(s), 1305(w), 1154(w), 
950(w), 722(s).  
 
4.5.3 Synthesis of Anhydrous Calcium Hydrogenphosphate (6): 
 To 6 mL distilled water, Ca(NO3)2·4H2O (0.48 g, 0.25 mmol) and 
tetramethylenephosphonic acid, H8EDTPA (0.153 g, 0.025 mmol) were added to form a 
cloudy mixture which was sealed in a Carius tube at 40 mTorr pressure and kept in a 170 
oC oven for 12 days. The tube containing a cloudy white mixture was allowed to cool to 
room temperature. The cloudy mixture was filtered to obtain a small amount of colorless 
crystalline solid along with white powder and a clear filtrate. The crystalline solid was 
transferred into the clear filtrate as seed for crystal growth and left at room temperature 
for slow evaporation of solvent. After about two weeks when there was no further 
observable increase in the crystal size, the crystalline solid was collected by filtration and 
dried. The amount of crystalline solid is too small to reliably determine the yield or 
conduct further analysis beyond single crystal X-ray diffraction. 
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4.6 Experimental Details 
Phenylphosphinic acid (HPPA), phosphonic acid (H3PO3), CaCl2 and C2H5OH 
were obtained commercially and used without further purification. The synthesis of 
ethylenediphosphonic acid and 4-(4’-phosphonophenoxy) phenyl phosphonic acid is 
described in Chapter 3. A Perkin-Elmer PE 1600–FT-IR spectrometer was used to collect 
IR spectra as Nujol mulls between KBr plates. Single crystals of compounds 1, 3, and 6 
were analyzed by single crystal X-ray diffraction, compounds 1 and 3 also by IR 
spectroscopy. Melting points were determined using a VWR Thermocouple device. 
Crystals were not soluble in common NMR solvents, hence no spectra could be obtained.  
 
4.7. X-ray Crystallography 
  X-ray quality crystals of compounds 1, 3 and 6, were grown as described above. 
Crystals were taken out of the solutions and covered with viscous hydrocarbon oil 
(Infineum). Using a microscope, suitable crystals were selected and attached to a glass 
fiber. The crystal was mounted onto a 3-circle goniometer under a low temperature 
nitrogen stream of the low temperature device. Crystallographic data of 1 and 6 were 
collected using a Bruker SMART diffractometer equipped with APEX I CCD system, 
while 3 was collected using a Bruker DUO APEX II CCD. In all cases, MoKα-radiation 
(λ = 0.71073 Å) at 96(2) K (1 and 6) and 97(2) K (3) was used. Crystal data, details of 
data collection and refinement of compounds 1, 3 and 6 are provided in Table 4.1. The 
structures of 1, 3 and 6 were solved by the Direct Methods as included in the SHELXS-
97 and the structures were refined with SHELXL-97 program package.4747 All non-
hydrogen atoms were refined with anisotropic displacement parameters. Positions of 
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hydrogen atoms of the hydroxyl groups were found at calculated positions. All the 
phosphonate hydrogen atoms in 3 were located from the Fourier difference map and 
refined freely, except H3 which was placed in a calculated position. All hydrogen atoms 
bonded to carbon in 1, 3 and 6 were also placed in calculated positions based on 
geometric considerations and refined as riding atoms. The hydrogen atom bonded to 
phosphorus atom in 1 and 3 were located and refined freely. 
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Table 4.2.  Crystal data and structure refinement for compounds 1, 3 and 6 
 1 3 6 
Empirical formula C24H26CaO8P4 H2Ca0.5O3P Ca2H2O8P2 
Formula weight 606.4 101.03 272.12 
Temperature (K) 97(2) 96(2) 96(2) 
Wavelength (Å) 0.71073  0.71073  0.71073 
Crystal system Triclinic Monoclinic Triclinic 
Space group P-1 C2/c P-1 
a (Å) 5.67(1) 15.12(1) 6.62(7)  
b (Å) 7.64(2) 5.53(5) 6.90(8)  
c (Å) 15.22(4) 7.18(6) 6.97(8)  
α (°) 86.5(5) 90 76.31(1) 
β (°) 84.4(4) 100.45(2) 83.69(1) 
γ (°) 87.4(4) 90 88.40(2) 
Volume (Å3) 654.41(3) 590.1(9) 307.7(6) 
Z 
Dcal(mg/m3)                  
1 
1.540 
8 
2.274 
2 
2.937 
µ  (mm-1) 0.532 1.564 2.379 
Crystal size( mm3) 0.40   
 0.10  
 0.05 
0.32  
0.20  
0.16 
0.45 
0.30 
0.20 
2θ range (°) 2.69-28.40 2.74-37.03 3.03-28.43 
Reflections collected 6452 3699 2848 
Independent 
reflections 
3230 1420 1395 
R1 [I>2sigma(I)] 0.0470 0.0238 0.0276 
wR2 [I>2sigma(I)] 0.1142 0.1026 0.0704 
R1 (all data) 0.0677 0.0246 0.0306 
wR2 (all data) 0.1237 0.1044 0.0725 
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CHAPTER 5 
 Synthesis and structural description of Calcium Formate 
5.1 Introduction 
Water has been the main solvent during the synthesis of the phosphonate based 
metal organic frameworks in this project, since most of the ligands (phenylphosphinic 
acid, ethylenediphosphonic acid, propylenediphosphonic acid and amino 
trimethylenephosphonic acid), are water soluble. However, on a few occasions, the use of 
N,N′-dimethylformamide (DMF, CH3)2NCHO) has been advantageous, specifically in 
cases where ligands are not water soluble. It was one of such syntheses that yielded the 
unexpected three-dimensional calcium formate (7).  
DMF is widely used as a polar solvent; it is hydrophilic, aprotic and boils at 153 
oC. DMF has been used in a wide range of  catalytic reactions1,2 and in industrial 
applications as a gas absorbent.3 DMF has been shown to decompose to generate 
dimethylamine and carbon monoxide in situ, its role in the preparation of carbonyl 
complexes2,4 and in the Heck carbonylation (palladium-catalyzed synthesis of aryl amides 
from aryl halides) has been widely described.5 The decomposition of DMF may occur at 
elevated temperatures or in the presence of a strong acid or base.6 In addition, the 
hydrolysis reaction of DMF yields formic acid (Scheme 5.1). Also, the formation of 
formic acid (Figure 5.1) resulting from the decomposition of DMF has been reported.7,8 
 
HC(O)N(CH3)2  +  H2O HCO2H  + HN(CH3)2
 
Scheme 5.1 Hydrolysis reaction of DMF 
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                 Figure 5.1. Formic acid pKa 3.779 (in H2O). 
 
The incorporation of decomposition products of DMF in coordination chemistry 
is a well described phenomenon.10,11,12,13 In addition, In effect, DMF acts as both solvent 
and a reagent through the products of its decomposition.6,10 In other instances, it may act 
as a ligand or a neutral donor molecule in coordination chemistry.14-17 
 The synthesis and structural analysis, along with structural studies on other of 
alkaline earth formate phases are described in this chapter. 
 
5.2 Synthetic Considerations  
Calcium formate, 7, reported in this chapter is the result of DMF decomposition 
during attempts to prepare compounds based on biphenyl-4,4′-diphosphonic acid ligand, 
H4BDPA (Figure 5.2).  
 
 
 
 
Figure 5.2. Biphenyl-4,4′-diphosphonic acid (H4BDPA) 
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This ligand system is only scarcely explored in metal organic framework 
chemistry. Formates based on alkaline earth derivatives are not common, but there are 
few examples involving Mg,18 Sr,19  Ba compounds,20 along with a few transition metal 
examples (V, Cu, Zn and Mo).21-28   
Focusing on the lighter alkaline earth metals magnesium and calcium, various 
strategies were employed to prepare the H4BDPA target compounds and to obtain single 
crystals. Prime amongst those was the variation of solvent to identify one which allowed 
the highest solubility for the ligand. Various reactions were carried out in methanol, 
ethanol, ethanol/methanol mixtures, DMSO (dimethylsulfoxide), DMSO /ethanol and 
water/methanol mixtures, all of which were chosen based on literature examples,22,23,29 
which resulted in amorphous products. Furthermore, various coligands, including 
DABCO (diazabycyclo[2,2,2]-octane), 1,4-dioxane and diglyme did not result in 
crystalline products. On the other hand, treatment of Ca(NO3)2·4H2O and 
Mg(NO3)2·6H2O with H4BDPA ligand in dimethyl formamide (DMF), afforded crystals 
based on the decomposition of DMF. The solvothermal synthesis was conducted at 150 
oC for five days. Crystalline colorless blocks in the tube (Scheme 5.2). 
 
+ C12H12O6P2 DMF
150 oC
[Ca(HCO2)2]n  (7) + Mg(NO3)2.6H2OCa(NO3)2.4H2O
 
 
Scheme 5.2. Synthesis of anhydrous calcium formate (7).  
 
 Since the ligand was not included in the final product, the reaction was repeated 
without the ligand. Subsequent solvothermal synthesis involving MgCl2, CaCl2 and SrCl2 
in DMF at 150 oC yielded crystals overnight that were identified, based on unit cell 
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parameters as the previously reported Mg formate,8,18,30-34 Ca formate,18,35,36 and Sr 
oxalate.37 
A proposed mechanism of DMF decomposition /hydrolysis during the synthesis 
affording formate is given in Scheme 5.3 where bimolecular nucleophilic substitution 
(SN2) results in the formation of formic acid. Formic acid then reacts with the metal salt 
yielding the metal formate compounds.  
 
   
-
-HX
 
Scheme 5.3 Mechanism of Acid hydrolysis of DMF to form formic acid. 
 
5.3 Synthesis of Calcium Formate, [Ca(HCO2)2]n (7): 
Compound 7 was obtained by treating a mixture of Ca(NO3)2·4H2O, 
Mg(NO3)2·6H2O with biphenyl-4,4′-diphosphonic (H4BPDA) acid in DMF in an 
evacuated Carius tube at 150 oC for five days. Colorless blocks of crystals formed in the 
tube. Compound 7 is structurally characterized by single crystal X-ray crystallography; it 
crystallizes in the orthorhombic Pbca space group. Detailed crystallographic data and 
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structure refinement parameters are summarized in Table 5.1 in the experimental section 
of this chapter. 
Compound 7 is a three dimensional framework containing a Ca2+ ion and two 
singly deprotonated formate ligands in the asymmetric unit. The calcium ion is 
coordinated to seven formate oxygen atoms, five of which coordinate in a monodentate 
fashion while the remaining two oxygen atoms are involved in chelate formation as 
shown in Figure 5.3.  
 
            Figure 5.3 Schematic labeling of calcium formate (7). 
The chelating oxygen atoms (O1 and O2) also bridge the calcium centers to form 
a two-dimensional structure as displayed in Figure 5.4a. The sheets are held together by 
bridging formate oxygen atoms, leading to a three-dimensional propagation as shown in 
Figure 5.4b.  
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                                                                     (a) 
 
(b) 
Figure 5.4 Extended sheet structure of calcium formate (7) showing a. chelate and bridge 
formation, viewed from z-axis b. in three-dimensions. Green Sphere represent calcium, red oxygen and 
grey/black represent carbon. Hydrogen atoms on the carbon atoms are removed for clarity. 
The average Ca-O distances of the chelating formates are longer (2.523(1) Å), 
compared to that of the monodentate ones, with average Ca-O distances of 2.370(5) Å. 
Not surprisingly, all the C-O distances fall within a narrow range of 1.245(2) - 1.267(2) 
Å. The values of the bond distances and angles are listed in Table 5.2. The bond distances 
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of compound 7 closely match those of α-calcium formate characterized by neutron 
diffraction. 38 
 
Table 5.2. Bond lengths [Å] and angles [°] for calcium formate 
_____________________________________________________________________________________ 
Bond lengths                               Bond angles                                         Bond angles 
_____________________________________________________________________________________ 
Ca(1)-O(1)       2.3204(9)         O(1)-Ca(1)-O(2)#1     95.39(3)         O(2)#1-Ca(1)-O(2)#3     70.46(4) 
Ca(1)-O(3)       2.3471(9)         O(1)-Ca(1)-O(3)         176.20(3)       O(4)-Ca(1)-O(2)#3       121.51(3) 
Ca(1)-O(2)#1   2.3494(9)         O(2)#1-Ca(1)-O(4)     166.90(3)       O(4)#2-Ca(1)-O(2)#3    149.85(3) 
Ca(1)-O(4)       2.4053(9)         O(1)-Ca(1)-O(4)#2     74.22(3)         O(1)-Ca(1)-O(1)#3        84.65(3) 
Ca(1)-O(4)#2   2.4274(9)         O(3)-Ca(1)-O(2)#1     87.84(3)         O(3)-Ca(1)-O(1)#3        91.95(3) 
Ca(1)-O(2)#3   2.5102(1)         O(1)-Ca(1)-O(4)         89.77(3)         O(2)#1-Ca(1)-O(1)#3   121.81(3) 
Ca(1)-O(1)#3   2.5505(9)         O(3)-Ca(1)-O(4)         87.48(3)         O(4)-Ca(1)-O(1)#3       70.59(3) 
O(2)-Ca(1)#2   2.5101(1)         O(3)-Ca(1)-O(4)#2     108.17(3)       O(4)#2-Ca(1)-O(1)#3    148.27(3) 
O(1)-C(1)         1.2509(2)         O(2)#1-Ca(1)-O(4)#2  84.18(3)        O(2)#3-Ca(1)-O(1)#3    51.43(3) 
O(2)-C(1)         1.2540(2)         O(4)-Ca(1)-O(4)#2      85.67(3)        C(1)-O(1)-Ca(1)#2        92.12(7) 
O(3)-C(2)         1.2450(2)         O(1)-Ca(1)-O(2)#3      91.75(3)        O(1)-C(1)-O(2)              122.50(1) 
O(4)-C(2)#6     1.2673(2)         O(3)-Ca(1)-O(2)#3      87.44(3)        O(3)-C(2)-O(4)#7         125.23(1) 
                                                                                                            O(3)-C(2)-H(1)              120.0(9) 
                                                                                                            O(4)#7-C(2)-H(1)          114.7(9) 
_____________________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 x-1/2,-y+1/2,-z+1    #2 -x+3/2,y-1/2,z    #3 -x+3/2,y+1/2,z       
#4 -x+1,-y+1,-z+1    #5 x+1/2,-y+1/2,-z+1    #6 x+1/2,y,-z+3/2       
#7 x-1/2,y,-z+3/2       
 
 
There are close structural similarities between 7 and calcium hydrogen phosphite 
monohydrate, 4 (discussed in Chapter 4). Previous examples of alkaline earth metals 
include a three-dimensional magnesium formate, γ-Mg3(HCO2)6 , where one oxygen 
bridges two metal centres (µ2) while the other binds in a monodentate fashion.33  
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Four forms of calcium formate have been reported; α-Ca(HCO2)2,38 β-
Ca(HCO2)2,39 γ-Ca(HCO2)2,19  and  δ-Ca(HCO2)2,39,40 structural information for all but the 
γ-phase19 is available. The four forms of calcium formate (α, β, γ and δ) as well as three 
forms of strontium formates (α, β and δ) have been established using Differential 
Thermal Analysis (DTA).19,40 At atmospheric pressure, the α-Ca(HCO2)2  phase exists at 
a temperature range of 298-493K,  whereas β-Ca(HCO2)2  is stable between 298-453K,  γ-
Ca(HCO2)2  at 493-573K, and the δ-Ca(HCO2)2  between 573-633K.40 Consequently, 
studies have shown phase transitions from α→β→ γ →δ on heating and cooling δ→ γ→ 
β → α among the calcium formate compounds,19 for example the α-form transforms  to 
β- Ca(HCO2)2 phase at temperatures above 338 K, whereas the β-polymorph converts 
back to the α-Ca(HCO2)2  on cooling in the presence of water vapor.19,39  
The crystal structure of α-Ca(HCO2)2 was determined by neutron diffraction 
studies at 100 K, revealing a seven coordinate calcium center with Ca-O distances from 
of 2.322(8)  to 2.558(6) Å. An additional weaker Ca-O interaction of 3.420(5) Å also 
exists. The ligand binding includes two chelating and four monodentate ligands.38  The 
structures of β-Ca(HCO2)239 and δ-Ca(HCO2)219 were obtained by powder diffraction 
pattern at temperatures below  333K and at 603 K respectively.19,39 β-Ca(HCO2)2 is six 
coordinate with Ca-O distances between 2.311(3) - 2.484(3) Å; two additional Ca-O 
distances of 2.944(3) Å are also observed.39 δ-Ca(HCO2)2 display an eight coordinate 
calcium center with two types of Ca-O bonds; four of the Ca-O bond distances are the 
same (2.280(3) Å) while the remaining four are longer - 2.790(3) Å.19  
There are also a few reported examples of Mg, Sr and Ba formates,37,38,41-43  
including a two dimensional Mg(HCO2)2 ·2H2O which reversibly dehydrates to the 
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anhydrous three-dimensional form,42,43 α-, β- and γ-Mg(HCO2)2    formates 33 and 
Mg3(HCO2)6  formate. 18 
 Four forms of Sr formate (Sr(HCOO)2 ·2H2O, α-, β-, γ and  δ-Sr(HCOO)2) have 
been reported.40 Sr(HCOO)2 ·2H2O dehydrates to α-Sr(HCOO)2 at 403 K in an 
irreversible process, although the presence of water vapor, the δ→ β→α transitions 
occurs on cooling.  β-Sr(HCOO)2  is isomorphous to β-Ca(HCOO)2.40 
 Transition metal formates include Cr,44 Cd,45 La,46 Co,47 V,48 Zn,49,50 Y51 and 
Fe.32 Recently in our laboratory, Sr formate as a result of DMF decomposition was also 
observed by another member of our research group.52  
Similar to 7, the above mentioned α-Ca(HCO2)2 crystallizes in the orthorhombic 
space group Pbca, with almost identical cell parameters, respectively (a = 10.168(4) Å, b 
= 13.407(2) Å, c = 6.278(2) Å) compared to (a = 10.230(2) Å, b = 6.260(7) Å, c = 
13.325(1) Å). The slight contraction in volume may be due to temperature difference 
during structural analysis. Single X-ray quality crystals of 7 were obtained via the 
hydrothermal synthetic route; however only the crystalline powder of the compound has 
been reported, indicating the advantage of hydrothermal synthesis for crystallization of 
compounds. 
 
5.4 Conclusions 
Single X-ray quality crystals of 7 were obtained hydrothermally and 
characterised. The seven calcium coordinate is three-dimensional. 
It is observed that phosphorous acid in 4 described in chapter 4 and formic acid in 
7 exhibit very similar metal coordination motif. 
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5.5 Experimental  
 In an attempt to form calcium biphenyl-4,4′-diphosphonates, H4BDPA (0.10g, 
0.31 mmol), Mg(NO3)2·6H2O (0.08 g, 0.31 mmol) and Ca(NO3)2·4H2O (0.14 g 0.59 
mmol) were dissolved in 4 mL DMF. The cloudy suspension was sealed in a Carius tube 
at about 40 mTorr pressure and placed at 150 oC for five days. Single colorless blocks of 
crystals formed in the tube. Yield 0.018 g,0.14 mmol, 40 % based on Ca(NO3)2·4H2O; 
m.p.: 500 oC; IR (Nujol): 2920.1(s), 2724.0(w), 1489.0(s), 1375.0(s), 1154.5(w), 
722.5(s). The yields were too low to allow for further analysis.  
 
5.6 Experimental Details 
 Ca(NO3)2·4H2O,  Mg(NO3)2·6H2O, C2H5OH and DMF, were obtained 
commercially. The reagents were used as purchased. A Perkin-Elmer PE 1600–FT-IR 
spectrometer was used to collect IR spectra as Nujol mulls between KBr plates. Single 
crystals of compound 7 were analyzed by X-ray diffraction and by IR spectroscopy.  
Crystals of 7 were not soluble in common NMR solvents hence no spectra was obtained.  
 
5.7. X-ray crystallography 
  X-ray quality crystals of compound 7 were grown as described above. Crystals 
were taken out of the solutions and covered with viscous hydrocarbon oil (Infineum). 
Using a microscope, suitable crystals were selected and attached to a glass fiber. The 
crystal was mounted onto a 3-circle goniometer under a low temperature nitrogen stream 
of the low temperature device (93(2) K). Crystallographic data of 7 were collected using 
a Bruker diffractometer equipped with Duo Kappa system equipped with MoKα-radiation 
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(λ = 0.71073 Å). Crystal data, details of the data collection and refinement details are 
provided in Table 5.1. The structure of 7 was solved by Direct Methods with the aid of 
SHELXS-97, the structure was refined using SHELXL-97.53 All non-hydrogen atoms 
were refined with anisotropic displacement parameters. All hydrogen atoms were placed 
on calculated positions.  
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Table 5.1.  Crystal data and structure refinement for compound  7 
  
Empirical formula C2H2CaO4 
Formula weight 130.12 
Temperature (K) 93(2) 
Wavelength (Å) 0.71073 
Crystal system Orthorhombic 
Space group Pbca 
a (Å) 10.23(1)  
b (Å) 6.26(7) 
c (Å) 13.25(1) 
α (°) 90 
β (°) 90 
γ (°) 90 
Volume (Å3) 848.2(2) 
Z 
Dcal(mg/m3) 
8 
2.038 
µ  (mm-1) 1.362 
Crystal size( mm3) 0.45 x 0.35 x 0.30 
2θ range (°) 3.08-28.22 
Reflections collected 6755 
Independent reflections 1008 
R1 [I>2sigma(I)] 0.0233 
wR2 [I>2sigma(I)] 0.0606 
R1 (all data) 0.0243 
wR2 (all data) 0.0611 
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CHAPTER 6 
Synthesis and Characterization of Magnesium Diphosphonates 
6.1 Introduction 
While the chemistry of transition metal phosphonates has seen remarkable growth 
with applications as diverse as gas separation, gas storage or catalytic systems,1-4 the 
corresponding chemistry with s-block elements has received significantly less attention. 
Nevertheless, the vast array of three dimensional porous solids available for transition 
metals suggests a rich structural chemistry for the s-block analogues.  
In our attempt to explore magnesium and calcium phosphonates with potential 
applications as biomimetric agents in bone therapy, we initiated a study to explore their 
structural chemistry in detail. Previous work on magnesium phosphonates has indicated 
challenges with respect to solubility and crystallization.5,6 Hydrothermal synthesis has 
emerged as methodology of choice, as it promotes the solubility of products and thus aids 
in crystal growth.7  
Magnesium is prevalent in many biological systems, for example the activation of 
enzymes for the synthesis of adenosine triphosphate (ATP) which is responsible for 
energy transfer in the cell.8,9 Also, compounds such as ‘Milk of Magnesia’ Mg(OH)2 and 
‘Epsom Salt’ MgSO4·7H2O have valuable medicinal applications,10 while MgO is used in 
animal feed.11  
With a size of 86 pm,12 the Mg2+ ion has a high charge to size ratio, resulting in a 
tendency towards bond polarization and covalent bond character, as well as strong 
tendency towards donor coordination.13,14 This is why Mg2+ ions easily binds to 
CHAPTER 6: Magnesium Phosphonates                                                                                 108 
 
oxygen15,16 and nitrogen based co-ligands,17,18 and the majority of  magnesium 
compounds prepared in aqueous media contain water,19-29 as shown in the two-
dimensional magnesium phosphonates  Mg(O3PC6H5)(H2O)6 and {Mg 
[(HO3PCH(C6H5)]2}.2·8H2O.30 In this work, the chemistry of magnesium phosphonates is 
explored to understand factors responsible for structural features. 
Aside of its prevalence in biological systems, the low weight of magnesium 
makes it suitable for the preparation of low density metal organic frameworks (MOFs) 
with important applications in gas storage and separation of gas mixtures.16,19,31-34 As 
discussed in Chapter 2 of this thesis, extensive work has been carried out on transition 
metal as compared to s-block metal organic frameworks (MOFs). Recent studies have 
also documented magnesium MOF’s activity toward hydrogen, making them suitable 
candidates for gravimetric hydrogen uptake.35  Common examples of  three dimensional, 
porous magnesium based metal organic frameworks35-37 are based on trinuclear 
carboxylate bound units.38 In [Mg3(BPT)2(H2O)4]∞ (BPT = bipyridine tricarboxylate) for 
instance, trinuclear magnesium clusters are coordinated to the rigid organic linker BPT 
ligand through oxygen atoms forming three-dimensional framework.35  
The detailed investigation on the relation between synthetic routes, ligand type 
and the resulting structural characteristics provide the foundation for the understanding of 
parameters governing the factors leading to framework geometry and dimensionality. 
This chapter describes the preparation and structural features of a three-dimensional 
magnesium ethylenediphosphonate 8 and two-dimensional magnesium 
propylenediphosphonate 9. In both compounds, dimensionality is affected by hydrogen 
bonding, adding an additional parameter in the understanding of structural principles. 
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The chemistry of propylenediphosphonic acid is quite limited, and this is in strong 
contrast to the corresponding ethylenediphosphonates. Compound 9 therefore represents 
the only example for this ligand involving alkaline earth metals with the exception of the 
[Ba2(O3P(CH2)3PO3)·3H2O)]n, reported by Tuikka et al.39 Single crystals of the Ba 
species were formed by gel crystallization. The three-dimensional structure of 
[Ba2(O3P(CH2)3PO3)·3H2O]n, is comprised of layers of eight coordinate barium centers 
that are pillared by the hydrocarbon chains of the fully deprotonated ligand (PDPA4-). 
Three water molecules complete the coordination sphere of  the Ba2+ ion.39 Other 
examples  of compounds made with H4PDPA include Ti,40Ag,41 Zn,42 V,43 Mo, Ni and 
Gd.44,45   
In most magnesium based MOFs, there is at least one water molecule in the 
coordination sphere of the metal,29,46,47  and compounds 8 and 9 are no exception. For 
some MOFs, the coordinated water molecules can be removed at elevated temperatures 
without decomposition of the MOF.48 Examples of three-dimensional MOFs with such 
characteristics include [Mg(3,5-pdc)H2O)] (pdc =  pyridine dicarboxylate),27  
[Mg2(btc)(CH3COO)(C4H9NO)3·H2O]n (btc = 1,3,5-benzenetricarboxylate),49   and 
[Mg(H2dhtp)(H2O)2]n (H4dhtp = 2,5-dihydroxy terephthalic acid).14 After removal of 
water molecule(s) the open magnesium sites of these compounds are available for 
binding to various gas molecules such as H2 and CO2.27  
In this chapter, the synthesis and characterization of two magnesium 
diphosphonates, one with an ethylene linker, H4EDPA (Figure 6.1a), the other with a 
propylene linker, H4PDPA (Figure 6.1b) are described.  
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Ethylenediphosphonic acid (H4EDPA)   
  (pKa1 1.5, pKa2 3.18, pKa3 7.62, pKa4 9.28)50                          
 
 
Propylenediphosphonic acid (H4PDPA) 
(pKa1 1.6, pKa2 3.06,  pKa3 7.65, pKa4  8.63)50 
Figure 6.1. Diphosphonic acid ligands used to prepare compounds 8 and 9. 
 
Diphosphonic acids have been shown to initiate a wide variety of compounds due 
to their ability to carry multiple degree of deprotonation but also due to the variety of 
metal binding modes.  
 
6.2 Synthetic Considerations     
   With scarce knowledge on the preferred synthetic pathways for alkaline earth 
metal phosphonate complexes, a number of synthetic procedures were evaluated in order 
to prepare the target compounds and obtain single crystals. In analogy with transition 
metal MOFs, the synthesis of magnesium and calcium phosphonates is based on ligand 
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acidity. As shown in detail in this chapter, slight changes in reaction conditions often lead 
to significant structural changes. Also, the framework geometry is influenced by several 
factors, chiefly the ligand and solvent characteristics; of particular importance is the pH 
of the solution, the temperature, and pressure and crystallization conditions. 
Demonstrating the challenges in designing feasible systematic route, but perhaps 
even more importantly, challenges in predicting structural parameters, the two ligands 
used in this chapter differ only by one carbon in the linker. Nevertheless, their 
crystallization required dramatically different approaches, and their structural parameters 
could not be more different. 
The ligand characteristics influence the mode of metal binding, with factors such 
as denticity, linker length and degree of deprotonation. The basicity of the solvent also 
plays a major role as there is competition between solvation and ligation.19  Compounds 8 
and 9 have been prepared using water as solvent as it is non-toxic, non-flammable and 
most relevant to biological systems.  
Single crystals of compounds 8 and 9 were analyzed by X-ray diffraction. 
Thermogravimetric studies were also conducted to determine the temperatures at which 
coordinated water is lost.  The characterization of compounds  8 and 9 is limited to solid 
state methods due to their  insolubility in common NMR solvents, as is the case of  most 
metal organic frameworks (MOFs) with extended structures.51  
 
6.2.1 Magnesium Ethylenediphosphonate (8): 
  Attempts to crystallize magnesium ethylenediphosphonates  from water or DMF 
at room temperatures and under hydrothermal or solvothermal conditions failed. Hence 
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the introduction of donors and coligands was explored, based on work by Best et al.52 
The introduction of the coligand phenylphosphinic acid resulted in the formation of Xray 
quality crystals of 8. 
Compound 8 was prepared by refluxing magnesium nitrate, ethylene-
diphosphonic acid and phenylphosphinic acid in dimethyl formamide (DMF) overnight. 
The resulting clear solution was sealed in a Carius tube at 40 mTorr. The sealed tubes 
were kept in an oven at 150 oC for seven days. After slow cooling, the tubes were opened 
and the resulting colorless solution transferred into a small glass vial and covered with 
Parafilm. Several holes were punctured in the Parafilm to allow slow evaporation of 
solvent. The vial was left at room temperature until colorless crystal appeared after two 
weeks (Scheme 6.1). 
 
H2O3P(CH2)2PO3H2 + Mg(NO3)2.6H2O 
Mg(H2O)6[HO3P(CH2)2PO3H)].2H2On  (8)
HPO(OH)(C6H5)
DMF/H2O
 
Scheme 6.1. Synthesis of compound magnesium ethylenediphosphonate 8. 
 
 
Based on the success of promoting crystal formation by the introduction of 
coligands, the introduction of DABCO (1,4-diazobicyclo[2.2.2]octane), promoted crystal 
growth within a few hours, even so that neither of the coligands is contained in the final 
product.  
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The reaction was repeated using water as solvent under the same hydrothermal 
conditions, affording crystals with identical unit cell parameters as 8 (Table 6.1, 
experimental section), indicating that the solvent type does not affect product formation. 
En route to explore product formation and crystallization conditions to optimize 
compound yields, a variety of magnesium salts, MgCl2, Mg(CH3CO2)2 and 
Mg(NO3)2·6H2O were used. All of them yielded powdery products. Furthermore, 
different ligand to metal salt ratios were utilized. While the ratios did not affect 
compound formation, a dependency on crystallization speed was observed, with the 
crystal formation being fastest with a ligand to salt ratio of 1:2.  
 
6.2.2 Magnesium Propylenediphosphonate, (9): 
 To determine the effect of carbon chain length on structural parameters of the 
product, propylenediphosphonic acid H4PDPA was introduced. X-ray quality crystals 
were obtained by treatment of Mg(NO3)·6H2O with H4PDPA in water in a small vial at 
80 oC. (Scheme 6.2). 
 
H2PO3(CH2)3PO3H2   +  Mg(NO3)2.6H2O H2O Mg(HO3P(CH2)3PO3H2)2(H2O)2n (9)
80 oC
 
                       Scheme 6.2. Synthesis of magnesium propylenediphosphonate 9. 
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6.3 Structural Aspects: 
6.3.1 Magnesium Ethylenediphosphonate, {Mg(H2O)6(HO3P(CH2)2PO3H)·2H2O}n   
             
(8): 
Compound 8 crystallizes in the triclinic space group P-1. Crystal data, details of 
data collection and refinement of compounds 8 are provided in Table 6.1 in the 
experimental section of this chapter. The compound is made up of a doubly deprotonated 
ligand and Mg2+ along with coordinated water molecules and waters of crystallization. 
There is no direct metal-ligand bond; instead, the association of cations and anions in 8 is 
achieved exclusively through hydrogen bonding via water molecules, resulting in the 
formation of a two-dimensional sheet structure.  
The magnesium centers are coordinated in an octahedral fashion by six water 
molecules resulting in the well documented [Mg(OH2)6]2+ cation. Extensive hydrogen 
bonding from coordinated water molecules to the diphosphonate ligands propagated the 
structure. Additional hydrogen bonding is provided by two waters of crystallization. The 
various O-H···O hydrogen bonds system in 8 have H···O distances of 1.925-2.066 Å, 
hydrogen bonding interactions, most of which are weak. As hydrogen positions are 
associated with a significant positional uncertainty, O-O distances are often used to 
determine their strength. O-O distances of 2.73-2.81 Å, along with a mean O-H-O angle 
of 176° which is near linear geometry, indicate strong hydrogen bonding. These values 
are summarized in Table 6.2. 
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Table 6.2. Hydrogen bonding  geometry for compound 8 
______________________________________________ 
 D-H…A                     d(D-H)     d(H..A)     <D-H..A        d(D..A) 
 
O1-H1O1…O5          0.797         2.014        172.65          2.806 
 
O1-H2O1…O4          0.774        2.042         175.87          2.814 
 
O2-H1O2…O5          0.727        2.066         166.71          2.778 
 
O2-H2O2…O7W       0.839        1.925         170.24          2.755 
 
O3-H1O3…O7W       0.800        1.928         176.37          2.727 
 
O3-H2O3 …O5         0.797        1.995         175.48          2.790 
 
O7W-H1W1…O4     0.727         2.066         177.53          2.792 
 
O7W-H2W1…O6     0.749         2.059         168.98          2.797 
 
Since each magnesium ion is located on a center of symmetry, only three of the 
metal coordinated water molecules are symmetry independent. The metal is surrounded 
in a slightly distorted octahedral fashion by six water molecules, with O-Mg-O angles 
ranging from 87.46 (4) ° to 92.54 (4) ° (Figure 6.2).  
 
Figure 6.2. Graphical representation of compound 8 indicating atom labelling, Hydrogen atoms on carbon 
atom and hydrogen bonding are omitted for clarity. 
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The Mg-O distances differ slightly, with O1 in the trans position (2.080(1) Å) 
being slightly longer than the equatorial positions (2.048(1) Å, 2.056 (1) Å). These values 
are summarized in Table 6.3. The average Mg-OH2 bond length in compound 8 is 2.06(1) 
Å, this value compares well with the average Mg-OH2 bond distance of 2.06(2) Å, as 
determined from the average of 50 [Mg(H2O)6]2+ structures by Dale S.H. et al.53   
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        Table 6.3. Selected bond lengths [Å] and angles [°] of magnesium ethylenediphosphonate 8 
            __________________________________________________________________________       
               Bond distances                                                 Bond angles 
______________________________________________________________________ 
P-O(5)                        1.5054(9)       O(5)-P-O(4)                      114.06(5) 
P-O(4)                        1.5260(8)        O(5)-P-O(6)                     107.21(6) 
P-O(6)                        1.5847(9)        O(4)-P-O(6)                      109.48(5) 
P-C                             1.8017(1) 
Mg-O(3)                     2.0471(1) 
Mg-O(2)                     2.0560(1) 
       O(3)-Mg-O(1)                    87.46(4) 
       O(3)-Mg-O(1)#1                92.54(4) 
       O(2)-Mg-O(1)                    91.87(4) 
Mg-O(1)                     2.0804(1)        O(3)#1-Mg-O(2)#1            89.82(5) 
O5-HaW                     2.002(1)        O(3)-Mg-O(2)#1                90.18(5) 
O- HeW                      2.036(1) 
O-HeW                       1.893(1) 
       O(2)-Mg-O(1)                    88.13(4) 
       C#2-C-P                             113.00(10) 
 
       ______________________________________________________________________ 
                                    
          Symmetry transformations used to generate equivalent atoms: 
        #1 -x+1,-y+2,-z    #2 -x,-y+1,-z+1  
 
 
Each of the six metal-coordinated water molecules is doubly hydrogen bridged. 
Of these, the water molecules in the equatorial positions are connected to one ligand and 
one lattice water. The two axial water molecules bridge two ligands. This arrangement is 
illustrated in Figure 6.3a with oxygen atoms of water molecules represented by yellow 
spheres. Figure 6.4 illustrates the hydrogen bonding network. 
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(a) 
 
(b) 
Figure 6.3. Hydrogen bonding in compound 8. Blue spheres represent lattice water molecule while the 
yellow spheres represent metal coordinated water molecules. Phosphorus is in purple, phosphate oxygen 
atom is red while carbon is represented by grey spheres. All hydrogen atoms are represented by white 
spheres. a. shows the hydrogen bonding around the metal in compound 8 while b. depicts hydrogen 
bonding  of one water molecule. 
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Figure 6.4. The two dimensional sheet of 8 showing alternating [Mg(OH2)6]2+ ions and diphosphonate 
layers. Waters of crystallization are represented by blue spheres. Dark green spheres represent magnesium, 
while the purple sphere represent phosphorus. The red spheres represent oxygen, black, carbon, while the 
grey spheres represent hydrogen atoms. 
 
Magnesium’s position on an inversion center (and thus half occupancy), requires 
only one half of the doubly deprotonated diphosphonate ligand in the asymmetric unit. 
The assignment of P=O, P-O and P-O- moieties is straightforward and confirms the 
dianionic state of the ligand. The longest distance being P-OH (involving O6 with 
1.5847(9) Å), with the P-O- moiety (involving O4) displaying shorter P-O bonds 
(1.5260(8) Å). In line with prior results, the P=O moiety (involving O5) has the shortest 
(1.5054(9) Å) bond.  
As compound 8 contains both metal bound water, as well as lattice waters, a 
thermogravimetric analysis was undertaken to analyze the ease of water loss. 
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[Mg(H2O)6]2+  
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with water molecules engaged in extensive hydrogen bonding.54-62 As an example, 
phenylphosphonate {Mg [(HO3PCH(C6H5)]2}2(H2O)6·2H2O}n30 also has a hydrogen 
bonded [Mg(H2O)6]2+ cation that result in a propagated arrangement. Other examples 
include [Mg(H2O)6][(C10H4O8)] (Figure 6.6),53 [Mg(H2O)6][2-AEPH-]2·2H2O56 (where 
AEPH = 2-aminoethylphosphonic acid) and [Mg(H2O)6][ CO2(CH2)2CO2].63 Another 
example includes [Mg(H2O)6][Cu2C8H2NO7)]·2H2O,18 with hydrogen bond length 1.96 
(9)-2.24 (1) Å. 
Water coordination involving the heavier alkaline earth cations is not uncommon, 
with the formation of [Ae(H2O)6]n Ae = Ca64 Sr20,65 and Ba65-67 with n usually 6-7 for Ca, 
and 8-9 for Sr and Ba respectively, depicting the effect of increasing metal ion size.  
Several hydrogen bonds exist between the [Mg(H2O)6]2+ cation coordinating 
water molecules and oxygen atoms from the adjacent ligands. Typical hydrogen bond 
lengths (H···A) involving the hexaqua species range from 1.19(2)-2.01(7) Å.18,53,63 
Compound 8 has hydrogen bond lengths of 1.92(1)-2.06(1) Å indicating they fall into the 
weaker range of those reported.  
 
Figure 6.6. Schematic diagram of  [Mg(H2O)6(C10H4O8)]53, showing hydrogen bonding between the 
carboxylate ion and [Mg(H2O)6]2+ cation . The dark green sphere represents magnesium ion, red oxygen, 
black carbon and grey hydrogen atoms. 
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In {[Mg(H2O)6][Mg(Cl2CP2O6(H2O)]·7H2O}n,68 two types of magnesium 
environments are observed;  a hexaqua magnesium and a magnesium ion coordinated by 
ligand oxygen atoms and two water molecules. The Mg-H2O distances within 
[Mg(H2O)6]2+ are 2.013(2)-2.121(2) Å, a value that compares well with 8. Mg-O 
distances to the ligand are 2.020(2)-2.308(2) Å. 
 
Figure 6.7 Structure of {[Mg(H2O)6][Mg(Cl2CP2O6(H2O)]·7H2O}n,68 showing the two magnesium 
environments. The dark green sphere represents magnesium, red oxygen, light green chlorine, purple 
phosphorus, black carbon and grey hydrogen atoms. 
 
6.3.2 Magnesium Propylenediphosphonate, [Mg(HO3P(CH2)3PO3H2)2(H2O)2]n (9): 
Compound 9 crystallizes in the monoclinic space group P2(1)/c as a 2D structure. 
Crystal data, details of data collection and refinement of compounds 9 are provided in 
Table 6.1 in the experimental section of this chapter. The O-Mg-O angles (87.44(4) ° - 
92.55(4) °) indicate a slightly distorted octahedral magnesium environment. In the 
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asymmetric unit, one singly deprotonated ligand is coordinated to one Mg center with an 
occupancy of 0.5. The P-O bond lengths of 1.5263(1) Å correspond to the deprotonated 
P-O- while the longest P-O distances (1.546(1) Å, to 1.588(1) Å) involve the P-OH 
moiety. The shortest P-O bond distances (1.506(1) Å), correspond to the P=O distances. 
The bond lengths and angles are summarized in Table 6.4. 
 
    Table 6.4. Bond lengths [Å] and angles [°] for magnesium propylenediphosphonate 9 
                         ________________________________________________________________ 
                           Bond lengths                                           Bond angles 
                         ________________________________________________________________ 
                             Mg(1)-O(1W)#1        2.0588(13)            O(1)-Mg(1)-O(5)             92.55(4) 
Mg(1)-O(1W)            2.0588(13)            O(1)-Mg(1)-O(5)#1         87.44(4) 
              Mg(1)-O(1)                2.0658(11)            O(5)-Mg(1)-O(5)#1         180.0 
Mg(1)-O(1)#1        2.0658(11)            O(1)-P(1)-O(2)                113.83(7) 
Mg(1)-O(5)        2.0998(11)            O(1)-P(1)-O(3)                109.57(7) 
Mg(1)-O(5)#1            2.0999(11)            O(2)-P(1)-O(3)                108.49(7) 
P(1)-O(1)        1.5061(12)            O(1W)-Mg(1)-O(1)         90.08(5) 
P(1)-O(2)        1.5458(13)            O(1W)-Mg(1)-O(5)         88.32(5) 
P(1)-O(3)        1.5629(13)            O(1W)#1-Mg(1)-O(1)     89.93(5) 
P(1)-C(1)        1.7764(16)            O(1W)#1-Mg(1)-O(5)     91.68(5) 
P(2)-O(4)        1.5059(12) 
P(2)-O(5)        1.5263(12) 
P(2)-O(6)        1.5877(13) 
P(2)-C(3)        1.7939(17) 
C(1)-C(2)                   1.538(2) 
_________________________________________________________________ 
                                   Symmetry transformations used to generate equivalent atoms: 
                
                             #1 -x+2,-y,-z+1    #2 -x+2,-y+1,-z+1  
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Each magnesium coordination sphere is saturated by four phosphonate oxygen 
atoms from two propylenediphosphonic forming a chain. The chains are propagated into 
sheets by hydrogen bonding, as shown in Figure 6.8. 
 
Figure 6.8. Schematic atom labeling of magnesium propylenediphosphonate 9, showing the sheet structure. 
                     
Hydrogen bonding in 9 involves the hydroxyl groups on the phosphonate ligand 
and the two coordinating water molecules on magnesium as shown in Figures 6.9 and 
6.10. The long interlayer distance of 4.001 (2) Å (between O2 on one chain and H1 on 
the adjacent chain) limits the compound to a two-dimensional structure. However, there 
is weak interaction between O6 in one layer and H3 on the adjacent layer. 
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Figure 6.9. Chains of magnesium propylenediphosphonate 9 viewed from the y-axis and propagated 
through organic linkers. Blue dotted lines indicate hydrogen bonding. Hydrogen atoms, except those 
involved in hydrogen bonding, are omitted for clarity. The dark green spheres represent magnesium, red 
oxygen, purple phosphorus, black carbon and grey hydrogen atoms. 
 
 
Figure 6.10. Magnesium propylenediphosphonates 9 viewed from the x-axis and showing adjacent chains 
of 9 connected by hydrogen bonds. The dark green spheres represent magnesium, red oxygen, purple 
phosphorus, black carbon and grey hydrogen atoms. 
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The O-O distances related to hydrogen bonding range between 2.57-2.78 Å, well 
below the sum of van der Waals radii (3.04 Å) for oxygen.69 Figure 6.11. Hydrogen 
bonding values are summarized in Table 6.5. 
 
Figure 6.11. Hydrogen-bonding in compound 9, methylene groups are eliminated for clarity. 
 
                                       Table 6.5. Hydrogen bonding geometry for compound 9 
                               ________________________________________________________ 
 D-H…A                    d(D-H)      d(H..A)       <DHA         d(D..A)   A 
                   O3-H3…O6                0.820          2.653           158.29         3.428 
 
                                  O6-H6 …O1               0.820          1.988           147.73         2.717 
 
                    O7W-H7W…O4        0.786          2.005           171.89         2.785 
 
                    O7W-H8W…O3        0.711          2.091           154.95         2.751 
 
                    O2-H2…O4                0.820          1.773           163.51         2.570 
 _______________________________________________________ 
 
Thermogravimetric analysis of 9, the trace of which is shown in Figure 6.12, 
indicates a gradual process of a mass loss of 8% starting at about 90 °C to 190 oC. This 
corresponds to the removal of two water molecules to yield the anhydrous 
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other, and thus, a decreased tendency towards metal coordination is observed.50 This is 
supported by 31P NMR studies indicating the shielding effect of the two P atoms.70 This 
effect diminishes with increasing chain length.71 These studies provide a rationale of the 
large structural differences between the two diphosphonate ligands. 
 
6.4 Conclusions 
 Two novel magnesium phosphonates have been synthesized. Both compounds 
form sheets involving Mg2+ centers with coordination environment of six oxygen atoms. 
However, significant structural differences exist for 8 and 9, with the formation of 
[Mg(H2O)6]2+ cations and no metal ligand interaction in 8, whereas 9 has no metal-water 
coordination. This work clearly shows the drastic effects small changes in ligand 
geometry as well as reaction conditions can have on compound formation. These results 
highlight the challenge to predict solid state structures as small changes in parameters 
will result in drastic structural effects. 
 
6.5 Experimental  
6.5.1 Synthesis of Magnesium Ethylenediphosphonate,          
         {Mg(H2O)6[HO3P(CH2)2PO3H)]2H2O}n (8): 
Phenylphosphinic acid (0.14 g, 1 mmol), ethylenediphosphonic acid (0.19 g, 1 
mmol), and Mg(NO3)2.6H2O (0.13 g, 0.5 mmol) of were combined in 10 mL of N, N –
dimethyl formamide (DMF), resulting in a white precipitate. The cloudy mixture was 
refluxed overnight yielding a clear solution. This solution was then transferred into a 
Carius tube and sealed at 40 mTorr pressure. The tube was heated at 150 ºC for seven 
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days. The resulting clear solution was filtered into small vials. The vials were covered 
with perforated Parafilm and kept at room temperature, yielding colorless crystals within 
two weeks at room temperature. Yield: 0.09 g, 0.25 mmol, 50.6 %. IR (Nujol): O-H 
3404(s), 3229.82(m), C-H 2903.08(s), P-OH 2700(w,br), 1631.12(m), O-H 1461.91(s), 
O-H 1362.72 (s), 1146.84(w), P=O 930.96(w). 
 
6.5.2 Synthesis of Magnesium Propylenediphosphonate,  
         {Mg(HO3P(CH2)3PO3H2)]2(H2O)2n (9): 
Propylene diphosphonic acid (0.2 g, 0.98 mmol) and magnesium nitrate hexahydrate 
(0.13 g, 0.51 mmol) were dissolved in 6 mL of distilled water. The clear colorless 
solution was transferred into a vial and kept at 80 oC for three days. The clear solution 
was allowed to cool to room temperature, covered with perforated Parafilm and left at 
room temperature to slowly evaporate. After a month, single colorless crystals were 
obtained. Yield: 0.071g, 0.30 mmol, 58.9%. IR (Nujol): C-H 1461.9(s), O-H 1376.57 (s), 
P=O 940.3 (m). 
 
6.6 Experimental Details 
Phenylphosphinic acid, Mg(NO3)2.6H2O, MgAc2 MgCl2, NaOH and DMF, were obtained 
commercially. The reagents were used as purchased. Thermogravimetric analysis was 
performed using a Q-500 Quantachrome Analyzer (TA-Instruments) with N2 as a carrier 
gas with a heating ramp of 10oC/min. A Perkin-Elmer PE 1600–FT-IR spectrometer was 
used to collect IR spectra as Nujol mulls between KBr plates. Single crystals of 
compounds 8 and 9 were analyzed by single X-ray diffraction and by FT-IR 
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spectroscopy.  Crystals of 8 and 9 were not soluble in common NMR solvents hence no 
spectra could be obtained 
 
6.7. X-ray crystallography 
For compounds 8 and 9, X-ray quality crystals were grown as described above. Crystals 
were taken out of the solutions and covered with viscous hydrocarbon oil (Infineum). 
Using a microscope, suitable crystals were selected and attached to a glass fiber. The 
crystals were mounted onto a 3-circle goniometer under the nitrogen stream of the low 
temperature device. Crystallographic data of  8 and 9 were collected using Bruker 
diffractometer equipped with a SMART CCD system, and using MoKα-radiation (λ = 
0.71073 Å) at 97(2) K. Crystal data, details of data collection and refinement of 
compounds 8 and 9 are provided in Table 6.1. The structures of 8 and 9 were solved by 
Direct Methods with the aid of SHELXS-97. The structures were refined with SHELXL-
97.72 Positions of hydrogen atoms of the hydroxyl groups on the phosphonate ligands 
were calculated and refined isotropically. Hydrogen atoms on water molecules in 8 were 
located from the Fourier difference map and refined with constraints. All other hydrogens 
were placed in calculated positions based on geometric considerations. 
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                 Table 6.1.  Crystal data and structure refinement for compounds 8 and 9 
 8 9 
Empirical formula C2H22MgO14P2 C3H11Mg0.5O7P2 
Formula weight 356.45 233.21 
Temperature (K) 97(2) 97(2) 
Crystal system Triclinic Monoclinic 
Space group P-1 P2(1)/c 
a (Å) 6.53(1)  9.95(6) 
b (Å) 6.57(1) 7.66(4) 
c (Å) 10.04(2) 12.41(7) 
α (°) 89.37(3)  90 
β (°) 74.13(3) 109.10(1) 
γ (°) 62.56(3)  90 
Volume (Å3) 364.6(1) 896.7(2) 
Z 
dcalc(mg/m3) 
1 
1.624 
4 
1.733 
µ  (mm-1) 0.41 0.52 
Crystal size(mm3) 0.20  
0.10  
0.05 
0.30  
0.15  
0.10 
2θ range (°) 3.50-28.28 2.17-29.84 
Reflections collected 3670 8847 
Independent reflections 1787 2391 
R1 [I>2sigma(I)] 0.0294 0.0341 
wR2 [I>2sigma(I)] 0.0831 0.0098 
R1 (all data) 0.0327 0.0389 
wR2 (all data) 0.0861 0.1038 
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6.8 Thermogravimetric Analysis (TGA) 
The TA Q 500 Instrument was used to perform the analyses.  About 13 mg of 
white powder of compound was loaded on a platinum pan. Purified nitrogen gas was used 
with a balance purge rate of 40 mL/min and a sample purge rate of 60 mL/min. The 
temperature was ramped at 10°C per minute until a final temperature of 700°C was 
reached. After 68 minutes, about 50% of weight loss was recorded and a black residue 
remained in the pan.  
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CHAPTER 7 
 Calcium Alkylene Diphosphonates 
7.1 Introduction 
Studies on phosphinates, phosphonates, phosphite and phosphates described in 
Chapter 4 suggest that as the number of oxygen atoms in a ligand increase, structures 
with a higher dimensionality are obtained. This chapter explores diphosphonic acids as 
ligands1,2 and examines how the linker length affects the overall structure of calcium 
alkylene diphosphonates. The diphosphonates utilize linkers with one, two and three 
carbon atoms as indicated in Figure 7.1. The compounds were phosphonate based metal 
organic frameworks to be used as scaffold material for bone in growth. 
 
n
 
Figure 7.1 Alkylenediphosphonic acids: (n = 1) methylenediphosphonic acid H4MDPA, 
(n = 2) ethylenediphosphonic acid H4EDPA and (n = 3) propylenediphosphonic acid H4PDPA. 
 
 
Bisphosphonates have found widespread use in medicinal applications and are the 
basis of the widely used drugs  Boniva®, Fosamax®, Reclast®,  Zoledronate®, Didronel®, 
Ibandronate®, Etidronate®, and Alendronate® 3-5  which are designed to treat bone diseases 
such as osteoporosis and bone cancer. 6-14 Bisphosphonates have found applications in 
industrial processes as ion exchangers, catalysts and sorption purposes.15  
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The majority of the diphosphonates are based on transition metals,16-22 in contrast, 
relatively very few complexes with main group metals 23-25 and lanthanides26,27  are 
reported. Several attempts to obtain single crystals of calcium ethylenediphosphonates 
failed, explaining why only limited work is available on alkaline earth metal 
phosphonates. So far, 3D Ba[HO3P(CH2)2PO3H] 28 is the only reported example, for 
which single X-ray quality crystals were obtained by gel crystallization.28  
This chapter discusses synthetic pathways towards four novel three-dimensional 
calcium based diphosphonates, namely calcium methylenediphosphonate (10), calcium 
sodium ethylenediphosphonate (11), calcium nitrate ethylenediphosphonate (12), and 
calcium propylenediphosphonate (13).  
 
7.2 Synthetic Considerations 
The synthesis of compounds 10 and 13 was straightforward, crystals of the 
compounds formed after combining calcium nitrate and H4MDPA( for 10) and H4PDPA 
(for 13) in aqueous solutions as shown in Scheme 7.1 and 7.2 respectively. 
    
H2O
[CaCH2(PO3H)2]n   (10)
150 oC
  +  H2PO3CH2PO3H2 Ca(NO3)2.4H2O
HPO(OH)(C6H5)
 
Scheme 7.1. Synthesis of compound 10. 
 
Ca(NO3)2.4H2O   +  H2PO3(CH2)3PO3H2 
85 oC
H2O [Ca(HO3P(CH2)3PO3H)]n   (13)
 
Scheme 7.2. Synthesis of compound 13. 
CHAPTER 7: Calcium Alkylene Diphosphonates                                                                   138 
 
In contrast, the crystallization of calcium ethylenediphosphonate was very 
challenging. A wider range of crystallization methods  were explored including  simple 
precipitation,29 slow evaporation of concentrated solutions as used during the 
crystallization of  substituted bisphosphonic acid based compounds. 11,30,31 
En route to the target species, two crystalline products were obtained; a Ca/Na 
heterobimetallic ethylenediphosphonate (11) by hydrothermal synthesis as shown in 
Scheme 7.3 and a species which contained remaining nitrate moieties (12), the crystals of 
which were obtained by crystallization from a silicate gel as indicated in Scheme 7.4. The 
gel method produces large crystals which are usually unattainable by slow evaporation of 
solvent or under hydrothermal condition; however, these crystals are difficult to separate 
from the gel.12,15,28,32  
 
1.NaOH
2.CaCl2
3.HCl
4.H2O
NaCa[HO3P(CH2)2PO3H2][HO3P(CH2)2PO3H]n  (11)
-NaCl2
  H2PO3(CH2)2PO3H2 
170 oC
 
Scheme 7.3. Synthesis of compound 11. 
 
H2O
   H2PO3(CH2)2PO3H2 +  Ca(NO3)2.4H2O
[Ca2(NO3)2(HO3P(CH2)2PO3H)(H2O)]n   (12)
 
                                               Scheme 7.4. Synthesis of compound 12 
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7.3 Structural Aspects 
7.3.1 Calcium methylenediphosphonate, [Ca(HO3PCH2PO3H)]n (10): 
 Compound 10 is a three dimensional compound which crystallizes as monoclinic 
space group C2/c. Single crystals were obtained by hydrothermal synthesis of 
methylenediphosphonic acid and calcium nitrate. Crystal data, details of data collection 
and refinement of 10 are provided in Table 7.1 in the experimental section of this chapter. 
The octahedral environment of Ca2+ is comprised of six phosphonate oxygen 
atoms from a doubly deprotonated ligand (O2). Each ligand therefore retains one 
protonated P-OH (O3) species per phosphonate moiety as shown in Figure 7.2. The 
asymmetric unit consists of a Ca ion in an inversion center coordinated to one half of the 
doubly deprotonated ligand.  
 
 
Figure 7.2. Structure showing the coordination environment of calcium in 10, the hydrogen atoms on the 
carbon atoms are omitted for clarity  
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The P-O distances vary in length based on the P-O bond order and whether P-OH 
is deprotonated or not. The shortest, 1.418 (1) Å is associated with P=O (O1). The 
intermediate bond length 1.516 (1) Å corresponds to P-O- (O2), whereas the longest bond 
1.519 (1) Å is associated with that of P-OH. The Ca-O bond lengths are between 2.264 
(1) Å–2.447 (1) Å. Selected bond length and angles are given in Table 7.2.  
 
Table 7.2. Selected bond lengths [Å] and angles [°] calcium methylenediphosphonate, 10. 
___________________________________________________________________ 
P(1)-O(1)                  1.4918(1)                        O(1)-P(1)-O(2)                  116.47(7) 
P(1)-O(2)                  1.5159(1)                        O(1)-P(1)-O(3)                  110.16(6) 
P(1)-O(3)                  1.5967(1)                        O(2)-P(1)-O(3)                  105.81(7) 
P(1)-C(1)                  1.8005(1)                        O(1)-P(1)-C(1)                  111.80(7) 
Ca(1)-O(1)                2.2636(1)                        O(2)-P(1)-C(1)                  107.08(8) 
Ca(1)-O(1)#1            2.2637(1)                        O(3)-P(1)-C(1)                  104.72(5) 
Ca(1)-O(2)#2            2.3486(1)                        O(1)-Ca(1)-O(1)#1            180.0 
Ca(1)-O(2)#3            2.3486(1)                        O(1)-Ca(1)-O(2)#2            86.48(4) 
Ca(1)-O(3)#4            2.4472(1)                        O(1)#1-Ca(1)-O(2)#2         93.52(4) 
Ca(1)-O(3)#5            2.4472(1)                        O(1)-Ca(1)-O(3)#4             82.61(4) 
O(2)-Ca(1)#6            2.3486(1)                        O(1)#1-Ca(1)-O(3)#4         97.39(4) 
O(3)-Ca(1)#8            2.4472(1)                        O(2)#2-Ca(1)-O(3)#4         81.27(5) 
C(1)-P(1)#7              1.8005(1)                        O(2)#3-Ca(1)-O(3)#4          98.73(5) 
_______________________________________________________________________ 
 Symmetry transformations used to generate equivalent atoms: 
  #1 -x,-y,-z    #2 x-1/2,y-1/2,z    #3 -x+1/2,-y+1/2,-z 
 
All the six phosphonate oxygen atoms on the ligand coordinate to a metal center, 
(Figure 7.3) achieving the three-dimensional structure of 10 via bridging O-P-O groups, 
as shown in Figure 7.4. 
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Figure 7.3. Structure of 10, showing the coordination environment of the ligand, the green spheres 
represent the Ca2+ centers. 
 
 
Figure 7.4. Extended structure of compound 10 viewed along the a-axis, showing the propagation 
of the structure in two dimensions. The green spheres represent the calcium ions coordinated by six 
phosphonate oxygen atoms shown in red. The phosphorus atom is represented by the purple, carbon black 
and hydrogen as grey spheres. 
 
The coordinating P-OH (H3) species is also involved in hydrogen bonding with 
O2 at a O3···O2 distance of 2.605(1) Å, and a DHA angle of 155.5 ° (Figure 7.5).  
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Figure 7.5. Three dimensional structure of 10, showing hydrogen bonds in blue dotted lines. 
 
There are several examples of bisphosphonates, some of which are calcium 
based,15,29-31,33 indicating the ligand’s affinity for Ca2+ ions.4 Compound 10 however 
represents a novel 3D species based on a non-substituted methylenebisphosphonic acid 
(H4MDPA). The only other alkaline earth based H4MDPA compound is the one-
dimensional Na3Mg(O3PCH2PO3)(µ-F)·H2O. 32 
In most bisphosphonate based compounds, the methylene hydrogen atoms in 
H4MDPA are substituted by OH, CH3, Cl or NH2.29,31,33-41 Notably, among these are 
dichloro methylenephosphonates, as reported in [Ca(CCl2(PO3H)2(H2O)5]n.29 The 
dichloro species contains a doubly deprotonated ligand, hepta-coordinated calcium, 
surrounded by phosphonate oxygen atoms and five water molecules; the chlorine atoms 
are not involved in the metal coordination. In analogy to the dichloro species 
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[Ca(CCl2(PO3H)2(H2O)5]n, the ligand in 10 is doubly deprotonated and coordinates the 
metal centers in a bidentate chelate fashion, a feature which is not observed in compound 
10.  
Another example of a calcium compound based on substituted H4MDPA is 
CaC(CH3)(OH)(PO3H)2(H2O)2 31 in which the coordination number of the calcium is 
eight. The predominant structural feature is a six membered chelate ring involving the P-
OH group as well as a five membered chelate ring involving the methylene hydroxyl 
groups.   
The mean Ca-O and P-O  bond distance in the dichloro species are 2.390(1) Å and 
1.530(9) Å respectively, the methyl/hydroxyl species values differ slightly  ((2.457(2) Å 
and1.5174(2) Å) but compare favorably with the respective Ca-O (2.353(3) Å) and P-O 
(1.535(3) Å) average distances in 10. Indicating the effect of ligand substitution, the Ca-
O bond lengths resulting from the methyl/hydroxyl substituted ligand is significantly 
longer (2.608(3).    
 
7.3.2 Heterobimetallic sodium calcium ethylenediphosphonate,       
         NaCa[HO3P(CH2)2PO3H2][HO3P(CH2)2PO3H]}n (11): 
The unique three dimensional heterobimetallic 11 was synthesized by sealing an 
aqueous solution of ethylenediphosphonic acid, Ca(NO3)2·4H2O, NaOH and concentrated 
HCl in a Carius tube at about 40 mTorr and keeping it at 170 oC for three days. Crystals 
of 11 grew from slow evaporation of solvent at room temperature. Compound 11 
crystallizes in the triclinic P-1 space group, crystal data, details of data collection and 
refinement of compounds 11 are provided in Table 7.1 in the experimental section of this 
chapter. 
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The asymmetric unit of 11 (shown in Figure 7.6) is comprised of one calcium and 
one sodium ion and two ethylenediphosphonate ligands with both metals in an inversion 
center. To achieve charge neutrality, one of the two ligands is singly deprotonated 
(H3EDP-), leaving three free OH groups on the two P-O while the other is doubly 
deprotonated (H2EDP2-). The compound has no water of crystallization.  
 
 
Figure 7.6. Labeling scheme in asymmetric unit structure of compound 11. 
 
The coordination sphere of Ca2+ is saturated by six phosphonate oxygen atoms to 
achieve a distorted octahedral environment, as represented by a wide variation of bond 
distances (Ca – O 2.267(3) – 2.385(3) Å) and angles (O-Ca-O 81.86(6)° - 101.78(9)°). Of 
the two diphosphonate ligands, the doubly deprotonated one is coordinating to calcium, 
while the other coordinates to sodium. The P=O, P-O- and P-OH moieties are 
distinguished by their difference in P-O bond lengths, with P=O the shortest (1.493(3), 
1.512(2), 1.506(2), and 1.488(2) Å), P=O- intermediate 1.514(2), 1.513(2) and 1.515(3) Å 
and P-OH the longest 1.591(3), 1.584(3), 1.581(3) and 1.561(3) Å. 
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All the metal centers are bridged by the O-P-O units, while the third P=O links 
alternating chains of calcium and sodium to form a sheet as shown in Figure 7.7. These 
sheets are joined by the organic linkers to form a pillared three dimensional structure. 
 
Figure 7.7. Structure of compound 11 showing the coordination environments of sodium (blue) and 
calcium (green) and bridging oxygen atoms (red) between the two metals. One of the carbon atoms (black) 
have been eliminated for clarity. 
 
Figure 7.8 displays the polyhedral form of the three dimensional structures of compound 
11 dipicting the pillared layered structure, typical of metal diphosphonates.16,42-52 
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Figure 7.8. Polyhedral form of compound 11, displaying the pillar layered structure. The phosphonate is 
represented by yellow tetrahedron, NaO6 by blue octahedron, CaO6 by green octahedron, oxygen red 
spheres and carbon black spheres.  
 
Considering the similar size of Ca2+ (114pm) and Na+ (116pm),11  the coordination 
environment of sodium is also distorted octahedral with Na-O bond distances ranging 
from 2.283(3) - 2.539(3) Å and O-Na-O  bond angles from 76.61(9) – 170.01(1)º. 
However, the coordination environment of Na+ is distinctively different from the 
coordination sphere of the Ca2+. While six oxygen atoms (O2, O3, O6, O7, O10, O12) 
from the two separate ligands coordinate, these six oxygen atoms form three donor sets 
comprising three P-OH (O3, O6, O12) groups, two P=O groups (O7, O10) and one 
deprotonated P-O- group (O2). Again, the distinction between the protonated and 
deprotonated oxygen sites can be made based on P-O distances, with P-OH the longest 
distances (1.591(2), 1.584(3), 1.561(3) Å), P-O- an intermediate distance (1.514(2) Å and 
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P=O groups have the shortest P-O bond (1.506(2), 1.488(2) Å)). There are two free 
pendant P-OH groups (O9 and O11) with long P-O bonds (1.581(3), 1.558(3) Å), 
however, these are shorter than the corresponding bridging P-OH distance (P-O3 
1.591(3) Å). Selected bond distances and angles of compound 11 are provided in Table 
7.3.  
 
Table 7.3. Selected bond lengths [Å] and angles [°] for sodium calcium ethylenediphosphonate 11    
Bond lengths                                     Bond lengths                                Bond angles___________________ 
 
Na(1)-O(2)#3    2.283(3) P(1)-O(1)        1.495(3)          O(2)#3-Na(1)-O(10)  170.01(1) 
Na(1)-O(10)      2.357(3) P(1)-O(2)        1.514(2)           O(7)-Na(1)-O(3)#1      76.73(9) 
Na(1)-O(7)        2.383(3) P(1)-O(3)        1.591(3)           O(2)#3-Na(1)-O(3) #1  98.53(9) 
Na(1)-O(3)#1    2.462(3) P(1)-C(1)        1.796(3)           O(2)#3-Na(1)-O(6) #1  94.02(1) 
Na(1)-O(6)#4    2.476(3) P(2)-O(4)        1.512(2)           O(7)#1-Na(1)-O(6)     165.49(9) 
Na(1)-O(12)#4  2.539(3) P(2)-O(5)        1.513(2)       O(4)-Na(1)-O(10)         78.70(9) 
Ca(1)-O(1)        2.267(3)        P(2)-O(6)        1.584(3) O(10)-Na(1)-O(3) #1    76.61(9) 
Ca(1)-O(8)#1    2.350(3) P(2)-C(2)        1.793(3)   Na(1)-O(10)-Ca(1)        97.88(9) 
Ca(1)-O(4)        2.366(3) P(3)-O(7)        1.506(2)   Ca(1)-O(7)-Na(1)          99.15(9) 
Ca(1)-O(7)        2.313(2)       P(3)-O(8)        1.515(3)  O(7)-Ca(1)-O(5)#2     167.54(9) 
Ca(1)-O(5)#2    2.347(3)       P(3)-O(9)        1.581(3)   O(1)-Ca(1)-O(8)#1     101.79(9) 
Ca(1)-O(10)      2.385(2) P(3)-C(3)        1.804(4)  O(1)-Ca(1)-O(4)           95.16(9) 
Ca(1)-O(10)      2.385(2) P(4)-O(10)      1.488(2) O(8)#1-Ca(1)-O(7)       87.08(9) 
 P(4)-O(11)      1.558(3) O(8)#1-Ca(1)-O(10)     84.03(9) 
 P(4)-O(12)      1.561(3) O(4)-Ca(1)-O(10)         78.70(9) 
 P(4)-C(4)        1.791(3)   
__________________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x,-y,-z+1    #2 -x,-y,-z    #3 x,y+1,z    #4 -x,-y+1,-z+1       
#5 x,y-1,z    #6 -x+1,-y,-z+1    #7 x+1,y,z    #8 x-1,y,z       
  
CHAPTER 7: Calcium Alkylene Diphosphonates                                                                   148 
 
The comparison of 11 with the barium analog Ba[HO3P(CH2)2PO3H]  reveals the 
influence of metal centers, with an increased coordination number, as shown in Figure 
7.9, with each oxygen atom originating from a different phosphonate group. 
 
Figure 7.9 Structure of barium ethylenediphosphonate, displaying the eight coordinate 
environment of Ba2+. All hydrogen atoms are eliminated for clarity.28 
 
Each ligand is doubly deprotonated and there are two types of bridging modes 
involving Ba-O-Ba and Ba-O-P-O-Ba fragments. Again this is an example of a pillared 
structure, with organic linkers extending the metal oxide sheets in a third dimension. The 
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Ba-Ba distance within each layer is 4.238 (1) Å but the interlayer distance based on the 
Ba-Ba centers are 6.498 (1) Å. The barium compound therefore has a more open structure 
than 11 whose interlayer distance is 5.4457(1) Å based on the calcium centers. 
Heterobimetallic ethylenediphosphonates involving transition and alkali metal are 
quite common, with combinations such as V/K, Co/Cs, Ga/K, Mo/K and Zn/Na.53  There 
is also an example of heterotrimetallic species containing Cu/K/V. 54  
Other related compounds include [NaZn(O3P(CH2)2PO3H], involving a triply 
deprotonated HEDP,3- in contrast to two differently deprotonated ligands in 11. The Zn 
center in the three-dimensional framework of [NaZn(O3P(CH2)2PO3H] has a tetrahedral 
geometry while Na has a distorted octahedral environment with an average Na-O bond 
distances of 2.463(1) Å;  not surprisingly, similar to those in 11 (2.417(2)Å. 
 
7.3.3 Calcium nitrate ethylenediphosphonate, [Ca2 (NO3)2(HO3P(CH2)2PO3H)(H2O)]    
         (12): 
            Large sword-like crystals of compound 12 grew in a sodium silicate nanohydrate 
gel prepared with ethylenediphosphonic acid (H4EDPA). The compound crystallizes  in 
the monoclinic C2/c space group.  Crystal data, details of data collection and refinement 
of compound 12 are provided in Table 7.1 in the experimental section of this chapter. 
The asymmetric unit of 12 contains one Ca2+, a nitrate, one water molecule, and 
half of a  ligand as indicated in Figure 7.10. The calcium center in 12 is coordinated by 
eight oxygen atoms; one from water (O1W), four from the diphosphonate ligand (2 O1 
and 2 O2), and three from the nitrate (O4, O5, O6).  
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Figure 7.10. Asymmetric unit of compound 12. Calcium is represented by green sphere, oxygen by red, 
phosphorus by purple and nitrogen by blue spheres. All hydrogen atoms have been removed for clarity. 
 
Each H4EDPA ligand is doubly deprotonated and bridges the calcium centers via 
O1 and O2. In addition O1 and O2, as well as two nitrate oxygen atoms (O4 and O5) bind 
to the Ca2+ ion, resulting in a sheet  structure as shown in Figure 7.11.  
 
 
Figure 7.11. 2D sheet of compound 12. Calcium is represented by green sphere, oxygen by red, 
phosphorus by purple and nitrogen by blue spheres. All hydrogen atoms have been removed for clarity. 
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In the sheet structure one oxygen atom is shared beteween two nitrogen atoms, 
indicating a 50 : 50 disorder of the O5 which has a 50% occupancy. 
The sheets are extended into a three-dimensional structure through interlayer 
hydrogen bonding involving the pendant OH groups on the diphosphonates and the 
metal-bound water molecule, with a O···O distance is of 2.726 Å and a DHA angle of 
146.2 o, indicating weak hydrogen bonding, as shown in Figure 7.12. Bond lengths and 
angles of 12 are provided in Table 7.5. 
 
 
 
Figure 7.12. Structure showing hydrogen bonds in blue dotted lines linking sheets of Ca in 12. 
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Table 7.4.  Selected Bond lengths [Å] and angles [°] for calcium ethylene nitrate diphosphonate 3 
_______________________________________________________________________ 
Bond length                                                                   Bond angles 
________________________________________________________________________ 
Ca(1A)-O(2A)#1  2.295(3)               O(2A)#1-Ca(1A)-O(1A)       158.23(10) 
Ca(1A)-O(1A)  2.304(2)               O(2A)#1-Ca(1A)-O(6A)        85.09(10) 
Ca(1A)-O(6A)  2.408(3)               O(1A)-Ca(1A)-O(6A)             83.07(9) 
Ca(1A)-O(1A)#2  2.476(3)               O(2A)#1-Ca(1A)-O(1A)#      271.59(9) 
Ca(1A)-O(5A)  2.493(3)               O(1A)-Ca(1A)-O(1A)#2        125.34(7) 
Ca(1A)-O(4A)  2.6368(8)             O(6A)-Ca(1A)-O(1A)#          285.52(9) 
Ca(1A)-O(2A)#2  2.641(3)               O(2A)#1-Ca(1A)-O(5A)          99.68(11) 
Ca(1A)-O(7A)  2.651(3)               O(1A)-Ca(1A)-O(5A)             95.93(10) 
Ca(1A)-Ca(1A)#4  3.9775(8)            O(6A)-Ca(1A)-O(5A)             166.78(12) 
P(1A)-O(2A)  1.513(2)              O(1A)#2-Ca(1A)-O(5A)           84.34(10) 
P(1A)-O(1A)  1.518(2)               O(2A)#1-Ca(1A)-O(4A)          87.31(11) 
P(1A)-O(3A)  1.557(3)               O(1A)-Ca(1A)-O(4A)              88.39(11) 
P(1A)-C(1A)  1.792(4)               O(6A)-Ca(1A)-O(4A)            135.43(8) 
O(4A)-N(1A)  1.488(6)               O(1A)#2-Ca(1A)-O(4A)         132.76(8) 
O(4A)-Ca(1A)#3  2.6368(               O(1A)-Ca(1A)-O(7A)               77.13(10) 
O(5A)-N(1A)  1.371)                 O(2A)#1-Ca(1A)-O(2A)#2      128.93(7) 
N(1A)-O(7A)#3  1.5(8)                 O(4A)-Ca(1A)-O(2A)#2           130.43(8) 
________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 x,y+1,z    #2 -x+3/2,y+1/2,-z+1/2    #3 -x+1,y,-z+1/2       
#4 -x+3/2,y-1/2,-z+1/2    #5 x,y-1,z       
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 Compound 12 is the only known phosphonate with nitrate embedded in its 
structure. More commonly, fluoride containing diphosphonates have been reported as a 
result of NaF addition to improve the crystallinity of products.55-59  
 
7.3.4 Calcium propylenediphosphonate, [Ca(HO3P(CH2)3PO3H)]n (13): 
            Calcium propylenediphosphonate 13 crystallizes from a solution containing 
calcium nitrate and propylenediphosphonic acid at room temperature. Compound 13 
crystallizes in the orthorhombic Pbcm space group. Crystal data, details of data collection 
and refinement of compound 13 are provided in Table 7.1 in the experimental section of 
this chapter. 
            Compound 13 is three-dimensional; the asymmetric unit is comprised of a half 
occupied calcium ion and one half of a dianionic ligand (Figure 7.13). Ca, C2, H3 and H4 
are all located on special positions (two fold) with occupancies of 0.5. 
 
 
Figure 7.13. Asymmetrical graphical representation of 13: indicating full atom labelling. 
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 The coordination number of calcium in 13 is eight. All six diphosphonate oxygen 
atoms ligand are coordinated to a Ca center, with O2 bridging two calcium centers. In 
addition, two chelate rings involving the Ca2+, O2 and O3 are observed as shown in 
Figure 7.14.  
 
 
Figure 7.14. Structure showing the eight coordinate Ca2+ centers, two chelates and O2 bridging in 13. 
 
 The structure is therefore propagated by Ca-O-Ca chains and linked by the O-P-O 
units into a sheet. Sheets of CaO polyhedral (Figures 7.15) are linked by carbon chains to 
form a three dimensional compound with a pillared layered structure, as displayed in 
Figure 7.16. 
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Figure 7.15 Sheet structure of compound 13. Calcium is represented by green spheres, oxygen in red, 
phosphorus in purple, carbon in black and hydrogen in grey spheres. 
 
 
Figure 7.16. Polyhedral representation of calcium propylenediphosphonate 13, showing the pillar layered 
structure carbons atoms are shown in black, phosphonate group as gold tetrahedron and CaO polyhedra 
represented in turquoise. 
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 By virtue of the long P-O3 distance (1.570(2) Å), compared with other P-O 
distances ranging from 1.505(2)-1.512(2) Å, it is the O3 that remains protonated. 
Selected bond distances and angles of 13 are provided in Table 7.5.  
         
Table 7.5 Selected Bond lengths [Å] and angles [°] for calcium propylene diphosphonates, 13. 
___________________________________________________________________________ 
Ca(1)-O(2)#1         2.385(2)                 O(2)#1-Ca(1)-O(2)#2                163.58(11) 
Ca(1)-O(2)#2         2.385(2)                 O(2)#1-Ca(1)-O(1)#3                83.64(8) 
Ca(1)-O(1)#3         2.395(2)                 O(2)#2-Ca(1)-O(1)#3                85.91(8) 
Ca(1)-O(1)#4         2.395(2)                 O(1)#3-Ca(1)-O(1)#4                100.78(11) 
Ca(1)-O(2)           2.426(2)              O(2)#1-Ca(1)-O(2)                  122.86(8) 
Ca(1)-O(2)#5        2.426(2)              O(2)#2-Ca(1)-O(2)                  70.15(9) 
Ca(1)-O(3)#5        2.864(3)              O(1)#3-Ca(1)-O(2)                  151.79(8) 
Ca(1)-O(3)           2.864(3)              O(1)#4-Ca(1)-O(2)                  91.44(8) 
P(1)-O(1)             1.511(2)              O(2)#1-Ca(1)-O(3)#5              123.20(7) 
P(1)-O(3)             1.566(2)              O(2)#2-Ca(1)-O(3)#5              68.54(7) 
P(1)-C(1)             1.793(4)              O(1)#3-Ca(1)-O(3)#5              86.49(7) 
                                                   O(2)-Ca(1)-O(3)#5                 71.25(8) 
                                                   O(1)#3-Ca(1)-O(3)                 150.76(7) 
                                                   O(3)#5-Ca(1)-O(3)                 100.98(10) 
________________________________________________________________________ 
 Symmetry transformations used to generate equivalent atoms: 
 #1 -x,y+1/2,z    #2 -x,-y,-z+1    #3 x-1,-y+1/2,-z+1 
  #4 x-1,y,z    #5 x,-y+1/2,-z+1    #6 -x,-y+1,-z+1 
  #7 x+1,y,z    #8 x,y,-z+1/2 
 
  
            Compound 13 represents the first propylenediphosphonate, prior alkaline earth 
examples are limited to a barium species, {Ba2[O3P(CH2)3PO3·3H2On, with a pillared 
layered three-dimensional compound comprised of BaO8 sheets connected by three-
carbon chains (Figure 7.17). The PDPA4- ligand is fully deprotonated, all the oxygen 
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atoms are involved in metal coordination. 
 
Figure 7.17. Pillared layered structure of Ba2[O3P(CH2)3PO33H2O]. Barium is represented by dark green 
spheres, phsophrus purple, oxygen red, carbon black and hydrogen by gray spheres. 
 
 Compounds 10, 11, 12 and 13 are all based on alkyl diphosphonates with varying 
carbon chain lengths, with a methylene unit in 10, ethylene in 11 and 12, and propylene 
in 13. There are major differences in their synthesis and crystallization as well as overall 
structural features, with metal coordination number of six (11) to eight (13). 
  
7.4 Conclusions 
Three-dimensional compounds of methylene, ethylene and 
propylenediphosphonate compounds have been prepared. By increasing the lengths of the 
alkyl linker in the diphosphonates and thereby increasing the interlayer distance, it is 
possible to achieve pillared layered compounds with a less dense framework.  
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7.5 Experimental 
7.5.1 Synthesis of calcium methylenediphosphonate, (10): 
            Methylenediphosphonic acid (0.1g, 0.056 mmol), phenylphosphinic acid (0.08g, 
0.056 mmol) and Ca(NO3)2·4H2O (0.15g, 0.056 mmol) were dissolved in 5 mL distilled 
water. The resulting clear colorless solution was sealed in a Carius tube at 40mTorr and 
kept at 150 oC for one week. Colorless crystals formed in the Carius tube from a 
yellowish green solution. Crystals were isolated by filtration, washed with water and air 
dried.  Yield: 0.009 g, 0.042 mmol  81 %; m.p.: 450 oC (decomposition);  IR (Nujol): 
2728.6(s), 1465.4(s), O-H 1378.6, 1304.6(m), 1154.4(m)  965.8(m), 722.3. 
 
7.5.2 Synthesis of sodium calcium ethylenediphosphonate (11):
 
Ethylenediphosphonic acid, H4EDA, (1 mL, 1.05 mmol, 1.05 M) and NaOH (1.05 
mL, 2.10 mmol, l2 M) were mixed in a 25 mL beaker and stirred for one minute, 
attaining a clear solution. To this, 1 mL of 1.05 M CaCl2 (1.05mmol) solution was added, 
upon which the solution turned cloudy under formation of a white precipitate. 100 µL of 
concentrated HCl were added, upon which the precipitate dissolved, resulting in a clear, 
colorless solution. 3 mL of distilled H2O were then added while stirring. The clear 
solution was transferred into a Carius tube and sealed under 40 mTorr of pressure. The 
tube was heated at 170 ºC for three days. The resulting clear solution was filtered. 
Colorless blocks of crystals formed within two weeks at room temperature. Yield 0.11 g 
0.25 mmol, 21.6 %. Yield: 0.07g, 0.30 mmol, 58.9%. IR (Nujol): 2724.1 (w), C-H 
1489.9(s), O-H 1376.2 (s), 1004.0(w), 722.5(m). 
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7.5.3 Synthesis of calcium nitrate ethylenediphosphonate (12):
 
Sodium metasilicate nano hydrate (12.20 g, 0.043 mol) was dissolved in 25 mL 
distilled water and warmed gently to dissolve the sodium metasilicate. In a separate 
beaker, ethylenediphosphonic acid (7.80 g, 0.041 mol) was dissolved in 25ml distilled 
water and warmed to 40 oC. The silicate was then added dropwise while stirring. The 
resulting clear colorless mixture was quickly transferred into 15cm x 2cm test tubes and 
left to stand for two days allowing the gel to set. To the surface of the set gel, about 1mL 
of calcium nitrate solution was added slowly. After about 5 weeks, large sword-like 
crystals grew in the tubes. Yield: 0.73 g, 0.003 mol 76 %. m.p.: 491 oC (decomposes); IR 
(Nujol): 3486.1(m), 2669.7(w) 1665.5(m), 1467.1(s), 1303.7(m), 1152.0(m), 1035.3(m), 
936.1(m), P-C 720.1(s), 609.3(w), 550.9(w). 
 
7.5.4 Synthesis of calcium propylenediphosphonate (13): 
Compound 13 was prepared by dissolving propylene diphosphonic (0.050g, 0.250 
mmol) of acid and Ca(NO3)2 ·4H2O (0.058 g, 0.250 mmol) in 4 mL of distilled water. 
The colorless clear solution was kept in a small vial at 85oC for three days. The clear 
solution was then left at room temperature until colorless crystals appeared after three 
weeks. Yield: 0.022 g, 0.045 mmol, 18.3 %; m.p.: 360 oC (decomposes); IR (Nujol): 
2728.9(m), 1488.3(s), 1389.5(s), 1304.4(m), 1154.6(w), 722.4(s). 
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7.6 Experimental Details 
Triethylphosphite (P(OEt)3), phenylphosphinic acid, Mg(NO3)2.6H2O, 
Ca(NO3)2.4H2O, CaCl2, NaOH, H3PO3, DMF, NH4Cl, CH2O, acetone, acetonitrile, 1, 3- 
dibromopropane and 1, 2-dibromoethane were obtained commercially. P(OEt)3 was 
distilled prior to use, while the other reagents were used as purchased. 1H NMR spectra 
were recorded using a Bruker DPX 300 spectrometer. A Perkin-Elmer PE 1600–FT-IR 
spectrometer was used to collect IR spectra as Nujol mulls between KBr plates. 
 
7.7 X-ray crystallography 
X-ray quality crystals of compounds 10 - 13, were grown as described above. 
Crystals were taken out of the solutions and covered with viscous hydrocarbon oil 
(Infineum). Using a microscope, suitable crystals were selected and attached to a glass 
fiber. The crystals were mounted onto a 3-circle goniometer under the nitrogen stream of 
the low temperature device. Crystallographic data of 10 - 13 were collected using a 
Bruker diffractometer equipped with a SMART CCD system, and using MoKα-radiation 
(λ = 0.71073 Å) at 96(2) K (10), 99(2) K(11), 100(2) K, (12) and 97(2) K (13).  Crystal 
data, details of data collection and refinement of compounds 10 – 13 are provided in 
Table 7.1. The structures of 10 – 13 were solved by direct methods with the aid of 
SHELXS-97 and the structures were refined withSHELXL-97.60  
Positions of hydrogen atoms of the hydroxyl groups on the phosphonate ligands 
were calculated; those on the on water molecules in 13, were however located from the 
Fourier difference map and refined freely. 
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Table 7.1.  Crystal data and structure refinement for compounds 10- 13 
 
       10           11        12        13 
Empirical formula CH4CaO6P2   C4H13CaNaO12P4 C4H8CaNO26P4 C6H16Ca2O12P4 
Formula weight 214.05   440.09      812.34 484.23 
Temperature (K) 96(2)   99(2) 100(2) 97(2) 
Wavelength (Å) 0.71073    0.71073  0.71073  0.71073  
Crystal system Monoclinic   Triclinic Monoclinic Orthorhombic 
Space group C2/c   P-1 C2/c Pbcm 
a (Å) 7.80(2)   8.38(1) 13.92(2) 5.50(1) 
b (Å) 8.03(2)   8.91(1) 6.97(1) 7.37(2) 
c (Å) 9.63(2)   10.46(1) 14.11(2) 19.05(3) 
α (°) 90   109.69(2) 90 90 
β (°) 102.68(2)   103.4 2(2) 103.95(2) 90 
γ (°) 90   93.28(2) 90 90 
Volume (Å3) 588.9(2)   706.93(2) 1329.2(3) 773.0(2) 
Z 
Dcalc(mg/mm3) 
4 
2.392 
  2 
2.068 
2 
2.030 
2 
2.080 
µ  (mm-1) 1.57   0.99 1.20 1.21 
Crystal size( mm3) 0.30   
 0.15  
 0.10 
  0.25  
0.18  
 0.06 
0.60   
0.35  
0.15 
0.30   
0.20  
0.10 
2θ range (°) 3.69-28.47   2.15-28.29 2.97-28.29 3.70-23.46 
Reflections collected 2516   7504 6452 4668 
Independent reflections 692   3482 1657 588 
R1 [I>2sigma(I)] 0.0311   0.0520 0.0525 0.0255 
wR2 [I>2sigma(I)] 0.1089   0.1242 0.1713 0.0626 
R1 (all data) 0.0316   0.0573 0.0549 0.0348 
wR2 (all data) 0.1105   0.1270 0.1733 0.0648 
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CHAPTER 8 
Synthesis and Characterization of Calcium amino trimethylenephosphonate 
8.1 Introduction 
         Recent research on metal organic frameworks (MOFs) has focused on 
predicting the dimension of the solids by careful choice of ligands.1-3 While the 
predictable preparation of design solids has not been achieved, may fascinating hybrid 
materials of different dimensions and with unique characteristic and functions have been 
prepared.4-6 In the preceding chapters, the chemistry of the mono- and diphosphonate 
alkaline earth metal based materials was discussed. The focus of discussion in this 
chapter is on the effect of the geometry of a triphosphonic acid ligand on the 
dimensionality of alkaline earth MOF structures.  
Phosphonates are good chelating agents, however the introduction of an amine 
group to form aminophosphonic acid has been shown to increase their metal binding 
abilities.7  Like the phosphonic acids, the aminophosphonic acids also form important 
medicinal compounds.8-10 Hence, ever since the first naturally occurring 2-
aminoethylphosphonic acid was discovered in living systems, the synthesis of the amino 
bis- and triphosphonic acids have been explored for their medicinal applications.11  
We herein present structural studies of alkaline earth metal compounds involving 
amino tris(methylenephosphonic) acid (H6ATMP), also called nitrilotrismethylene 
triphosphonic acid,  other abbreviations used  include ATMP,12 AMP,13 or H6ntmp.14 The 
structure of the H6ATMP ligand is shown in Figure 8.1, it’s synthesis and properties have 
been discussed in Chapter 3. 
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(pKa1 < 2, pKa2 < 2, pKa3 4.30, pKa4 5.46, pKa5 6.66, pKa6 12.34)15 
Figure 8.1. Amino tris(methylenephosphonic) acid  (H6ATMP) 
 
The chelating property of the  H6ATMP  makes it useful as scale inhibitor,16 
corrosion inhibitor,17-19 and as cement retarder to delay the setting time of cements.14 The 
polyphosphonic acids are also used in supramolecular chemistry and crystal engineering. 
In industry, triphosphonates have applications in oilfield drilling, mineral processing, 
corrosion control, metal complexation and sequestration.20 
Despite these special properties, the H6ATMP ligand has not been used 
extensively in coordination chemistry. Hence, studies on the synthesis and structural 
characterization of calcium amino triphosphonate (14) {Ca[HN(CH2PO3H)3]}n were 
conducted. These will expand insight into alkaline earth metal triphosphonate chemistry 
and promote the understanding of how an additional phosphonate moiety will affect the 
structural characteristics of the resulting MOFs. 
In analogy with diphosphonates, a variety of metal-ligand binding modes, as 
illustrated in Figure 8.2, are possible.  
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Figure 8.2.  Different binding modes of phosphonates in the alkaline earth amino trimethylene 
phosphonates compounds. 
 
 
Of these possibilities,. Table 8.1 gives a summary of alkaline earth AMTPA 
compounds and their respective binding modes.the compounds and their binding modes.  
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      Table 8.1. Binding modes of the alkaline earth metal amino trimethylenephosphonate compounds. 
Compound P1 P2 P3 
{Ca[HN(CH2PO3H)3]}n (14) µ2η1η1 µ2η2   µ2η1η1 
[Ca(HN(CH2PO3H)3)(H2O)]∞·3.5H2O 13,20  µη1 µ2η1η1 µ2η1η1 
{Mg[HN(CH2PO3H)3(H2O)3]}n 20  µ0 µ2η1η1 µη1 
{Sr[HN(CH2PO3H)3]}n20  µ2η1η1 µ3η2η1 µ2η1η1 
{Ba[HN(CH2PO3H)3(H2O)]}n 20  µ2η1η1 µ2η1η1 µη1 
 
 
8.2 Synthetic Considerations 
Advantages of using the amino trimethylenephosphonic acid as a ligand include 
solubility in water and increased denticity due to the larger number of phosphonate sites 
for metal-ligand interaction, as compared to the more common diphosphonates. 
Furthermore, the H6AMTP ligand has six acidic protons that may deprotonate to form 
anions with a range of charges. In addition, the ligand shows zwitterionic characteristics, 
as shown in Figure 8.3.21   
+ 2H +
 - 2H +
 
Figure 8.3. Amino trimethylenephosphonic acid (H6AMTP) in equilibrium with its zwitterions. 
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A closely related ligand demonstrating zwitterion behavior is 2-amino 
ethylphosphonic acid (Figure 8.4), with pKa values of 6.21 and 10.9222 for the acid 
dissociation.  
 
 
Figure 8.4. 2-aminophosphonic acid 
 
 Calcium amino trimethylenephosphonate (14) {Ca[HN(CH2PO3H)3]}n  is 
prepared by dissolving calcium nitrate and amino trimethylenephosphonic acid in water. 
Colorless crystals appear overnight at room temperature. Crystal formation can be 
accelerated in the presence of phosphonic acid, as shown in Scheme 8.1. 
 
Ca(NO3)2.4H2O  + nN(CH2PO3H2)3   
+  Ca(NO ) ⋅ 
H3PO3/H2O Ca[HN(CH2PO3H)3]
 
Scheme 8.1. Synthesis of calcium amino trimethylenephosphonate (14) 
 
The ease of coordinating amino trimethylenephosphonic acid ligand to metals is a 
result of its good solubility due to its zwitterionic form.20,21 By carefully selecting soluble 
metal salts, quality single crystals may be obtained even at room temperature. Crystals of 
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compound 14 were obtained at ambient and hydrothermal conditions; however those 
obtained hydrothermally at 200oC were of higher quality. Furthermore, initial 
crystallization attempts included the introduction of phosphonic acid, and it is believed 
that this promotes rapid crystallization.  
Previous alkaline earth metal amino trimethylenephosphonate compounds include 
[Ca(HN(CH2PO3H)3)(H2O)]n·3.5H2O,13,14,20  {Mg[HN(CH2PO3H)3(H2O)3]}n, 
{Sr[HN(CH2PO3H)3]}n and {Ba[HN(CH2PO3H)3(H2O)]}n,20 prepared under similar 
reactions conditions. Details of the synthesis of the novel anhydrous 
{Ca[HN(CH2PO3H)3] 14 and it’s structural parameters are herein discussed.  
 
8.3 Structural Aspects of Calcium amino trimethylenephosphonate, (14): 
         Compound 14 crystallizes in the monoclinic space group P21/c. The compound 
displays a three dimensional network with an octahedral calcium geometry. Crystal data, 
details of data collection and refinement of compounds 14 are provided in Table 8.2 in 
the experimental section of this chapter.  
 The asymmetric unit of 14 consists of one calcium and a triply deprotonated 
ligand and a protonated N, the result of the zwitterionic form of the ligand.  (Figure 8.5). 
The coordination environment of calcium in 14 (Figure 8.5) is completed by six 
phosphonate oxygen atoms from two symmetrically identical ligands. Each dianionic 
H4ATMP2- pairs with one the Ca2+ ion to maintain charge neutrality.  
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(a)                                                                                         (b) 
Figure 8.5. Figure a. The environment of one doubly deprotonated ligand in [Ca(H4ATMP]n.  The zwitter 
ion is indicated with the protonation of N. b. Structure of 14 showing zwitterionic effects in the amino 
trimethylenephosphonate.  The gold polyhedral represent the octahedral calcium (green sphere) 
environment while the blue, puple, black and grey spheres represent nitrogen, phosphorus, carbon and 
hydrogen atoms respectively. 
 
A calcium derivative involving the H6ATMP ligand has been reported previously 
in the form of the hydrated species [Ca(HN(CH2PO3H)3)(H2O)]n·3.5H2O. 13,14,20 This 
compound displays a sheet structure comprising of a central calcium coordinated by six 
oxygen atoms, five of which originate from the doubly deprotonated phosphonate ligand 
and one from a coordinated water molecule (Figure 8.6). In addition, the nitrogen center 
in the amino triphosphonate ligand is protonated. The protonation of the nitrogen is 
evident from the tetrahedral structure of the N with C-N-C bond angles of 110.96 - 
112.88 (1) ° (Table 8.3).  However N-H IR stretches for 14 were not observed.  
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Figure 8.6. The coordination environments of calcium in [Ca(H4ATMP]n (14 ). The octahedral geometry of 
calcium in 14 is comprised of six phosphonate oxygen atoms. All hydrogen atoms except those on the 
coordinating water molecule have been removed for clarity. 
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Table 8.3. Selected bond [Å] lengths and angles [o] for anhydrous calcium amino trimethylenephosphonate 
(14)   
____________________________________________________________________________________                 
Bond length                                                                                         Bond angle 
____________________________________________________________________________________ 
Ca(1)-O(1)#1          2.2592(1)          N(1)-C(2)          1.510(2)           O(1)#1-Ca(1)-O(2)          176.81(5) 
Ca(1)-O(2)              2.3121(1)          N(1)-C(3)#5      1.506(2)           O(2)-Ca(1)-O(7)#1            79.86(5) 
Ca(1)-O(7)#1          2.3284(1)          N(1)-C(1)#3     1.508(2)            O(1)#1-Ca(1)-O(8)            95.31(5)  
Ca(1)-O(8)              2.3371(1)           P(3)-C(3)          1.8322(2)        O(2)-Ca(1)-O(8)                 84.03(5) 
Ca(1)-O(5)#2          2.4428(1)           P(3)-O(9)          1.5714(2)        O(7)#1-Ca(1)-O(8)           163.25(5) 
Ca(1)-O(5)              2.5257(1)                                                             O(1)#1-Ca(1)-O(5)#2        90.50(5) 
P(1)-O(1)                1.4922(2)                                                             O(7)#1-Ca(1)-O(5)#2        98.11(5) 
P(1)-O(2)                1.5091(1)                                                             O(8)-Ca(1)-O(5)#2            87.13(5) 
P(1)-O(3)                1.5733(1)                                                             O(1)#1-Ca(1)-O(5)            85.59(5) 
P(1)-C(1)                1.8209(2)                                                             O(2)-Ca(1)-O(5)                 91.25(5) 
P(2)-O(4)                1.4970(2)                                                             O(7)#1-Ca(1)-O(5)             90.34(5) 
P(2)-O(5)                1.5214(1)                                                             O(8)-Ca(1)-O(5)                 85.41(5) 
P(2)-O(6)                1.5784(2)                                                             O(5)#2-Ca(1)-O(5)            171.22(2) 
P(2)-C(2)                1.829(2)                                                               N(1)#3-C(1)-P(1)              113.50(1) 
P(3)-O(7)                1.4950(1)                                                             N(1)-C(2)-P(2)                  118.00(1) 
P(3)-O(8)                1.5105(1)                                                             N(1)#4-C(3)-P(3)              120.48(1)    
______________________________________________________________________________________                                                     
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1/2,y+1/2,-z+1/2    #2 -x+1/2,y-1/2,-z+1/2       
#3 -x,-y+2,-z+1    #4 -x-1/2,y-1/2,-z+1/2    #5 -x-1/2,y+1/2,-z+1/2 
 
In 14, the calcium centers are linked by O-P-O units involving O1,O2 or O7,O8 
and by O5 as shown in Figure 8.7, resulting in two six-membered rings (Ca-O2-P1-O1-
Ca-O5) and (Ca-O2-P1-O1-Ca-O5), and an eight-membered ring (Ca-O2-P1-O1-Ca-O7-
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P3-O8). A three dimensional structure is achieved by extending above and below the six 
and eight membered ring systems (Figure 8.8). Ca –O bond distances (2.259(1) - 2.443(1) 
Å) as well as the P-O bond distances 1.492(2) - 1.578(2) Å of 14 compare favorably with 
those of [Ca(HN(CH2PO3H)3)(H2O)]n·3.5H2O (Ca-O 2.305-2.511 Å  and P-O1.483-1.569 
Å), slight variation are based on the different metal-ligand binding modes. 
 
 
Figure 8.7. Labeling scheme of [Ca(H4AMTP]n  showing chelating and bridging modes of the ligand in the 
extended sheet. All hydrogen atoms have been removed for clarity, except the ammonium hydrogen. 
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Figure 8.8. Extended three dimensional view of 14, all methylene and hydroxyl hydrogen atoms have been 
removed for clarity. 
 
 
Remarkably, the three-dimensional array in 14 is achieved without hydrogen bond 
interactions considering that 14 was prepared in water. Previous examples of hydrated 
ATMP species include M[NH(CH2PO3H)3(H2O)3] (M = Co, Mn, Ni, Cu Zn, Cd),23 in 
addition to [Ca(HN(CH2PO3H)3)(H2O)]∞·3.5H2O20 where the three-dimensional 
structures were obtained by extensive hydrogen bonding (H···O distance of 1.70-1.96 Å). 
For manganese hydrated and anhydrous phases exist Mn[NH(CH2PO3H)3(H2O)3] and 
[NH(CH2PO3H)3] has three dimensional structure.24 
As shown in Figure 8.9, pendant P-OH groups in 14 (O3, O6 and O9) generate a 
number of hydrogen bonds to the phosphonate oxygen atoms (O2, O4, O6 and O8) with 
average H···A distances of 2.11 Å and D-H···A angles that range from 126.6-177.0 o as 
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indicated in Table 8.4. In addition, there are hydrogen bonds from the N-H  group to O1 
and O4.  
 
Figure 8.9. Hydrogen bonding shown between phosphonate oxygen atoms (O2, O4 and O8) the pendant O-
H groups (H, H6 and H9) and N-H in compound 14. 
 
Table 8.4. Hydrogen bond distances and angles of 14 
                   ___________________________________________________________________ 
D- H ···A         d(D-H)         d(H···A)         <DHA          d(D···A) 
_____________________________________________________ 
N1-H1···O4            0.801          2.000             147.83            2.711 
N1-H1···O1            0.801          2.621             112.10            3.015 
 
O3-H3···O2            0.684          2.004             174.42            2.685 
 
O6-H6···O8            1.029          1.496             177.03            2.524 
 
O9-H9···O4            0.770         1.991              164.81            2.741 
O9-H9···O6            0.770          2.554             126.60            3.075 
_____________________________________________________ 
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The overall structural parameters of 14 and the hydrated form 
[Ca(H4AMTP)(H2O)]n·3.5H2O compare well, as shown in Figure 8.10. The main 
difference is that the three-dimensional hydrated phase is achieved via hydrogen bonding.  
 
 
 
 
 
Figure 8.10. Structure of the hydrated [Ca(HN(CH2PO3H)3)(H2O)]n·3.5H2O20 
 
showing the coordination 
environments of calcium  its extended structure. The octahedral geometry of calcium is comprised of five 
phosphonate oxygen atoms and one water molecule. All hydrogen atoms except those on the coordinating 
water molecule have been removed for clarity. 
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Figure 8.11. .Polyhedral structure of the hydrated compound,20  showing the phosphonates as pink 
tetrahedrons, calcium as green octahedrons, while the ammonium ion is represented by blue tetrahedrons. 
The water molecules are red spheres, lying in the space between parallel sheets of calcium 
trimethylenephosphonate. Hydrogen atoms have been removed for clarity. 
 
8.4 Powder Diffraction Pattern Studies 
The bulk purity of compound 14 was verified by X-ray powder diffraction. Figure 
8.12 shows an overlay of the powder patterns of 14 (red) and the hydrated form (black),20 
 
(calculated from single crystal data). The difference in the diffraction patterns indicates 
different structural composition between 14 and its hydrated form. 
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Figure 8.12. Powder diffraction
for  the hydrated form 
8.5 Thermogravimetric 
The thermogravimetric analysis of 
around 350 oC, with gradual weight loss to about 
phosphonate group, leaving about 76.25 % (wt) residue corresponding to Ca
                                  
 pattern for 14 in red. The black trace shows a calculated powder pattern
(calculated from single crystal data). 
 
 
Studies 
14 (Figure 8.13) indicated decomposition 
650 oC, consistent with the loss of one 
        179 
 
 
3(PO4)2.  
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Compound 14 is a novel anhydrous calcium triphosphonate. Most other 
trimethylenephosphonates contain at least one H
frequently results in hydrogen
structure is achieved without hydrogen bonding, making the compound 
robust. 
Amino trimethylenephosphonates 
prepared under similar conditions of low pH and ambient temperatures
equimolar amounts of the ligand and 
exception of strontium, all the compounds contain at least one coordinating water 
molecule. Figure 8.14 shows the coordination sphere of magnesium in
{Mg[HN(CH2PO3H)3(H2
W
ei
gh
t (
%
) 
                                  
13. Thermogravimetric analysis of [Ca(H2AMTP)]∞, 14. 
2O donor.The presence of water 
 bonding.23,25,26 In compound 14, a three-dimensional 
thermally quite 
compounds involving Mg, Sr and Ba have been 
,
20
alkaline earth metal chlorides in water.
 
O)3]}n,20 comprised of three phosphonate oxygen atoms and 
Temperature (oC)  
        180 
 
 by dissolving 
 With the 
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three water molecules. A zigzag chain is formed by the use of two ligand phosphonates to 
bridge the magnesium centers, leaving one phosphonate group uncoordinated (denoted by 
µ0 in Table 8.1). The three coordinating water molecules are involved in hydrogen 
bonding between the zigzag chains (Figure 8.15), resulting in a two-dimensional 
structure.  
 
Figure 8.14. Stucture of magnesium amino trimethylenephosphonate, showing the bridging between two 
Mg2+ centers by two phosphonate and the unbound phosphonate group. Dark green spheres represent 
magnesium ion, purple phosphorus, blue nitrogen, red oxygen, black carbon and grey hydrogen atoms. 
 
 
Figure 8.15. The octahedral geometry of magnesium in {Mg[HN(CH2PO3H)3(H2O)3]}n, ( dark 
yellow polyhedron), propagated in a zigzag chain fashion is shown. The phosphonate oxygen atoms are 
represented by red spheres, phosphorus as purple spheres, nitrogen (blue), carbon (black) and hydrogen 
black.  
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 Showcasing the role of metal diameter, the three dimensional anhydrous 
strontium compound {Sr[HN(CH2PO3H)3]}n, is hepta-coordinated, whereas the barium 
species {Ba[HN(CH2PO3H)3(H2O)]}n, displays a three-dimensional structure with two 
crystallographically independent Ba2+ centers. One Ba2+ is nine-coordinate while the 
other is ten-coordinate. As expected, M-O bond lengths increase with increasing metal 
size.  
Other structurally characterized examples involving amino 
trimethlenephosphonates of divalent metals include several Zn species such as 
Zn2[HO3PCH2NH(CH2PO3H)2], Zn[NH(CH2PO3H)(H2O)3], Zn[NH(CH2PO3H)3],18,24 
and Al,24 Cu,27 Cd,25,28 Ti,12,29 Mn,23  Pb30  and Pr.31 
As mentioned above, the H6ATMP ligand can deprotonate to various degrees, a 
rare example involving H5ATMP- exist,32 the most common anionic species  is 
H4ATMP2-, also observed in 14 but H2ATMP4- and the fully deprotonated form have also 
been reported.33  
 
8.6 Conclusions 
   Simple synthetic methods have been used to prepare a novel, anhydrous form of 
calcium amino trimethylenephosphonate. Synthetic studies of 14 have shown that the 
presence of phosphonic acid in the synthesis of compound 14 greatly improved crystal 
quality and isolated yield. This may be extended to other synthetic routes towards the 
preparation of phosphonate compounds.  
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8.7 Experimental 
Compound 14 was prepared by dissolving aminotrimethylenephosphonic acid, 
H6ATMPA, (0.1g, 0.334 mmol) in 5mL of water to afford a colorless clear solution. To 
this, Ca(NO3)2·4H2O  (0.0789 g, 0.334 mmol) and H3PO3 (0.088g, 0.107mmol) were 
added and stirred. The clear solution was left in a test tube at room temperature. Colorless 
blocks of single crystals were obtained overnight. Yield: 0.05g , 0.15 mmol, 50%. IR 
(Nujol): 3358.4(w), 2716.3(m), 1374.4(s), 12985(m), 937.6(m). Due to low solubility, 
NMR spectra could not be obtained.  
 
8.8 Experimental Details 
Amino trimethylenephosphonic acid was synthesized by the Mannich reaction34 
involving an amine, formaldehyde and phosphorous acid, as described in detail in chapter 
3. Ca(NO3)2·4H2O and H3PO3  were obtained commercially and used as received. A 
Perkin-Elmer PE 1600–FT-IR spectrometer was used to collect IR spectra as Nujol mulls 
between KBr plates. 
 
8.9  X-ray Crystallography 
X-ray quality crystals of 14 were grown as described above. Crystals were taken 
out of the solution and covered with viscous hydrocarbon oil (Infineum). Using a 
microscope, suitable crystals were selected and attached to a glass fiber. The crystal was 
mounted onto a 3-circle goniometer under a low temperature nitrogen stream of the low 
temperature device. Crystallographic data of 14 was collected using Bruker 
diffractometer equipped with a SMART CCD system, and MoKα-radiation (λ = 0.71073 
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Å) at 86(2) K. The structure of 14 was solved by the Direct Method with the aid of 
SHELXS-97; and the structures were refined with SHELXL-97.35 Positions of hydrogen 
atoms of the hydroxyl groups on the phosphonate ligands were placed on calculated 
positions and refined isotropically. The hydrogen atom on nitrogen in 14 was located 
from the Fourier difference map and refined freely. All other hydrogens of the ligand in 
14 were placed in calculated positions based on geometric considerations. Crystal data 
and structure refinement information is presented in Table 8.2. 
.
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Table 8.2.  Crystal data and structure refinement for compound 14  
 
 
 
  
                                   
Empirical formula  C3H10 O9CaNP3        
Formula weight  337.11 
Temperature (K)  86(2) 
Wavelength (Å)  0.71073  
Crystal system  Monoclinic 
Space group  P2(1)/n 
a (Å)  9.28(7) 
b (Å)  8.43(6) 
c (Å)  13.61(1) 
α (°)  90 
β (°)  96.44(1) 
γ (°)  90 
Volume (Å3)  1057.6(1) 
Z 
dcal(mg/m3) 
 4 
2.117 
µ  (mm-1)  1.087 
Crystal size( mm3)  0.40 x 0.20 x 0.15 
2θ range (°)  2.53-28.27 
Reflections collected  10267 
Independent 
reflections 
 2620 
R1 [I>2sigma(I)]  0.0275 
wR2 [I>2sigma(I)]  0.0766 
R1 (all data)  0.0300 
wR2 (all data)  0.0786 
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8.10 Thermogravimetric Studies 
Thermogravimetric analysis was performed using a Q-500 Quantachrome 
Analyzer (TA-Instruments). Compound 14 was loaded on a platinum pan. Purified 
nitrogen gas was used with a balance purge rate of 40 mL/min and a sample purge rate of 
60 mL/min. The temperature was ramped at 10 °C per minute until a final temperature of 
800° C was reached. At about 650 oC, about 23.75% of weight loss was recorded and a 
black residue remained in the pan.  
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CHAPTER 9 
 Conclusions 
The purpose of this project is to design magnesium and calcium based 
frameworks suitable as scaffolds for bone ingrowths or as potential biocompatible and 
bioactive additives to bone cement. In contrast to extensive work on transition metal 
bisphosphonates, very limited information is available on the main group counterparts, 
specifically alkaline earth metal based compounds. This thesis is exploring multiple 
synthetic avenues as well as crystallization methodologies to obtain samples suitable for 
structural analysis. Illustrating the synthetic challenges involved in the preparation of the 
target compounds, a range of synthetic methodologies was employed. Likewise, X-ray 
quality single crystals were grown using hydrothermal/solvothermal approaches, gel 
crystallization and slow evaporation, but at this time, no uniform methodology is 
emerging. However, one-dimensional calcium phosphinate, sheets of magnesium 
phosphonates, and finally three dimensional pillar layered calcium phosphonates, were 
synthesized by careful choice of ligand and reaction conditions. 
The outcome of this research has provided a library of calcium and magnesium 
based compounds with interesting structural features. Novel compounds obtained include  
a 1D calcium phenylphosphinate (1), 2D anhydrous calcium hydrogen phosphite (3), 2D 
magnesium ethylenediphosphonate (8), 2D magnesium propylenediphosphonate (9), 3D 
calcium methylenediphosphonate (10), 3D calcium sodium ethylenediphosphonate (11), 
3D calcium nitrate ethylenediphosphonate (12), 3D calcium propylenediphosphate (13) 
and 3D calcium amino trimethylenephosphonate (14). All novel compounds have been 
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successfully characterized by single crystal X-ray diffraction. Structural studies of the 
novel compounds and closely related alkaline earth metal phosphonates indicate there is a 
correlation between ligand type and compound dimensionality.  
Each of these compounds however required a different synthetic approach and 
even for closely related ligands that differ only by a single linker carbon atom such as 
ethylenediphosphonate (HO3P(CH2)2PO3H)2- and propylenediphosphonate 
(HO3P(CH2)3PO3H)2-, remarkable structural differences are observed. Crystalline 
products of compounds 3,  8, 10, 11 and 12 were all obtained by hydrothermal synthesis 
at temperatures ranging between 150 - 170 oC while crystals of 1, 9 and 13 were formed 
from solutions heated to 80 oC followed by slow evaporation at room temperature. In 
contrast, crystals of 12 were obtained only by gel crystallization while crystals of 14 
formed at room temperature. Synthetic studies of 14 have shown that, the presence of 
phosphonic acid in the synthesis of 14 greatly improved crystal quality and yields. 
The dimensions of the resulting compounds rely on the number of deprotonated 
oxygen atoms in the sample. These results outline the challenge to predict solid state 
structures as small changes in parameters often result in drastic structural effects. 
Another important structural feature observed among the three-dimensional 
methylene, ethylene and propylenediphosphonates is length of organic linker and their 
role in the interlayer distance of the resulting compounds. Mostly, with a linker length of 
two or more carbon atoms, it is possible to achieve pillared layered three-dimensional 
compounds, as in 11 and 13. The longer the length of the linker, the less dense the 
framework. 
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